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ABSTRACT 
In recent years, human exposure to nanofibres (i.e., fibres with diameters < 100 nm) has 
considerably increased due to their incorporation in a wide range of consumer products. 
As such, there is a growing concern that the distinctive physicochemical characteristics 
of nanofibres may lead to adverse human health effects, mainly by their inhalation in 
occupational settings. Several toxicological studies have indicated that some nanofibres, 
such as the MWCNT-7, display in vitro toxicity and induce pulmonary inflammation, 
fibrosis, granulomas and carcinogenesis in vivo. Others, like cellulose nanofibrills (CNF), 
seem biocompatible and promising for biomedical applications. Thus, the genotoxic 
effects of nanofibres must be deeply studied to identify their possible hazard, and new 
“omics” methodologies can uncover their underlying mechanisms of action. Moreover, 
distinctive genomic or epigenomic expression profiles may be biomarkers of 
occupational exposure to nanofibres. In this work, the two above-mentioned nanofibres 
are analyzed in vitro, and the toxic effects of MWCNT-7 compared to those of crocidolite 
asbestos. Cytotoxicity and genotoxicity were investigated through conventional assays, 
and the differentially expressed microRNA (DE miRNA) in alveolar epithelial cells 
exposed to MWCNT-7 or crocidolite identified by next-generation sequencing. The 
overall results demonstrate that MWCNT-7 is cytotoxic, genotoxic and immunotoxic. 
Notably, it induced nucleoplasmic bridges in alveolar cells, possibly due to its 
resemblance with the microtubules and physical interference with the mitotic spindle. 
Different viabilities and micronucleus frequencies were observed in alveolar cells when 
using a conventional monoculture or a co-culture of these cells with macrophages, which 
may be related to their epithelial-mesenchymal transition and consequent increase of 
cell resistance to apoptosis. Regarding CNF, at low concentrations it stimulates cell 
proliferation, whereas at higher ones it is moderately toxic. Although no immunotoxicity 
and no significant DNA damage were detected, low CNF doses induced micronucleus. 
Concerning the epigenotoxic study, several DE miRNA were identified in alveolar cells 
exposed to MWCNT-7 or crocidolite, and a unique set was identified for each exposure. 
Both materials caused common changes in pathways related to cell metabolism, cell 
growth and death, cell-to-cell communication, protein processing, and signal 
transduction. Other functional pathways were distinctively identified for each material that 
sugest particular mechanisms of action. Since most are cancer related, a network of DE 
miRNA and target cancer genes was constructed, highlighting the carcinogenic potential 
of both materials. 
Keywords: Occupational exposure, in vitro genotoxicity, carbon nanotubes, 
nanocellulose, miRNA expression. 
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RESUMO 
Nos últimos anos, a exposição humana a nanofibras (i.e., fibras com diâmetros <100 
nm) tem vindo a aumentar, devido à sua incorporação em vários produtos para consumo 
humano. Como tal, a preocupação de que as características singulares das nanofibras 
possam ter efeitos adversos na saúde humana tem-se intensificado, particularmente por 
inalação em contexto ocupacional. Diversos estudos toxicológicos indicam que certas 
nanofibras, como o MWCNT-7, têm toxicidade in vitro e induzem inflamação pulmonar, 
fibrose, granulomas e carcinogénese in vivo. Outras, como a celulose nanofibrilar (CNF), 
aparentam biocompatibilidade e são prometedoras para aplicações biomédicas. Desta 
forma, é essencial aprofundar o estudo sobre a sua genotoxicidade para conhecer a sua 
perigosidade. Neste contexto, as metodologias “ómicas” permitem compreender os 
mecanismos de ação das nanofibras e, além disso, os perfis genómicos ou 
epigenómicos podem ser úteis como biomarcadores de exposição ocupacional. Neste 
trabalho, as nanofibras acima citadas são analisadas in vitro, sendo o MWCNT-7 
comparado à crocidolite (amianto). A citotoxicidade e genotoxicidade são analisadas 
pelos ensaios convencionais, sendo ainda identificados quais os microRNA 
diferencialmente expressos (miRNA DE) nas células alveolares expostas ao MWCNT-7 
ou à crocidolite, por sequenciação de nova geração. Os resultados globais indicam que 
o MWCNT-7 é citotóxico, genotóxico e imunotóxico. De realçar a indução de pontes 
nucleoplásmicas nas células alveolares, provavelmente relacionadas com a 
semelhança do MWCNT-7 aos microtúbulos e interferência com o fuso mitótico. A 
diferente viabilidade e frequência de micronúcleos nas células alveolares em 
monocultura ou co-cultura com macrófagos pode estar relacionada com a sua transição 
epitelial-mesenquimal e aumento da resistência à apoptose. Quanto à CNF, observou-
se proliferação celular nas doses baixas e citotoxicidade moderada nas doses mais 
elevadas. Embora não se tenham detetado danos significativos no DNA ou 
imunotoxicidade, foram induzidos micronúcleos nas doses baixas. No que respeita ao 
estudo de epigenotoxicidade, foi identificado um conjunto único de miRNA DE nas 
células expostas ao MWCNT-7 ou à crocidolite. Ambos os materiais causaram as 
mesmas alterações em vias de metabolismo celular, crescimento e morte celular, 
comunicação célula-a-célula, processamento proteíco e transdução de sinal. Outras 
vias distintamente alteradas sugerem mecanismos de acção específicos. Uma vez que 
a maioria está associada a cancro, foi construída uma rede entre miRNAs DE e genes 
alvo associados a cancro que realça o potential carcinogénico de ambos os materiais. 
Palavras-chave: Exposição ocupacional, genotoxicidade in vitro, nanotubos de carbono, 
nanocelulose, expressão de miRNAs. 
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1.1. Occupational exposure to nanomaterials 
Worker safety and health is a cornerstone of an emergent technology responsible 
development, because workers are the first population group likely to be exposed to the 
products of that technology and the workplace offers the first opportunity to develop and 
implement responsible practices1. Already in 2015, the Institut de Recherche Robert-
Sauvé en Santé et en Sécurité du Travail (IRSST) of Québec has estimated that about 
10% of manufacturing jobs worldwide were associated with nanotechnologies, and more 
than 2.000 commercial products contained nanomaterials (NM)2.  
Nanotechnology is a fast-evolving multidisciplinary field that comprises the production of 
materials in the nanoscale, i.e., with a size range from approximately 1 to 100 nm3. Below 
100 nm, the ratio between the particle surface area and its mass increases exponentially, 
exerting a strong reactive effect on the adjacent materials4. Nanotechnology has been 
producing different types of manufactured NM that hold unique interesting electrical, 
mechanical and thermal properties for applications in science, technology, medicine and 
industry. These include carbon-based NM (e.g., fullerenes and carbon nanotubes), metal 
NM (e.g., Au), oxide NM (e.g., TiO2), organic NM (e.g., dendrimers), among others. NM 
can be grouped according to their external dimensions (figure 1). 
  
 
Figure 1. Hierarchy of terms related to nano-objects (from ISO/DRT12885:2017) 
 
Occupational exposure to NM, during their production or incorporation into products, is 
more likely to happen when they are dispersed in the environment, particularly in the air 
or in liquid suspensions that may form aerosols, and, consequently, inhalation is the most 
probable route of exposure. In the workplace, this can happen during several stages: (i) 
production of solid NM in open or poorly sealed enclosures; (ii) handling of nanometric 
powders or liquid suspensions; (iii) packaging, storing or transport; (iv) incorporation into 
matrices; (v) mechanical work on products containing NMs; (vi) aerosol application; (vii) 
leaning of equipment, work areas and ventilation systems; (viii) repair and maintenance 
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of equipment; (ix) leaks, accidental spills, equipment malfunction, and (x) waste 
management2. 
Previous studies on human exposure to ultrafine aerosols, atmospheric pollution and 
manufactured mineral fibres have demonstrated the association between small-scale 
material exposure and respiratory disease5,6,7,8. Concerning manufactured NM, several 
in vitro and in vivo toxicological studies have shown that the very same properties of NM 
that are intentionally exploited may have detrimental biological effects. These are 
associated with their physicochemical properties, including chemistry, size, shape, 
surface area, solubility, surface reactivity, charge, functional groups at the surface, 
crystalline structure, tendency to agglomerate and the presence of impurities9. One 
group of NM that has been a cause of concern about their potential hazard to human 
health is nanofibres, which refer to nano-objects with two similar dimensions in the 
nanoscale and the third dimension significantly larger3. 
The IRSST has published a best practices guide for handling NM, recommending a 
preventive approach designed to minimize occupational exposure on a case-by-case 
basis, taking into account the risk assessment of each workstation2. The recommended 
measures for preventing workplace exposure to nanofibres are listed in table I.  
 
Table I. Summary of the measurement operations and recommendations for fibrous nanoparticles of the 
Institut de Recherche Robert-Sauvé en Santé et en Sécurité du Travail (IRSST).  
NM type 
Type of 
Enterprise 
Potential 
Exposure 
Airborne 
particle 
size (nm) 
Controls 
Specific recommendations 
based on emission readings 
at workstations 
Nano 
cellulose 
Research/ 
Production 
Grinding 
Production 
Sieving 
Cleaning 
[5–40] Fume hood 
Capture NMs at source 
Repair and maintain general 
ventilation 
Follow recommendations for 
fume hood use 
Modify work practices 
Set up a respiratory protection 
program 
Single-
walled 
carbon 
nanotubes 
Producer 
Collection 
Cleaning 
[200–
10,000] 
Fume hood 
Contained production room 
Locker room adjoining work area 
Respiratory protection 
(APF=100) 
Follow recommendations for 
fume hood use 
Revise respiratory protection 
program and 
Conduct airtightness tests 
Multiwalled 
carbon 
nanotubes 
Research/ 
Integration 
Homogenization 
Thermal analysis 
Milling 
[24–500] 
Glove box 
Respiratory protection (APF=10) 
Change gloves in glove box 
Do the homogenization under 
a fume hood 
Modify polishing and sawing 
practices 
Maintain respiratory protection 
program 
Carbon 
nanofibres 
Research/ 
Integration 
Collection 
Cleaning 
[100–400] 
Contained area 
Double locker room adjoining 
work area 
Fume hood 
General ventilation (20 air 
changes/h) 
Respiratory protection (APF=25-
1,000) 
Follow recommendations for 
fume hood use 
Modify locker room exit 
sequence 
Maintain respiratory protection 
program 
APF: assigned protection factor. 
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1.1.1. Carbon nanotubes and cellulose nanofibrils 
Carbon nanotubes (CNT) are one of the most promising and widespread class of NM. 
CNT consist of graphite sheets with a cylindrical arrangement, displaying various 
lengths, and a diameter within the nanoscale. They can have a single wall (SWCNT) or 
multiple walls (MWCNT) assembled in concentric layers, and can be functionalized by 
the introduction of specific elements, other than carbon, on the pristine CNT (figure 2). 
 
 
Figure 2. A scheme showing how graphene could be ideally rolled-up to form single- or multi-walled carbon 
nanotubes10. 
 
Only in relation to SWCNTs, more than 50,000 potential combinations existed in 2012, 
depending on structural types, length, manufacturing and purification processes, and 
surface coatings11. According to the ISO/TS 80004-4:2011, CNTs are hollow nanofibres, 
although the National Institute for Occupational Safety and Health (NIOSH) distinguishes 
between a carbon nanofibre and a CNT depending on the graphene plane alignment (if 
the graphene plane and fibre axis do not align the structure is defined as carbon 
nanofibre; when they are parallel, it is a CNT).  
CNT display unique physicochemical properties: they are mechanically strong, flexible, 
lightweight, heat resistant, and have high electrical conductivity. Currently, they have 
several industrial and biomedical applications, including electronics, lithium-ion batteries, 
solar cells, super capacitors, thermoplastics, polymer composites, coatings, adhesives, 
biosensors, enhanced electron-scanning microscopy imaging techniques, inks, as well 
as in pharmaceutical/biomedical devices for bone grafting, tissue repair, drug delivery, 
and medical diagnostics1 (figure 3). 
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Figure 3. Carbon nanotubes applications (available at http://www.meijo-nano.com/en/ applications/ 
use.html). 
 
The highest release of CNT has been detected during their production and handling, and 
cleaning of the production reactors, and ranged from 0.68 to 38 μg/m3 in the personal 
breathing zone of workers that performed key work operations and procedures in 11 on-
site exposure studies in different workplaces12. To date, several professional and 
scientific organizations assumed a precautionary approach and agreed in that there is 
sufficient information for CNT to be regarded as an occupational hazard13. NIOSH set a 
recommended exposure limit (REL) of 1 µg/m3 elemental carbon as a respirable mass 
8-hour time-weighted average (TWA) concentration1, even if this limit seems lower than 
some values that have been measured on-site12. 
Another emergent-engineered nanofibre is nanocellulose. Nanocellulose exhibits unique 
characteristics that include high tensile strength and stiffness, besides being renewable 
and biodegradable in nature14,15,16. Nanocelluloses can be divided in different categories, 
according to the source, methodology and final characteristics. These are bacterial 
nanocellulose, nanocrystalline cellulose - also known as cellulose nanocrystals or 
nanowhiskers - and cellulose nanofibrils (CNF) - also referred to as cellulose nanofibres 
or nanofibrillated cellulose. CNF are usually obtained from wood, cotton, hemp, flax, 
sugar beet or potato tuber. Depending on the source and on the production method, the 
size of the fibrils can vary significantly, but usually nanofibrils are defined as materials 
with diameters inferior to 100 nm and lengths in the micrometre scale (TAPPI standard 
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proposal WI3021)17,18. CNF have exceptional high mechanical resistance and low 
density, being a prime candidate for strength-enhancement of the mechanical properties 
of other composite materials, such as paper, carton and packaging materials. They also 
have a wide array of applications in the form of gels or emulsions, e.g., as a rheology 
modifier. Due to its likely biocompatibility, CNF have been investigated in regenerative 
medicine as scaffolds for tissue-engineered meniscus, blood vessels, ligaments or 
tendons19,20,21,22. Other biomedical applications of CNF are on wound healing23,24,25,26,27, 
stem cell decorated threads for surgical suturing28, haemodialysis membranes29, long-
lasting sustained drug delivery systems30 or 3D cell culture scaffolds31,32,33 (figure 4). 
 
 
Figure 4. Nanocellulose potential applications (available at https://www.researchgate.net/publication/ 
313618565_Cellulosic_Biocomposites_Potential_Materials_for_Future). 
 
Currently, there are no occupational exposure limits (OEL) or recommended exposure 
limits (REL) for nanocellulose. The NIOSH REL for bulk cellulose particles is 10 mg/m3 
for total dust and 5 mg/m3 as a respirable fraction, both expressed as a TWA. The 
Occupational Safety and Health Administration (OSHA) permissible exposure limits are 
15 mg/m3 and 5 mg/m3, both as TWA. However, based on previous knowledge about the 
adverse effects of other nanofibres, e.g., CNT, it is expected that the high aspect ratio of 
CNF and its biodurability in the human lungs34 increases its toxicity compared to that of 
bulk cellulose.  
20 
 
A study by Vartiainen et al. (2011) concluded that workers’ exposure to particles in the 
air during grinding and spray drying of birch cellulose was low or non-existent with the 
implementation of appropriate protection equipment and proper handling35. The NIOSH 
in partnership with the Forest Products Laboratory conducted two exposure 
characterization studies to evaluate the potential for occupational exposure to cellulose 
nanocrystals and CNF. The results indicated that nanocellulose is aerosolized during 
centrifugation, handling of dry product, and production and manipulation of nanocellulose 
polymer composites, but none of these measures exceeded the applicable OEL for 
cellulose36,37. 
 
1.1.2. Biomarkers of exposure to nanofibres 
Biological monitoring assesses human exposure to occupational hazardous substances 
through biomarkers. A biomarker is a chemical, its metabolite, or the product of an 
interaction between a chemical and some target molecule or cell that is measured in the 
human body38. In addition to exposure biomarkers, the consequent biological effects and 
the individual susceptibility to the risk factor are characterized by biomarkers of early 
biological effect and biomarkers of susceptibility, respectively39. At present, biomarkers 
suitable for routine biomonitoring of occupational exposure to nanofibres are not 
available, representing a challenging task of extreme importance in occupational health 
research. The evaluation of early biological effects associated to human exposure to NM 
has been based on the evaluation of oxidative stress markers, antioxidant enzyme 
activity, expression of acute phase proteins or alterations in the distribution of lymphocyte 
subclasses40. These effect biomarkers, although highly sensitive, are influenced by other 
non-occupational factors and are not specific for NM-induced damage, although their 
validity may improve through their combined use41.  
According to a 2013 NIOSH guideline, the health surveillance and medical monitoring of 
workers exposed to CNT should include: i) a nonspecific initial evaluation of the medical 
and occupational history of the worker, with emphasis on the respiratory system 
(including the use of a standardized questionnaire for respiratory symptoms); ii) a 
physical examination that may include spirometry testing and iii) a baseline chest X-ray, 
and iV) other tests deemed appropriate for each case. Then, an annual update of the 
occupational and medical history, and a spirometry test at least every 3 years should be 
performed1. These are useful medical procedures to detect illness, but it would be more 
valuable to detect early adverse effects before they are noticeable, in order to prevent 
further exposure and the clinical manifestation of disease. 
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One of the few published studies on workers exposed to MWCNT described a significant 
increase in interleukin 1β (IL-1β), interleukin 6 (IL-6), tumour necrosis factor α (TNF-α), 
inflammatory cytokines, and Krebs von den Lungen-6 (KL-6), a serological biomarker for 
interstitial lung disease, in the sputum of these workers. Moreover, transforming growth 
factor beta 1 (TGF-β1), a known regulator of fibrosis, was increased in the serum from 
the youngest exposed workers42. Besides providing possible biomarkers, this study 
confirmed the adverse health effects from human occupational exposure to MWCNT. 
 
1.2. Assessment of nanofibres toxicity  
Toxicological studies aim to predict the health effects caused by exposure to a given 
substance or agent, thus reducing the risk to humans associated with its hazard. In vitro 
toxicological studies are typically conducted prior to in vivo studies with the objective of 
evaluating if the tested compound interacts with the cellular components or its functions, 
leading to alteration or disruption of cellular homeostasis. In vitro conventional 
toxicological assays evaluate, among other endpoints, the substance effect on cell 
viability (cytotoxicity) leading to cell death through apoptosis or necrosis, and the direct 
or indirect damaging effects on DNA or chromosomes, such as gene mutations and 
chromosomal aberrations, respectively (genotoxicity) that can ultimately lead to 
carcinogenicity. To date, several in vitro and in vivo studies have characterized the toxic 
effects of CNT; a literature review is presented in Chapter 2, as well as the limitations of 
in vitro and in vivo studies to predict human adverse effects. On the contrary, few studies 
have assessed CNF toxicity, and they are summarised in Chapter 3, where the 
genotoxicity assessment of a CNF is reported. 
Large-scale gene expression studies and epigenomic studies are increasingly being 
used in toxicology as a promising new area of research. Through the identification of the 
differentially expressed genes following exposure to a toxicant, a global overview of all 
molecular pathways that are modified in the cell, tissue or organism is achieved in a time- 
and dose-dependent manner. An example of the potential of these new approaches to 
generate more comprehensive data is presented in Chapter 2, where a functional 
pathway and gene ontology analysis were performed from transcriptomic data available 
in the literature.  
Regarding epigenotoxicity, there is evidence that NM possibly cause epigenetic 
alterations43,44, i.e., histone modifications, changes in DNA methylation and changes in 
microRNA (miRNA) expression (figure 5). 
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Figure 5. Different epigenetic mechanisms for regulating gene expression: histone tail modifications, 
changes in DNA methylation and different miRNA expression. 
 
Concerning miRNAs, they are small non-coding RNAs involved in nearly all key 
biological processes45, usually acting as endogenous repressors of gene activity via 
transcriptional repression and degradation of mRNA (figure 6). Lung has a specific 
miRNA expression profile, and several pulmonary diseases such as chronic obstructive 
pulmonary disease, asthma, cystic fibrosis, pulmonary hypertension and lung cancer 
have been associated with alterations in the expression of lung related miRNAs46,47,48.  
Moreover, miRNAs are highly sensitive, reproducible, specific and stable in serum49 and 
its expression patterns have been successfully evaluated in a wide range of solid cancers 
as promising biomarkers of early disease onset or relapse50. Differential expression of 
cell-free circulating miRNAs after exposure to a toxicant has been considered a 
promising area of research to identify biomarkers suitable for monitoring human 
exposure. For example, in mouse, serum miR-122 demonstrated a sensitivity at least as 
good as alanine aminotransferase and aspartate aminotransferase to predict liver 
adverse effects induced by silica51 and miR-103 has been suggested as a possible 
biomarker for mesothelioma using the cellular fraction of human peripheral blood52.  
Chapter 2 presents an extensive review of the transcriptomic and epigenomic studies of 
CNT exposure, performed in vitro and in rodents. In addition, the results of the functional 
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analysis of differentially expressed miRNA in cells exposed to a MWCNT or crocidolite 
are displayed in chapter 4. As to CNF, no such studies were found in the literature. 
 
Figure 6. In the nucleus, DNA is transcribed by the RNA polymerase II (Pol II) or Pol III enzyme into the 
primary miRNA (pri-miRNA). The pri-miRNA transcript folds into a single or a cluster of multiple hairpin 
structures that are cleaved by the complex formed by the enzyme Drosha, a nuclear RNase III, and the RNA 
binding protein cofactor DGCR8 (also known as Pasha). This 60–70 nucleotides stem-loop structure, the 
precursor miRNA (pre-miRNA), is transported across the nuclear membrane by Exportin 5. In the cytoplasm, 
the hairpin loop of the pre-miRNA is cropped off by Dicer, a second RNase enzyme, leaving a miRNA duplex 
that is unwound by a helicase. This single-stranded miRNA is cleaved into a mature miRNA (18–25 
nucleotides), and integrated into an RNA-induced silencing complex (RISC). RISC incorporates an 
Argonaute protein that cleaves the target mRNA strand in the 3' untranslated region (UTR) complementary 
to their bound miRNA, inhibiting protein translation or degrading the mRNA itself. 
 
1.3. Research objectives 
As the number of nanofibres produced and the spectrum of their application grow, also 
the number of workers exposed to nanofibers, e.g., the MWCNT-7, has been greatly 
increasing. Consequently, there is a huge demand for accurate and rapid testing of NM 
safety in vitro, in order to infer their potential impact on human health. For this purpose, 
it is not only important to deepen their in vitro toxicological characterization, but also to 
investigate the mechanisms behind their biological effects at molecular, cellular and 
organismal levels, particularly through the application of innovative high throughput 
methodologies. In view of the stated above, this research has two general aims: i) to 
contribute to the assessment of the potential impact of occupational exposure to 
nanofibres on the health of exposed workers, and ii) to discover new biomarkers of 
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exposure to MWCNT-7 and its early biological adverse effects, based on an epigenomic 
approach. To this end, the specific goals to be achieved are: 
i) Gathering background information about the CNT pulmonary toxicity and identify gaps 
in knowledge that need to be investigated, particularly, using new approaches; 
ii) Characterization of the in vitro pulmonary cytotoxicity and genotoxicity of MWCNT-7 
comparatively to that of crocidolite, a well characterized asbestos fibre; 
iii) Characterization of the in vitro pulmonary cytotoxicity and genotoxicity of CNF; 
iv) Application of novel “omics” approaches to identify miRNAs that can represent 
possible biomarkers of respiratory exposure to MWCNT-7 and also the cellular pathways 
that are altered by the up- or down-regulation of their target genes, as compared to 
crocidolite. 
 
1.4 Experimental approaches used in this research 
To achieve the specific above-mentioned goals, the experimental design used in this 
research, which will be presented in the next chapters, is shown in figure 7. 
 
Figure 7. Schematic representation of the workflow developed in the following chapters of this thesis. DE - 
differentially expressed. White boxes represent the techniques used while grey boxes represent the 
objectives for their use. 
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1.4.1. Implementation of a co-culture cell model 
A co-culture of alveolar epithelial cells (A549) and macrophages (THP-1) was 
implemented in an attempt to better mimic the human lung epithelium, as detailed in the 
“Materials and Methods” section of the following chapters 3 and 4.  
The A549 cell line (ATCC, Manassas, VA, USA, CCL-185) is a human alveolar type II 
epithelial cell line derived from a human lung adenocarcinoma53, and the human 
monocytic cell line THP-1 (ATCC, TIB-202) is derived from the blood of a boy with acute 
monocytic leukemia54.  
A first step to optimize the differentiation of monocytes to macrophages was to evaluate 
the 12-O-tetradecanoylphorbol-13-acetate (TPA) concentration that resulted in 
macrophages that better resembled the phenotype of human monocyte-derived 
macrophages. For this purpose, THP-1 cells were incubated with 10, 20, 50 and 100 
ng/mL of TPA for 24 h and 48 h. Some of the macrophages features are: adherence to 
surfaces, altered morphology into flat and amoeboid cells with increased cytoplasmic 
volume, enhanced cytoplasmic granularity with well-developed Golgi apparatus, rough 
endoplasmic reticula and many ribosomes, and increased auto-fluorescence55. Based 
on the cells adherence capacity and morphology (figure 8), the condition chosen 
consisted of a TPA concentration of 100 ng/mL during 48 h, followed by a resting period 
of 48 h in serum-free medium. 
 
 
Figure 8. THP-1 cells after 48 h incubation in culture medium only (A) and supplemented with100 ng/mL 
TPA (B), followed by a resting period of 48 h in serum-free medium without TPA. 
 
To set up the co-culture, A549 cells were cultured on 12–well plates at a density of 
0.5x105 cells/mL. THP-1 cells were cultured in transwell inserts with a nominal pore size 
of 0.4 µm at a density of 0.2x105 cells/mL and, following differentiation, they were placed 
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on top of the A549 cells. Both cultures were grown in RPMI 1640 medium supplemented 
with 10% heat-inactivated foetal bovine serum, 1% penicillin/ streptomycin and 1% 
fungizone at 37 ºC in 5% CO2. The resulting co-culture presented a proportion of one 
macrophage per five epithelial cells, which mimic the normal proportion of these cells in 
human lungs56. 
 
1.4.2. Nanofibres and crocidolite characterization 
The MWCNT-7 (Mitsui-7) used in this work was provided as a sub-sample (NRCWE-
006) by the National Research Centre for the Working and Environment 
(http://ihcp.jrc.ec.europa.eu/our_activities/nanotechnology/nanomaterials-repository/list 
_materials_JRC_rep_oct_2011.pdf) in the context of the European NANOGENOTOX 
project (www.nanogenotox.eu). Its physicochemical characteristics are listed in detail in 
table I, included in the Materials and Methods section of Chapter 4. 
The cellulose nanofibrills were produced and characterized by the Department of 
Chemical Engineering of the University of Coimbra, and their physicochemical properties 
are described in Chapter 3. 
The crocidolite standard reference material was obtained from the Union for International 
Cancer Control (UICC, Geneva, Switzerland) and was kindly provided by the Department 
of Environmental Health of the INSA. Their preparation and characterization was 
described in detail in several publications57,58,59,60.  
 
1.4.3. Cytotoxicity and genotoxicity assessment  
Three different citotoxicity assays were applied in this study, as shown in figure 7:  
- The MTT assay, which is based on the ability of metabolically active viable cells to 
use NAD(P)H-dependent cellular oxidoreductase enzymes to reduce the tetrazolium 
dye MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to insoluble 
formazan. This is a purple coloured product whose  absorbance is 
spectrophotometrically read at 570 nm, being its intensity directly related to the 
number of viable cells61; 
- Determination of the lactate dehydrogenase (LDH), a cytosolic enzyme that is 
released into the culture medium from cells with a damage membrane (non-viable 
cells). The LDH released into the culture medium is measured with an enzymatic 
assay that converts resazurin into a fluorescent resorufin product. The amount of 
fluorescence produced is proportional to the number of lysed cells62. 
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- The clonogenic assay, also called colony forming efficiency, a cell-surviving assay 
that measures the retained ability of a single cell to form a large number of progeny 
after exposure to xenobiotics63. 
The evaluation of the genotoxicity of nanofibres and crocidolite was performed by the 
comet assay and its modified form, and the cytokinesis-block micronucleus (CBMN) 
assay: 
- The comet assay allows the quantification of DNA single and double strand breaks 
and alkali-labile sites that, under alkaline electrophoresis conditions (pH > 13) of 
previously lysed cells that are embedded in low melting point agarose and spread on 
agarose-precoated microscope slides, migrate further towards the anode than the 
cell nucleoid, appearing as “comets” on a fluorescence microscope. Scoring of DNA 
damage is done by measuring the percentage of DNA in the tail of the nucleoids,  
previously stained with ethidium bromide64. 
- In the CBMN assay, micronuclei that remain in the cytoplasm of cytokinesis-blocked 
(binucleated) cells after mitosis are scored under bright field or fluorescence 
microscopy. Cytokinesis is blocked with cytochalasin-B, an inhibitor of microfilament 
ring assembly required for the completion of cytokinesis. Micronuclei originate from 
chromosome fragments or whole chromosomes that lag behind at anaphase during 
nuclear division, nucleoplasmic bridges correspond mainly to dicentric chromosomes 
resulting from telomere end-fusions or DNA misrepair, and nuclear buds are a 
biomarker of gene amplification65. Afterwards, the cells can be scored for its viability 
status (necrosis, apoptosis), its mitotic status (mononucleated, binucleated, 
multinucleated) and its chromosomal damage or instability status (presence of 
micronuclei, nucleoplasmic bridges and nuclear buds).  
Apoptosis was also analysed through the determination of caspase-3 and -7 activities, 
which are apoptotic executioner caspases (cysteine-aspartic acid-specific proteases), 
i.e., they are the final endonucleases of the caspase activation signalling cascade with 
the role of degrading cellular compounds to initiate apoptosis66. Apo-ONE® 
Homogeneous Caspase-3/7 Assay Kit (Promega) was used, in which the caspase-3/7 
substrate rhodamine 110, bis-(N-CBZ-Laspartyl-L-glutamyl-L-valyl-L-aspartic acid 
amide; Z-DEVD-R110) exists as a profluorescent substrate. Cells are lysed and upon 
sequential cleavage and removal of the DEVD peptides by caspase-3/7 activity and 
excitation at 499 nm, the rhodamine 110 leaving group becomes intensely fluorescent. 
The amount of fluorescent product generated is proportional to the amount of caspase-
3/7 cleavage activity present in the sample.  
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Other complementary assays and methodologies were applied as necessary to elucidate 
the results obtained by the above-mentioned assays, e.g., fluorescence in situ 
hybridisation (FISH), confocal microscopy and western blotting. These techniques are 
described in chapter 4. 
 
1.4.4. Next-generation sequencing of miRNA 
The identification of the differently expressed miRNAs in the exposed A549 cells, as 
compared with non-exposed cells, was accomplished by next-generation sequencing 
(NGS), also called massively parallel or deep sequencing. NGS consist of a set of 
technologies that allow rapid sequencing of a large number of DNA segments 
simultaneously, including the entire human genome or exome, as opposed to the Sanger 
sequencing technique in which one fragment of DNA was sequenced at a time. In this 
work, Illumina NGS technology was applied (figure 9) to sequence all the miRNA of A549 
cells expressed after exposed to Mitsui-7 or crocidolite during 24 h, and in the non 
exposed cell cultures performed simultaneously. Further analytical details can be found 
in Chapter 5. 
 
1.4.5. Differentially expressed miRNAs and functional pathway analysis 
NGS data analysis for identifying the differently expressed miRNA in the exposed 
alveolar cells, and the corresponding functional cellular pathways that are activated or 
repressed as a consequence of gene expression modifications, is a complex task that 
requires bioinformatics resources and skills. The bioinformatics analyses were 
performed in collaboration with the Technology and Innovation Unit of INSA.  
Two different R software packages were used to identify the differently expressed 
miRNAs, in order to verify data concordance and obtain an improved consistency, 
namely DESeq2 v1.18.16867 and RNASeqGUI v1.1.26968. The latter was used for 
performing differential expression analysis with the EdgeR Exact Test7069. This 
methodology allowed the identification of unique differentially expressed miRNA profiles 
in alveolar epithelial cells exposed 24 h to MWCNT-7 or crocidolite. Further details are 
given in Chapter 5. 
The over or under-expressed miRNAs were then used as input in DIANA-miRPath 
(http://www.microrna.gr/miRPathv2). This software performs an enrichment analysis of 
the predicted target genes of the multiple miRNAs and compares each set to the KEGG 
(Kyoto Encyclopedia of Genes and Genomes) pathways70. 
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Figure 9. Summary of the four steps of Illumina next-generation sequencing of miRNA. Image adapted from 
“An introduction to Next-Generation Sequencing Technology” (available at 
https://www.illumina.com/documents/products/illumina_sequencing_introduction.pdf). 
 
KEGG pathway (https://www.genome.jp/kegg/) is a database resource of pathway maps 
that represent the current knowledge on the molecular interaction, reaction and relation 
networks about metabolism, genetic information processing, environmental information 
processing, cellular processes, organismal systems, human diseases and drug 
development71.  
In addition to investigating the KEGG pathways altered after exposure to MWCNT-7 and 
crocidolite, the potential gene targets of the differentially expressed miRNA were also 
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classified according to gene ontology (GO) terms, e.g., to concepts/classes that describe 
biological functions and their relationships to one another. This comprehensive 
computational model of biological systems concerning gene function (molecular function 
of the gene products, the cellular component where they are active, and the biological 
process made up of the activities of multiple gene products), is provided by the Gene 
Ontology Consortium (http://www.geneontology.org/)72, 73. 
 
1.4.6. Network of differentially expressed miRNAs and target cancer genes 
Given the over-representation of functional pathways related to cancer in the above-
mentioned cellular pathways affected by exposure to MWCNT-7 and crocidolite, a 
network analysis of the differentially expressed miRNAs and their target cancer genes, 
included in the KEGG subcategory “pathways in cancer”, was constructed. Cytoscape 
version 3.7.074 was used for network extension using CyTargetLinker 4.0.175. Detailed 
information on this bioinformatics analysis is given in Chapter 5. 
The comparison of all results obtained for MWCNT-7 and crocidolite will provide further 
knowledge of the differences and similarities of the molecular modes of action of both 
materials, and the hazard of MWCNT-7 for occupational human exposure. 
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The widespread application of carbon nano-
tubes (CNT) on industrial, biomedical, and con-
sumer products can represent an emerging
respiratory occupational hazard. Particularly,
their similarity with the fiber-like shape of asbes-
tos have raised a strong concern about their
carcinogenic potential. Several in vitro and in
vivo studies have been supporting this view by
pointing to immunotoxic, cytotoxic and geno-
toxic effects of some CNT that may conduct to
pulmonary inflammation, fibrosis, and bronchio-
loalveolar hyperplasia in rodents. Recently, high
throughput molecular methodologies have been
applied to obtain more insightful information on
CNT toxicity, through the identification of the
affected biological and molecular pathways.
Toxicogenomic approaches are expected to
identify unique gene expression profiles that,
besides providing mechanistic information and
guiding new research, have also the potential
to be used as biomarkers for biomonitoring pur-
poses. In this review, the potential of genomic
data analysis is illustrated by gene network and
gene ontology enrichment analysis of a set of
41 differentially expressed genes selected from a
literature search focused on studies of C57BL/6
mice exposed to the multiwalled CNT Mitsui-7.
The majority of the biological processes annotated
in the network are regulatory processes and the
molecular functions are related to receptor-binding
signalling. Accordingly, the network-annotated
pathways are cell receptor-induced pathways. A
single enriched molecular function and one bio-
logical process were identified. The relevance of
specific epigenomic effects triggered by CNT
exposure, for example, alteration of the miRNA
expression profile is also discussed in light of
its use as biomarkers in occupational health stud-
ies. Environ. Mol. Mutagen. 59:334–362, 2018. VC 2018
Wiley Periodicals, Inc.
Key words: toxicogenomics; toxicoepigenomics; carbon nanotubes; gene expression; miRNA;
nanotoxicology
INTRODUCTION
Nanotechnology is a fast-evolving field and carbon
nanotubes (CNT) are one of the most promising and
widespread classes of manufactured nanomaterials.
According to the ISO/TS 80004-4:2011, CNT are nanofib-
ers, thar is, nano-objects with two similar dimensions in
the nanoscale (size range from approximately 1 to
100 nm) and the third dimension significantly larger
(ISO, 2011). They consist of graphite sheets with a cylin-
drical arrangement, and can have a single wall (SWCNT),
double wall (DWCNT) or multiple walls (MWCNT)
assembled in concentric layers, and can be functionalized
by the introduction of specific elements on the pristine
CNT other than carbon. Only in relation to SWCNT,
more than 50,000 potential combinations may exist
depending on structural types, length, manufacturing and
purification processes, and surface coatings (WHO, 2012).
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CNT display unique physicochemical properties: they are
mechanically strong, flexible, lightweight, heat resistant,
and have high electrical conductivity (nanowires). They
currently have several industrial and biomedical applica-
tions, including electronics, lithium-ion batteries, solar
cells, super capacitors, thermoplastics, polymer compo-
sites, coatings, adhesives, biosensors, enhanced electron-
scanning microscopy imaging techniques, inks, as well as
in pharmaceutical/biomedical devices for bone grafting,
tissue repair, drug delivery, and medical diagnostics
(NIOSH, 2013). Many novel applications of CNT are
expected to be developed in the coming years and their
commercial market is expected to grow fast (WHO,
2012).
Although great societal and economic benefits are
expected from CNT usage, the very same properties
which are intentionally exploited and are responsible for
their success, may have detrimental effects. Those effects
may raise some concern, especially in occupational set-
tings where, upon unintentional exposure and interaction
with the biological systems CNT have the potential to
impact on workers’ health (WHO, 2012). Previous studies
on human exposure to fine aerosols, atmospheric pollution
and manufactured mineral fibers have already demon-
strated the association between small-scale material expo-
sure and respiratory disease (Donaldson et al., 2004;
Oberd€orster et al., 2005a; Borm et al., 2006; Oberd€orster,
2010). Regarding manufactured nanomaterials, several in
vitro and in vivo studies have already established that
they can also lead to adverse biological responses. These
responses are associated with the nanomaterial intrinsic
physicochemical properties, including chemistry, size,
shape, surface area, solubility, surface reactivity, charge,
functional groups, crystalline structure, tendency to
agglomerate and the presence of contaminants (Lanone
et al., 2013). Baytubes, for example, are entangled
agglomerated macro-sized MWCNT with high physical
stability and chemical purity (Wirnitzer et al., 2009).
They will probably induce a very different biological
effect as compared to straight, needle-like MWCNT, for
example, MWCNT-7. Biopersistence is an important
aspect because lung injury caused by nanomaterials with
low biopersistence is less severe than the burden caused
by nanomaterials with high biopersistence, even if the
former have higher toxicity, due to the protracted adverse
effects on lung tissue that result in chronic inflammation
(Landsiedel et al., 2014). The dimension, durability and
dose (the so-called three D’s) of CNT are well known
key parameters for their hazard (Donaldson et al., 2013),
and their high aspect ratio (length to width ratio) is a
characteristic very relevant to their toxicity.
The present work intends to critically review the
knowledge about the pulmonary adverse effects of CNT
particularly related with occupational exposure, with a
special emphasis on the information gathered from toxi-
cogenomic and toxicoepigenomic studies using high
throughput technologies. These new ‘‘omics’’ paradigm
best fits the next generation testing strategy based on the
identification of CNT adverse outcome pathways and
derived points of departure for risk assessment of geno-
mic damage (Dearfield et al., 2017). In addition, a critical
analysis of the ‘‘omics’’ data allowed a network analysis
and gene ontology enrichment analysis to be performed
on a set of 41 differentially expressed genes identified in
the literature. The utility of the toxicological findings that
are herein reviewed envisaging their potential use as bio-
markers for biomonitoring studies in occupational settings
are also discussed.
OCCUPATIONAL EXPOSURE TO CNT
The human health risk from exposure to CNT is proba-
bly more relevant when they are dispersed in the environ-
ment or in suspensions, which is more likely to occur in
an occupational setting. The highest release of CNT has
been observed during their production and handling, as
well as during cleaning of the production reactors, and
ranged from 0.68 to 38 lg/m3 in the personal breathing
zone of workers performing key work operations and pro-
cedures in 11 on-site exposure studies in different work-
places (IARC, 2014). In the USA, a 2013 survey
identified 43 companies with an estimated total number
of 375 workers engaged in CNT manufacturing, but when
extending the workforce to the fabrication or handling of
nanofiber-enabled materials and composites this number,
although unknown, is likely to be significantly higher
(NIOSH, 2013). Adopting a precautionary approach, sev-
eral professional and scientific organizations agreed that
there is sufficient information for CNT to be regarded as
an occupational hazard (Trout and Schulte, 2010).
Although the National Institute for Occupational Safety
and Health (NIOSH) distinguishes between carbon nano-
fiber (CNF) and CNT depending on the graphene plane
alignment (if the graphene plane and fiber axis do not
align, the structure is defined as CNF; when they are par-
allel, it is considered a CNT), the recommended exposure
limit (REL) for both is 1 mg/m3 elemental carbon as a
respirable mass 8-hr time-weighted average (TWA) con-
centration (NIOSH 2013). This limit seems to be lower
than some values that have been measured on-site (IARC
2014), even though it is difficult to extrapolate the values
relative to key work events performed within minutes to
an 8-hr TWA.
In the occupational setting, inhalation is most likely to
occur and gastrointestinal absorption can result from the
mucociliary transport of inhaled CNT in case of accidents
or when hygiene standards are not met (Iavicoli et al.,
2014). According to NIOSH guidelines, health surveillance
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and medical monitoring of workers exposed to CNF and
CNT should include a nonspecific initial evaluation of the
medical and occupational history of the worker, with
emphasis on the respiratory system (including the use of a
standardized questionnaire for respiratory symptoms), a
physical examination that may include spirometry testing
and a baseline chest X-ray, followed by other tests deemed
appropriate for each case. Then, an annual update of the
occupational and medical history, and a spirometry test at
least every 3 years should be performed (NIOSH, 2013).
The deposition of ultrafine particles in the respiratory
system (the first site of contact of the particle after inhala-
tion) is predominantly determined by diffusion that redi-
rects the particles of inhaled and exhaled air currents
towards the airway walls and its subsequent impaction
and sedimentation. This movement is affected by (i) the
particle size, shape, and possible dynamical change dur-
ing breathing, (ii) the geometry of the respiratory tract
and alveolar structures, (iii) the pattern of breathing
(including breathing through the nose or mouth) that
determines the speed of the air stream, and (iv) the resi-
dence time in the respiratory system (Kreyling et al.,
2006). Depending on the inhaled particles diameter,
which may result from the aggregation or agglomeration
state of the individual particles, their regional deposition
in the lungs will vary from the extra-thoracic regions
(larger particles) to the alveoli (smaller particles; Kreyling
et al., 2006). Under real-life conditions, the majority of
airborne nanomaterials are in an agglomerated form, and
their deposition in the lungs follows the pattern of larger
particles (Laux et al., 2017). Furthermore, particle
agglomerate volume may better explain the effects of
repeated dosing leading to inflammation, as opposed to
surface area that may be the dose metric applied to
describe the acute effects of instilled or inhaled particles.
In addition to agglomeration, particle dissolution is also
fundamental to the toxicity of inhaled particles, due to
the reduction of their size and related changes of dissolu-
tion kinetics (Laux et al., 2017). It is considered that par-
ticles as CNT, which are not dissolved in the epithelial
lining fluid, may be phagocytized by the alveolar macro-
phages and be cleared by mucociliary transport, be trans-
ported across the epithelial barrier and be stored in
interstitial tissue or be carried for storage in tracheobron-
chial and bifurcational lymph nodes (Kreyling, 1990). In
mouse models, it was observed that the lung burden of a
MWCNT at 56 days post-exposure by pharyngeal aspira-
tion was about 68.7%, 7.5%, and 22% in the alveolar
macrophages, alveolar tissue and granulomatous lesions,
respectively, demonstrating its potential to reach the
alveolar region (Mercer et al., 2011). In this microenvi-
ronment, nanoparticles may possibly be translocated to
distant organs and systems or interact with the cells of
the immune system. The translocation of MWCNT
from the lungs to the liver, kidney, heart, brain,
tracheobronchial lymph nodes, parietal pleura and the dia-
phragm has been documented on male C57BL/6J mice
exposed in a whole-body inhalation system for 5 hr/day
for 12 days (lung burden 28.1 lg/lung; Mercer et al.,
2013b). One day after the exposure ended, most of the
extrapulmonary MWCNT fibers were found in the tra-
cheobronchial lymph nodes (1.08% of lung burden). At
336 days post-exposure, the extrapulmonary burden of
MWCNT was significantly higher than at 1 day post-
exposure, that is, the lymph nodes accumulated 7.34% of
the lung burden, while the levels in extrapulmonary
organs as a whole increased approximately in the same
proportion, that is, 6–7-fold (Mercer et al., 2013b). Other
toxicological studies have shown that inhaled MWCNT
are able to reach the pleura (Porter et al., 2010; Donald-
son et al., 2010; Donaldson et al., 2013). The route of
translocation of nanofibers from the lungs to the visceral
pleura, into the pleural space, and to the parietal pleura is
unknown. It is postulated that translocation to the lung
intestitium and visceral pleura can occur either by a para-
cellular route or by direct penetration across injured alve-
olar epithelial cells, and translocation to the pleural space
via the lymphatic and blood vessels (by themselves or
within macrophages) or passively in the same manner as
interstitial fluid (Broaddus et al., 2011). Given the fiber-
like shape similarity of MWCNT with asbestos fibers,
there are concerns about their fibrogenic and carcinogenic
potential to the mesothelium (Pacurari et al., 2010), which
will be further discussed along the text.
An important acquired property of CNT that it is
thought to influence its pharmacokinetics and pharmaco-
dynamics is the corona, that is, the biomolecules that
nanomaterials, due to their high surface energy, adsorb
from their biological environment. This interaction trans-
forms bare nanomaterials into nanomaterials with a bio-
logical coating (Westmeier et al., 2016). Plasmatic
proteins can possibly form a corona around CNT, altering
their physicochemical properties and biological effects,
for example, inflammatory effects. This highly relevant
and less consensual issue as been already reviewed else-
were (Monopoli et al., 2012).
Although occupational studies of CNT exposure are
still missing, much information regarding the toxicologi-
cal potential of CNT has been gathered in the last years
from in vitro and rodent studies.
TOXICOLOGICAL STUDIES IN VITRO
Cytotoxicity and Genotoxicity Assessment
Several studies have demonstrated the ability of CNT
to induce cytotoxic, genotoxic effects, or even epigeno-
toxic effects (the last two categories of effects are further
developed in Fig. 1), even though some studies have also
reported negative results. Whereas genotoxicity relates to
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DNA or chromosome damage and may lead to genetic
instability, epigenotoxicity comprises mechanisms that
change gene expression through transcription inhibition,
chromatin remodeling or degradation of RNA, in response
to environmental stimuli. Both genotoxic and epigeno-
toxic effects can trigger cell death by apoptosis or lead to
malignant transformation and eventually to cancer
development.
When comparing the cytotoxicity of asbestos (crocido-
lite), MWCNT, and SWCNT (up to 48 mg/cm2) in Chi-
nese hamster lung fibroblasts (V79 cell line), Kisin et al.
(2011) reported a concentration- and time-dependent loss
of viability for all tested materials, the magnitude of the
effect being asbestos>MWCNT>SWCNT. Additionally,
all tested materials revealed genotoxicity with the stron-
gest effect seen for the MWCNT (Kisin et al., 2011).
Previously, in another study from the same authors per-
formed using lung fibroblasts, SWCNT exposure caused
(i) loss of cell viability in a concentration- and time-
dependent manner and (ii) an increase in the level of
DNA damage in a concentration-dependent manner (Kisin
et al., 2007). It should be emphasized that a major factor
of the cyto-genotoxic potential of asbestos is ROS genera-
tion mainly induced by the mobilizable surface iron of its
fibers (Srivastava et al., 2010). In fact, only Fe-rich
MWCNT at concentrations of 50 and 100 m/cm2 were
significantly cytotoxic and genotoxic and induced oxida-
tive stress in murine alveolar macrophages, while Fe-free
MWCNT did not exert any of these adverse effects, sup-
porting the view that iron content represents an important
key constituent in promoting MWCNT-induced toxicity
(Aldieri et al., 2013). Nevertheless, very high levels of
ROS and decreased metabolic activity were observed in
A549 cells after exposure to pristine MWCNT (Thurnherr
et al., 2011). Noteworthy, another study reported that
agglomerated MWCNT decreased human epithelial and
mesothelial cell viability without being internalized or
producing oxidative stress, contrasting to asbestos (Tabet
et al., 2008).
In another study, dispersed SWCNT stimulated fibro-
blast proliferation, induced collagen production without
cell damage, and increased the activity of MMP-9, one of
the major matrix metalloproteinases involved in lung
fibrosis (Wang et al., 2010). In vitro exposure of mesothe-
lial cells to SWCNT increased oxidative stress, cell death,
enhanced DNA damage, including histone H2AX phos-
phorylation, and activated poly(ADP-ribose) polymerase 1
(PARP-1), activator protein-1 (AP-1), nuclear factor jB
(NF-jB), protein p38, and protein serine-threonine kinase
(Akt). However, the tested SWCNT had metal contamina-
tion, a characteristic already suggested to mediate CNT
toxicity, that could have induced the observed effects
Fig. 1. Possible genotoxic and epigenotoxic effects from exposure to CNT. The genotoxicity of CNT can be caused by
direct action of the CNT on the DNA molecule, or due to indirect mechanisms, for example, mediated by ROS genera-
tion or secondary to inflammation. Epigenotoxic effects are changes in the regulation of gene expression in response to
CNT exposure: methylation of DNA, histone tail alterations and differential microRNA (miRNA) expression.
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(Pacurari et al., 2008). In fact, a more recent study
showed that SWCNT and MWCNT caused a low level of
DNA damage on mesothelial cells as assessed by the
comet assay, in some cases only at relatively high doses
(48-hr exposure to 80 mg/cm2), and little or no effect was
observed on bronchial epithelial cells. No evidence of
chromosomal damage was found in both cell lines (Lind-
berg et al., 2013). These observations suggest that meso-
thelial cells are more sensitive to the CNT-associated
DNA damaging effects than bronchial epithelial cells.
The low g-glutamylcysteine synthetase reactivity in pleu-
ral mesothelium may be associated with the highest sensi-
tivity of mesothelial cells to fiber-induced toxicity due to
glutathione depletion (Puhakka et al., 2002). In a more
recent study using a human lung adenocarcinoma epithe-
lial cell line, the A549 cell line and the human-derived
bronchial epithelial cell line BEAS-2B, there was no
induction of DNA single or double DNA strand breaks
(comet assay) by any of the four benchmark MWCNT
tested. However, discrepant results were observed in the
two cell lines: cytotoxic effects were detected only in
A549 cells with the IC50 values varying from approxi-
mately 8 to 61 mg/cm2 and the two longest MWCNT sig-
nificantly raised the micronucleus frequency in A549
cells at the highest tested concentrations (64 and 128 mg/
cm2), whereas in BEAS-2B cells negative results were
obtained for all MWCNT. This discrepancy was
explained by the different size-distribution of MWCNT in
the cell culture medium, rather than by the cell line spe-
cificities (Louro et al., 2016). In another study, the rigid
MWCNT-7 (2.5 and 15 mg/ml) was able to induce micro-
nuclei formation in human lymphocytes exposed ex vivo,
supporting the chromosome damaging effect of some
MWCNT with the potential to mediate a tumorigenic
effect in humans (Tavares et al., 2014). It should be noted
that also a lower MWCNT specific surface area, and
therefore, a larger diameter, has been associated with
increased genotoxicity (Poulsen et al., 2016).
As to the type of genetic lesions that MWCNT have
been able to induce, the majority of positive results have
been associated with chromosome damage rather than to
DNA strand breaks. In fact, a 11.3-nm diameter and
0.7 lm length MWCNT (10–50 mg/ml) with traces of
cobalt and iron catalysts displayed a dose-dependent
increase in the micronucleus frequency in the human
breast epithelial cell line MCF-7 due to clastogenic and
aneugenic events (Muller et al., 2008). MWCNT, at occu-
pationally relevant exposure levels (0.024–24 mg/cm2),
also induced a dose-related increase in the frequency of
disrupted centrosomes, abnormal mitotic spindles and
aneuploid chromosome number in BEAS-2B cells (Sieg-
rist et al., 2014). Noteworthy, the study showed that CNT
were integrated into microtubules, DNA and centrosome
structure. In addition, a G1/S block of the cell cycle was
observed, probably as a consequence of the CNT
integration into the centrosome structure and interaction
with the microtubules as well as a potential to pass the
genetic damage to daughter cells. The mechanical interac-
tion of MWCNT with the mitotic spindle microtubules
and its adjacent structures may explain their ability to
induce micronuclei by an aneugenic mechanism of action.
This mechanism also supports the moderate to null ability
of MWCNT to generate positive results in the comet
assay that detects primary DNA lesions (Azqueta et al.,
2014). However, this mode of action may not be inherent
to all MWCNT, given that for instance Baytubes (2.5–
10 mg/ml, 4 and 18 hr exposure), induced neither cyto-
toxic nor clastogenic effects in the chromosome aberra-
tion test using Chinese hamster lung fibroblasts
(Wirnitzer et al., 2009).
A more recent analysis of 15 MWCNT with different
physicochemical characteristics in rat epithelial lung cells
showed no significant cytotoxicity and only a weak geno-
toxicity at a concentration-range of 12.5–200 mg/ml. Nev-
ertheless, cell proliferation decreased at the highest doses
of some MWCNT, this effect being associated with a
higher CNT surface area and ROS production (Jackson
et al., 2015). Oxidative stress was also reported in rat
lung epithelial cells exposed to 0.5–10 mg/ml MWCNT,
which stimulated the apoptosis signaling pathway through
caspase activation (Ravichandran et al., 2009).
Immunotoxicity Assessment
Inflammasomes comprise a group of large intracellular
multiprotein signaling complexes that can respond to
exogenous stimuli and control the proteolytic activation
of IL-1b and IL-18. Lung inflammation is probably
caused by the induction of NLRP3 inflammasome activa-
tion in the airway epithelial cells (Fig. 2), a mechanism
already linked to several pulmonary diseases (Birrell and
Eltom, 2011; Im and Ammit, 2013; Nardo et al., 2014)
and to exposure to nanomaterials (Yazdi et al., 2010; Sun
et al., 2013), including MWCNT (Hussain et al., 2014).
The NLRP3 inflammasome can assemble through a wide
range of stimuli including pathogen-associated molecular
patterns (PAMPs), damage-associated molecular patterns
(DAMPs), fibers/particles, metabolic products, environ-
mental hazards, and engineered nanomaterials (Sun et al.,
2013). Long, needle-like CNT activation of the NLRP3
inflammasome depends on ROS production, cathepsin B
activity, P2X7 receptor, and Src and Syk tyrosine kinases,
inducing IL-1b secretion (Palomaki et al., 2011). Note-
worthy, pyroptosis, a highly inflammatory form of pro-
grammed cell death, was observed in primary human
bronchial epithelial (HBE) cells exposed to 1.5–24 mg/ml,
due to NLRP3 activation (Hussain et al., 2014).
Macrophages are alveolar cells that play a key role in
the alveolar tissue indirect response to nanomaterials,
especially for poorly soluble nanomaterials, as CNT. It
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has been proposed that neutrophils begin the process of
nanoparticle degradation, converting long particles into
shorter ones, thus facilitating their uptake by the activated
macrophages present in the lungs for complete degrada-
tion with peroxynitrite generated by superoxide anion rad-
icals and nitrogen oxides produced via the NADPH
oxidase pathway (Kagan et al., 2014). If these oxidative
species formation is excessive, injury to the neighbor
cells and tissue can occur, especially for biopersistent
particles as CNT. Following macrophage activation,
phagocytosis of CNT also leads to the release of proin-
flammatory cytokines and chemokines (e.g., TNFa, IL-
1b, IL-6, IL-10, and MCP1) and transcription factors
associated with inflammation (NF-kB and AP-1; He et al.,
2012; Oberd€orster et al., 2005b).
Long, straight, and well-dispersed nanofilaments pro-
duced significantly more TNF-a and ROS in monocytic
cells (15.625–62.5 m/ml, 4 hr exposure) as compared to
highly curved and entangled materials, confirming that
fiber morphology and state of aggregation are important
factors in the immunotoxicity of CNT (Brown et al.,
2007). In addition, it was suggested that when nanofiber
length exceeds the pleural macrophages length, it triggers
an inflammatory response in the pleural cavity due to
‘‘frustrated phagocytosis’’, which in turn stimulates a
cytokine proinflammatory response from adjacent meso-
thelial cells (Brown et al., 2007; Murphy et al., 2012;
Landsiedel et al., 2014).
Moreover, it was observed that MWCNT (30 mg/ml)
directly promote the fibroblast to myofibroblast and
Fig. 2. Schematic representation of the mechanisms involved in NLRP3
inflammasome activation in lung macrophages and epithelial cells. The
mechanisms of inflammasome activation by nanofibers are not completely
understood. Phagocytosis of nanofibers results in mitochondrial damage
leading to the production of reactive oxygen species (ROS). ROS produc-
tion can induce a direct genotoxic effect, namely DNA single-strand
breaks (SSB). ROS can also cause lysosome destabilization and conse-
quent cathepsin B release and further mitochondrial damage. Futhermore,
high aspect-ratio nanomaterials can cause lysosomal rupture and release
of cathepsin B to the cytosol. ROS generation leads to the oxidation of
the redox-active thioredoxin (TXN) dissociating it from thioredoxin-
interacting protein (TXNIP). In its free form, TXNIP can activate
NLRP3. NLRP3 inflammasome activation causes caspase-1 proteolysis of
the precursor forms of cytokines IL-1b and IL-18 into their active forms,
which are powerful inflammation inducers. Caspase-1 activation can also
induce cell pyroptosis. The production of the pro-cytokines is under the
control of the NF-jB signaling pathway via activation of the Toll-like
receptor 4. In addition, K1 efflux may be a common trigger of NLRP3
inflammasome activation, causing mitochondrial membrane potential dis-
ruption. The increase of extracellular ATP from damaged cells binds to
the P2X purinoreceptor 7 (P2X7) activating this ion channel, contributing
to the K1 efflux.
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epithelial to mesenchymal transitions through the activa-
tion of the TGF-b/Smad2 signaling pathway (Wang et al.,
2015). SWCNT also stimulate TGF-b1 production in
BEAS-2B cells and macrophages promoting fibroblast to
myofibroblast transformation (He et al., 2012). These
findings corroborate the evidence from the rodent studies
that indicated the pro-fibrotic potential of CNT.
Much of the described cytotoxic, genotoxic and immu-
notoxic effects of CNT that were identified in vitro have
been also documented in the rodent studies presented in
the next section, allowing linking them to in vivo adverse
health effects. One of the most relevant questions stands
on whether the concentration-ranges of CNT tested in
vitro are somehow comparable to the ones used in rodent
studies, which, in turn, should ideally mimic real human
exposure. Considering the peak airborne concentrations of
MWCNT in an occupational setting, and the difference
between the surface area of the lung alveoli of humans
and rodents, Porter et al. (2010) concluded that a 10 mg
MWCNT exposure to a mouse would correspond to
approximately one month of exposure to a human per-
forming light work in an environment with aerosol con-
centrations of 400 mg/m3 MWCNT. Thus, if the human
average daily MWCNT aerosol exposure was of 4–40 mg/
m3, the 10 mg MWCNT exposure in mouse would
approximate a person performing light work for approxi-
mately 9 months to 7.5 years (Porter et al., 2010). If this
concentration is extrapolated for use during in vitro stud-
ies, a concentration lower than 1 mg/ml (or generally
lower than 0.5 mg/cm2) in standard tissue culture proto-
cols is obtained. As described above, however, many in
vitro MWCNT pulmonary toxicity studies use exposure
concentrations much higher than that, although this may
be admissible in toxicological in vitro studies that typi-
cally use very short exposure lengths, for example, 4–
72 hr (Snyder-Talkington et al., 2012).
TOXICOLOGICAL STUDIES IN RODENTS
In recent years, experimental intratracheal instillation
or pharyngeal aspiration of CNT liquid suspensions in
rodents resulted in the development of acute or persistent
pulmonary inflammation and persistent interstitial fibrosis
with granuloma formation, and bronchiolar or bronchio-
loalveolar hyperplasia (Fig. 3; NIOSH, 2013; Landsiedel
et al., 2014).
Already in the first rodent studies performed by intra-
tracheal instillation of CNT in mice (Lam et al., 2004)
and rats (Warheit et al., 2004), multifocal granulomas
were a major finding. Another study performed in
C57BL/6 mice exposed to SWCNT through pharyngeal
aspiration demonstrated the induction of dose-dependent
acute inflammation with early onset progressive fibrosis
and granulomatous bronchial interstitial pneumonia
(Shvedova et al., 2005). Granuloma was mainly associ-
ated with hypertrophic epithelial cells around SWCNT
dense aggregates, whereas the diffuse interstitial fibrosis
and thickening of the alveolar wall was probably linked
with dispersed SWCNT. A sequential increase in neutro-
phil, lymphocyte and macrophage counts was also
observed at day 1, 3, and 7, respectively, accompanied by
an elevation of proinflammatory cytokines (day 1) and
TGF-b1 (day 7). Another study from the same group
demonstrated that inhalation exposure to respirable
SWCNT was more potent in inducing oxidative stress,
inflammatory response, collagen deposition and fibrosis
than aspiration of an equivalent mass of SWCNT, proba-
bly due to the exposure to less agglomerated and smaller
SWCNT structures (Shvedova et al., 2008). The same
conclusion was observed later, that is, inhalation exposure
to SWCNT in mice showed significantly greater inflam-
matory, fibrotic, and genotoxic effects than bolus pharyn-
geal aspiration. Nevertheless, even one year after a single
pharyngeal aspiration, CNT, similarly to asbestos, could
still be visualized in mouse lungs, inducing chronic
bronchopneumonia and lymphadenitis, accompanied by
pulmonary fibrosis (Shvedova et al., 2014). These obser-
vations are in agreement with the evidence that exposure
to dispersed SWCNT triggers a more potent interstitial
fibrotic reaction with an increase in collagen deposition
and without granuloma formation, than the exposure to
less dispersed material (Mercer et al., 2008). Furthermore,
not only CNT dispersion but also their clearance from the
lungs are related to their hydrophilicity and hydrophobic-
ity. The latter depends on the CNT preparation method
and the use of their pristine versus functionalized form
(Kim et al., 2010).
It has been suggested that direct stimulation of fibro-
blasts, the lung cells that produce the collagen matrix,
may play a significant role in lung fibrosis. SWCNT seem
to be more fibrogenic than MWCNT or asbestos, that
have a stronger inflammatory effect (Shvedova et al.,
2014). However, despite the relatively low fraction of
MWCNT delivered to the alveolar tissue, a progressive
and persistent fibrotic response was observed 336 days
post-exposure reflected by up to 73% increase in the aver-
age thickness of connective tissue and a time- and dose-
dependent increase in its collagen content (Mercer et al.,
2011, 2013).
Concerning mesothelial cells, direct instillation of CNT
into the mouse pleural cavity resulted in a similar acute
inflammatory and progressive fibrosis response in the
parietal pleura as compared to asbestos. It was also
observed that the pathogenicity of long fibers is greater,
probably due to its length-dependent retention in the pari-
etal pleura stomata (Donaldson et al., 2010; Murphy
et al., 2011).
In vivo studies also demonstrated cytotoxic effects
associated with exposure to DWCNT and MWCNT, as
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evidenced by the dose-dependent elevation in lactate
dehydrogenase activity in bronchoalveolar lavage fluid of
rats (Muller et al., 2008; Sager et al., 2013; Snyder-
Talkington et al., 2016a). Albumin levels were also
increased in bronchoalveolar lavage fluid of rats exposed
to DWCNT, indicating loss of the integrity of the blood–
gas barrier in the lung (Sager et al., 2013). Genotoxic
effects as well as hyperplasia and dysplasia (mitotic fig-
ures, binucleated cells, anisocytosis, and anisokaryosis)
were reported in bronchial epithelial cells of mice
exposed to MWCNT by tracheal instillation (Kim et al.,
2010). MWCNT induced a significant and dose-dependent
increase in the micronucleus frequency in rat type II
pneumocytes (Muller et al., 2008). Furthermore, SWCNT
exposure induced cytogenetic alterations reflected as
micronucleus formation and nuclear protrusions and
increased the incidence of K-ras oncogene mutations,
similarly to MWCNT, but not to asbestos exposure (Shve-
dova et al., 2014).
Regarding possible carcinogenic efects of CNT, the
discordant evidence obtained for different CNT led the
International Agency for Research on Cancer (IARC) to
categorize all SWCNT and MWCNT, except MWCNT-7,
as not classifiable as to their carcinogenicity to humans
(Group 3). On the contrary, MWCNT-7 was classified as
possibly carcinogenic to humans (Group 2B; IARC,
2014). In fact, MWCNT-7 has been shown to induce peri-
toneal mesothelioma after a single intraperitoneal injec-
tion in mice (0.003–3 mg/animal; Takagi et al., 2008,
2012), after two intraperitoneal injections with a one-
week interval in rats (0.5–5 mg/animal; Nagai et al.,
2011), after intrascrotal injection (1 mg/animal) in rats
Fig. 3. Lung adverse effects of inhalatory exposure to CNTs. Although all CNT can lead to inflammation, fibrosis,
granuloma and cancer, SWCNT in the aggregated form are related to granuloma, but when well dispersed are usually
associated with lung fibrosis due to an increase in the collagen content. MWCNT are commonly related with chronic
inflammation due to cell membrane piercing and frustrated phagocytosis. Ultimately, this adverse affects can culminate
in lung cancer.
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(Sakamoto et al., 2009) and lung carcinomas after whole-
body inhalation exposure of male rats (0.2–2 mg/m3) and
female rats (2 mg/m3; Kasai et al., 2016). Moreover, it
promoted growth and neoplastic progression of lung cells
of B6C3F1 mice previously exposed to methylcholan-
threne, leading to lung bronchioloalveolar adenomas and
adenocarcinomas at doses similar to the ones that can be
achieved in human occupational exposure (Sargent et al.,
2014). In another study, Mitsui-7 injection in the peritoneal
cavity of rats induced, like asbestos, an early and selective
sustained immunosuppressive response characterized by
the accumulation of monocytic Myeloid Derived Suppres-
sor Cells (CD11b/cint and His48hi). These cells possess
the ability to suppress polyclonal activation of T lympho-
cytes and correspond to M-MDSC, counteracting the effec-
tive immune surveillance of tumor cells (Huaux et al.,
2016).
Several MWCNT demonstrated carcinogenic effects.
For example, the administration of 1 mg MWCNT/rat by
trans-tracheal intrapulmonary spraying during the initial
2 weeks of the experiment, using three groups of ani-
mals—MWCNT before filtration (4.2 mm average length),
flow-through fraction after filtration (2.6 mm average
length) and retained fraction (length not determined)—
caused malignant mesothelioma (6/38) and lung tumors
(14/38). All malignant mesotheliomas were localized in
the pericardial pleural cavity (Suzui et al., 2016).
The malignant mesotheliomas induced by intraperito-
neal injection of MWCNT in rats had a histopathology
and immunohistochemistry analogous to that of the meso-
theliomas induced by asbestos, suggesting similar patho-
genesis (Rittinghausen et al., 2014). Interestingly,
mesotheliomas induced by thin (diameter 50 nm) and
highly crystalline MWCNT share a homozygous deletion
of the tumour suppressor genes Cdkn2a/2b, similar to
mesotheliomas induced by asbestos (Nagai et al., 2011).
In this latter study, it was proposed that thin and crystal-
line MWCNT might have a piercing effect in the meso-
thelial cell membrane causing in vitro cytotoxicity, and in
vivo inflammatory and carcinogenic effects. Aggregative
and thick MWCNT do not penetrate mesothelial cells and
cause no direct cell injury, the observed carcinogenicity
being likely mediated by indirect effects (Nagai et al.,
2011).
PITFALLS AND CHALLENGES IN CNT HAZARD
ASSESSMENT
As seen in the studies reviewed above, toxicological
studies of CNT can sometimes generate conflicting results
mostly due to different methodological approaches (Lan-
one et al., 2013; Landsiedel et al., 2014), which hinders
the comprehension of their relevance in terms of exposure
to humans. Moreover, many of these studies use different
concentration metrics (rarely, fiber number, but fre-
quently, weight/unit volume of medium or weight/unit
area of cells), which makes comparisons between studies
more laborious and frequently impossible. To ensure that
the observed effects are due to the CNT characteristics
and to be able to compare the results from different labo-
ratories it is essential to harmonize the experimental pro-
tocols, such as the nanofiber preparation, exposure
conditions (biological model, route and mode of adminis-
tration, dose, and exposure duration) and endpoints. Even
so, other factors can influence the results, for instance,
the dispersing agent used for keep the nanofibers dis-
persed in the cells culture medium in in vitro studies, cru-
cial for the protein corona formation and consequent
nanofiber biokinetics, or the interaction of the CNT with
the culture media components, assay reagents or detection
molecules (Casey et al., 2008; Lanone et al., 2013; Land-
siedel et al., 2014).
In this regard, the use of reference well characterized
CNT can contribute to improve inter-laboratory compara-
bility. In addition, in rodent studies, CNT/CNF aerosol
characterization of size distribution, mass, number con-
centration, agglomeration/aggregation state, density, and
other physicochemical characteristics (surface properties,
impurities, length, diameter, dissolution, and leaching) is
recommended (Oberd€orster et al., 2015).
CNT surface functionalization is extremely diverse and
can thus modify the biological effects, for example, acid-
treated MWCNT induce a less severe inflammatory
response than pristine MWCNT and are less tumorigenic
(Kim et al., 2010; Yu et al., 2013); carboxylated (COOH)
MWCNT are more cytotoxic and genotoxic than
hydroxylated-oxigenated (O1), aminated (NH2) and pris-
tine MWCNT (Chatterjee et al., 2014). Another example
is the thin film coating of MWCNT through an atomic
layer deposition of Al2O3: it alters cytokine production by
human mononuclear cells in vitro and cytokine expression
in mouse lungs, reducing fibrosis (Taylor et al., 2014).
Therefore, the identification of the properties that are crit-
ical to determine the CNT hazard can allow the design of
safer and sustainable products, a concept known as
‘‘safer-by-design’’. Thus, the uniqueness of each CNT
makes it necessary to assess its individual hazard(s),
though it is foreseeable that some concepts can be shared
by applying a grouping approach (Oberd€orster, 2010).
Indeed, the categorization of nanomaterials in hazard
groups, the so-called grouping strategy depending on
their intrinsic characteristics, lifecycle, biokinetics and
effects is useful for risk assessment, and can prevent
unnecessary laborious testing (Braakhuis et al., 2016;
Dekkers et al., 2106).
Moreover, if the aim is to identify and characterize the
hazard through the establishment of a dose-effect (or
exposure-adverse effect) curve, the experimental design
often does not reflect the reality. Much criticism has thus
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emerged from the high CNT mass doses commonly used
in toxicity studies, since real life human airway deposi-
tion can take weeks to reach a dose that is administered
instantaneously in the experimental setting. Bearing those
criticisms in mind, various calculation models of the
effective dose metrics have been developed (Oberd€orster,
2010; Klein et al., 2012; Landsiedel et al., 2014).
It is now anticipated that more useful toxicological
information can be gathered from low-dose studies exam-
ining multiple endpoints, than from a single acute expo-
sure. In addition, in rodent studies, intratracheal instillation
and pharyngeal aspiration were also criticized for not
reproducing the real deposition pattern of exposure, and
inhalation has been the recommended exposure route to
obtain data necessary for the risk assessment of CNT and
CNF following pulmonary exposure (Oberd€orster, 2010).
Nevertheless, some studies suggested that pharyngeal aspi-
ration of a well-dispersed suspension of MWCNT result in
a pulmonary distribution and inflammatory response that
closely simulates the inhalation exposure (Snyder-Talking-
ton et al., 2016a). Other recommendations have recently
been provided for rodent inhalation studies, for example,
(i) the preference of 90-day inhalation studies in rats using
whole-body exposure to pristine material (with no treat-
ment with dispersant or sonication) (ii) using aerosols pro-
duced by dry powder generator methods with (iii) a
minimum of three concentrations that include a no
observed adverse effect level (NOAEL) and a maximum
tolerated dose, (iv) using positive and negative benchmark
controls and (v) preceding the 90-day inhalation study by
an acute 1- to 10-day inhalation study followed by a post-
exposure observation/recovery period (Oberd€orster et al.,
2015). The same authors recommend the endpoints (e.g.,
lung weight changes) and the minimal data set to be gath-
ered and analyzed (e.g., specific bronchoalveolar lavage
parameters, and determination of retained lung burden).
All these concerns have to take into consideration that
there are significant differences in the lung structure and
function between rodents and humans, for instance, in the
branching patterns of the tracheobronchial tree that affects
the deposition of inhaled materials (Miller et al., 1993),
and in the thickness of the interstitium and pulmonary
capillary endothelium (Crapo et al., 1983).
Actually, both the initial transport rate of nanoparticles
from the lungs to the gastrointestinal tract, as the decay
of the transport rate, vary considerably between species.
Generally, in humans and large animals, the particle ini-
tial transport rate is an order of magnitude less than in
rodents. This can be a consequence of the shorter distance
from the alveolus to the terminal bronchiolus in rodents,
compared to dogs, monkeys, and humans (Kreyling,
1990). Dosimetric risk extrapolation from animals to
humans has to consider other species differences related
to the biokinetics of inhaled particulate materials, for
example the greater interstitial compartmentalization of
retained particles in primates versus rodents (Laux et al.,
2017). However, despite these differences, the distribution
of cells in the alveolar tissue and their average volume
and surface area seem to be constant among rats, dogs,
baboons, and humans (Crapo et al., 1983).
In the last decades, there has been an effort to replace
animal testing by in vitro studies for ethical reasons.
However, a modest correlation has been found between
toxicological results obtained in vitro and those obtained
in vivo. Therefore, there has been an attempt to improve
conventional monoculture cell systems through the co-
culture of various cell types present in the target organ to
better mimic in vitro, the in vivo model and to provide
more reliable information on nanoparticles’ toxicity
(Snyder-Talkington et al., 2012). For example, an in vitro
co-culture model of human small airway epithelial cells
(SAEC) and human microvascular endothelial cells
(HMVEC) has correlated better than the two cell mono-
culture models with the in vivo mouse lung transcriptomic
profile following MWCNT exposure (Snyder-Talkington
et al., 2015) confirming the utility of these more complex
cell systems. Nonetheless, even the use of more sophisti-
cated cellular models and more realistic exposure systems
will not overcome the lack of other important factors that
affect a whole organism response, for instance, the com-
plexity of the immune system response. Moreover, if an
air-liquid interface exposure or the use of 3D cell cultures
would be more realistic for inhalation exposure or animal
studies replacement, their use is not yet generalized in
most laboratories.
NEWPERSPECTIVES IN CNT TOXICOLOGY
Toxicogenomics
Genomic studies begin to have a significant impact on
toxicology, as they allow a global overview to be made
of all molecular pathways that are modified in the cell,
tissue or organism in response to a toxic insult. For
instance, it was demonstrated that the accuracy of predict-
ing acetaminophen (paracetamol, APAP) toxic effects
based on blood cell gene expression patterns was signifi-
cantly better than that based on conventional clinical
parameters such as clinical chemistry, hematology, or his-
topathology (Bushel et al., 2007). For this reason, large-
scale gene expression studies are increasingly being used
leading to the emergence of ‘‘toxicogenomics’’ (Nuwaysir
et al., 1999; Aardema and Macgregor, 2002; Newton,
Aardema, and Aubrecht, 2004).
Through the identification of the differentially
expressed genes following a CNT exposure, a detailed
assessment of their potential health hazards, in a time-
and dose-dependent manner, can be achieved. Microar-
rays and, more recently, high throughput next generation
sequencing (NGS), are techniques that provide a massive
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amount of toxicogenomics data. The objective of finding
a gene signature for each mechanism of toxicity from an
initial set of thousands of up- or down-regulated genes
can be cumbersome, and it is only feasible with the help
of sophisticated bioinformatics tools. This is obvious
when considering the number of differentially expressed
genes and the complexity of related pathways that have
been identified in each CNT toxicogenomic in vitro and
rodent study listed in Table I. They include apoptosis,
inflammation, oxidative stress, fibrosis, cell cycle and pro-
liferation, among others.
The objective of finding a particular set of genes that
could be related with nanofiber exposure often relies on
their previously known participation in cellular pathways
suspected to be critical for the observed toxic effects, as
seen in Table I for cancer. The selection of genes to be
further analysed, from the original gene sets, based on
their foreseen participation in processes like inflammation
or fibrosis can simplify the data analysis (Guo et al.,
2012; Dymacek et al., 2015; Snyder-Talkington et al.,
2016a). Nevertheless, this biased approach (the so-called
candidate gene approach) can let unlooked other impor-
tant pathways leading to the toxicity of the stressor. Some
examples are given below.
InVitro Studies
Cancer-related gene expression and signaling pathway
alterations following exposure to CNT are frequent end-
points of toxicological studies. There is compelling evi-
dence that human lung epithelial cells chronically
exposed to SWCNT, that is, continuously exposed to low,
physiologically relevant concentrations of SWCNT for a
prolonged period of 6 months, leads to carcinogenesis by
the acquisition of cancer stem cells (CSC) subpopulations,
which possess high tumorigenic potential. These CSC
have characteristics similar to those observed in the cells
of non-small cell lung cancer and chronic asbestos-
exposed lung cells and display aberrant stem cell markers,
notably Nanog, SOX-2, SOX-17, and E-cadherin, and the
specific stem cell surface markers CD24low and CD133high
(Luanpitpong et al., 2014).
Long-term in vitro exposure of normal lung epithelia to
SWCNT showed malignant cell transformation with
altered expression of several genes involved in apoptosis,
cell cycle control and oncogenic progression (activation
of pAkt/p53/Bcl-2 signaling axis, increased expression of
the Ras family involved in cell cycle control, Dsh-
mediated Notch 1, and down-regulation of the apoptotic
genes BAX and PMAIP1). Activated immune responses
were among the major changes of biological function
(Chen et al., 2015). Moreover, SWCNT exposure of pri-
mary normal human bronchial epithelial and alveolar cells
resulted in down-regulation of the mRNA expression and
consequent enzymatic activity of the drug-metabolizing
enzymes CYP1A1 and CYP1B1, as a consequence of pre-
venting the binding of activated aryl hydrocarbon receptor
(AhR) to the enhancer region of the corresponding genes.
Down-regulation of these enzymes may affect detoxifica-
tion of xenobiotics, may reduce the procarcinogen bioacti-
vation in the lungs and alter the metabolism of drugs in
this organ (Hitoshi et al., 2012).
Regarding MWCNT exposure, the comparative analysis
of asbestos- and MWCNT-induced effects in epithelial
lung cells revealed that both materials triggered changes
in 12 mesothelioma related genes and 22 lung cancer
genes (Kim et al., 2012).
Furthermore, both MWCNT and asbestos seem to
decrease mitochondrial membrane potential in human
bronchial epithelial BEAS-2B cells at a dose of 0.25 and
2 mg/cm2, respectively. This decrease was associated with
a 330-gene signature; 49 of those genes show highly sim-
ilar expression patterns over time and are regulated by
two transcription factors, APP and NRF-1 (Nymark et al.,
2015).
Studies in Rodents
When analyzing the relationship between MWCNT and
carcinogenesis using mice exposed by pharyngeal
aspiration, 7 and 11 biomarker genes showed significant
expression changes at 7 and 56 days post-exposure,
respectively. In particular Ccdc99, Msx2, NOS2, and
Wif1, were differentially expressed at both time points.
These gene signatures were suggested as of possible util-
ity for medical surveillance of MWCNT exposed workers
(Pacurari et al., 2011). In another genome-wide study per-
formed in C57BL/6J mice exposed to MWCNT, a 35-
gene signature identified at 56 days post-exposure and a
further set of 16 consistently differentially expressed
genes was found to be potentially useful to predict lung
cancer risk in humans (Guo et al., 2012). Nevertheless,
even using the same experimental model, different
MWCNT can have dissimilar genomic responses. A long/
thick MWCNT (NM-401) and a small/thin curled
MWCNT (NRCWE-026) showed overall similar changes
in gene expression, but a subset of 14 genes was specifi-
cally associated with the long MWCNT, possibly linked
to the increased fibrotic response at day 28 post-exposure,
observed in vivo only for this MWCNT (Poulsen et al.,
2015). When comparing MWCNT and asbestos toxicity,
although similar outcomes are observed (inflammation
and fibrosis), they may be mediated by the activation of
different cellular signaling pathways through a different
gene expression profile. The exposure to MWCNT tends
to favor pathways involved in immune responses, namely,
canonical interleukin and B- and T-cell signaling, whereas
asbestos exposure tends to favor pathways involved in
ROS production, electron transport, and cancer (Snyder-
Talkington et al., 2016a).
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Similar biological responses through different molecu-
lar mechanisms are well known findings between in vivo
and in vitro systems. In fact, although most of the altered
pathways that were identified are shared between the two
experimental models, the specific genes that are involved
are different (Poulsen et al., 2013). Moreover, although
differences in gene expression exist between in vivo and
in vitro exposure to CNT, in vitro exposures can effi-
ciently recapitulate the significantly altered molecular
functions in vivo (Kinaret et al., 2017).
In a near future, the meta-analysis of the large tran-
scriptomic datasets that are becoming available in the lit-
erature will possibly allow the validation of the proposed
up- or down-regulated genes to be made. Noteworthy is
the fact that the comparison of gene expression profiles
from the lungs of mice exposed to three different
MWCNT within the framework of an adverse outcome
pathway (AOP) for lung fibrosis, permitted the calculation
of transcriptional benchmark doses (BMD) for MWCNT-
induced lung fibrosis (Labib et al., 2016). These transcrip-
tional BMD were comparable to the apical BMD derived
by NIOSH for MWCNT-induced lung fibrotic lesions,
suggesting that they could be used to establish acceptable
levels of exposure applicable to human health risk assess-
ment. Nevertheless, the comparative analysis of the tran-
scriptomic results available in the literature is still a
challenging task.
A Representative Functional Network and Gene Ontology
Enrichment Analysis
In this section of the review, a simple comparison of
the altered gene sets presented in the four studies listed in
Table I that share the same animal model (C57BL/J6
mice), exposed to a similar CNT (Mitsui-7) is presented,
in order to evaluate the consistency of the ‘‘omics’’
findings among them. It should be noted that in the study
by Guo et al. (2012) only 59 differentially expressed
genes were accounted for, because the full list was not
available. The result of this comparison is shown in Fig-
ure 4 that highlights the limited concordance among the
published data.
The reduced number of overlapping genes among the
four studies may be due to several factors: different expo-
sure methods and doses, different time points of analysis,
different RNA quantitation (RT-PCR or microarray) or
even different selection of microarray probe sets. More-
over, an important number of commonly expressed genes
was uniquely identified between the Poulsen et al (2013)
and the Snyder-Talkington et al. (2016a) studies, probably
because they were the ones with the largest transcrip-
tomic dataset, that is, 1,635 and 720 genes, respectively.
This fact supports the need of analyzing a large number
of genes in order to reach sufficient statistical power.
Nonetheless, the same significant gene expression changes
observed in both studies occurred at exposure doses that
differ by up to two orders of magnitude (Table II). This
can possibly be explained by the different experimental
setup: in the Snyder-Talkington et al. (2016a) study, the
animals were sacrificed 1 year after a single pharyngeal
aspiration whereas in the Poulsen et al. (2013) study, the
animals were sacrificed 24 hr after a single intratracheal
instillation and a higher acute dose was needed to reach
the same transcriptional alteration. Nevertheless, when the
overlapping gene list was filtered for genes related to
inflammation and fibrosis using the IPA analysis in these
two reports, their number was reduced to four genes
related to inflammation (Ccl19, Ccl5, Cd14, and Myd88)
and none related to fibrosis. Since inflammation and fibro-
sis are the two main pulmonary adverse effects associated
with CNT exposure, the lack of overlapping fibrosis-
related genes was an unexpected finding. It should be
noted that these differentially expressed genes have to be
confirmed by independent studies, as it is usually done,
for instance, in all genome-wide association studies, to
validate the positive findings.
In view of the fact that the genes listed in Table II rep-
resent the largest set of overlapping genes found in the
various studies, a network analysis of the possible exist-
ing interactions among them was additionally performed.
The obtained functional interaction (FI) network consists
of 32 genes structured according to four different modules
of highly-interacting groups of genes and 17 linker genes,
that is, genes included to connect the input genes in the
network (Fig. 5).
The pathway enrichment results are showed in Table
III. This set of 41 genes was also analysed using PAN-
THER Overrepresentation Test annotation version 11.0
(release 2016-07-15) with the Bonferroni correction and a
P value 0.05. Gene Ontology enrichment analysis iden-
tified helicase activity (GO:0004386) as the single
enriched molecular function (P value5 1.27E-02) and the
Fig. 4. Venn diagram showing the overlapping differentially expressed
genes in the available transcriptomic datasets on the effect of Mitsui-7 on
C57BL/6J mice. Guo et al. (2012), Pacurari et al. (2011) and Snyder-
Talkington et al. (2016a) studies do not have any gene in common among
them, but all these three studies share some genes with the Poulsen et al.
(2013) study, which has the largest gene set. Therefore, all studies
together have no common altered gene expression. Nevertheless, there are
41-shared genes between the Poulsen et al. (2013) and the Snyder-
Talkington et al. (2016a) study. The Guo et al. (2012) study does not pre-
sent the complete gene set, but only the genes selected for further analy-
sis. All these toxicogenomic studies were performed using microarray
technology, except Pacurari et al. (2011) that used RT-PCR.
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TABLE II.Limited concordance of the transcriptomic published data. Overlapping differentially expressed genes identified in
the publicly available gene sets from Poulsen et al. (2013) and Snyder-Talkington et al. (2016a) following mouse exposure to
different doses of the MWCNT Mitsui-7
Poulsen et al. (2013; intratracheal instillation; 24 hr)
Dose (mg/animal) 18 mg 54 mg 162 mg
Snyder-Talkington et al. 2016a
(pharyngeal aspiration; one year)
1 mg Ddx21 Ddx21
Gzma
Nudt8
Sp110
10 mg Kcna6
Spcs3
Sprr1a
Wdr74
H2afv Brix1
Ccl19
Cd72
Fam188a
H2afv
Kcna6
Myd88
Npc2
Nubp2
P2rx4
Sprr1a
Wdr74
40 mg Cdc14a
Emp3
Mcm5
Wdr74
Blnk
Brix1
Ccl5
Cd14
Cd19
Cd2
Cd72
Cdc14a
Cirbp
Hexb
Ltb
Ly6a
Ly6d
Mrps18b
Nt5e
Pinx1
Rnase6
Rps8
Spib
Ufd1l
Wdr74
80 mg Emp3
Wdr74
H2afv Blnk
Ccl5
Cd19
Cd2
Cd72
D130062J21Rik
Ddx5
H2afv
Irf1
Ltb
Mthfd1l
P2rx4
Pinx1
Ufd1l
Wdr74
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response to interferon-gamma (GO:0034341) as the only
enriched biological process (P value5 4.55E-02) among
the set of 41 genes.
As can be observed in Table III, most biological pro-
cesses annotated in the network are regulatory processes
(e.g., the positive regulation of endocytosis, presumably
involved in the nanofiber uptake by the cells). The molec-
ular functions are related to receptor binding signaling.
Accordingly, the annotated pathways include cell receptor
induced pathways (e.g., B cell receptor signaling and
Toll-like receptor signaling), and their downstream path-
ways (e.g., NF-kB signaling).
The results obtained suggest that the activation of the
innate immune cells, including macrophages and other
cells contributing to immunity (epithelial cells, endothelial
cells, and fibroblasts) depends on the nanofiber recogni-
tion by Toll-like receptors (TLR) as already described for
other PAMPs (Takeuchi and Akira, 2010). The binding to
TLR up-regulates the transcription of genes that encode
proinflammatory cytokines, type I interferons, and chemo-
kines, through the nuclear translocation of transcription
factors such as NF-kB. As seen above, NF-kB activation
was observed in a dose-dependent manner in normal and
malignant mesothelial cells and RAW264.7 macrophages
exposed to SWCNT (Pacurari et al., 2008; He et al.,
2012), and in A549 epithelial lung cells exposed to
MWCNT (Ye et al., 2009). TLR stimulation also up-
regulates the expression of hundreds of genes in macro-
phages, and induces the expression of noncoding RNAs
(Takeuchi and Akira, 2010). Helicase activity is required
for the transcriptional regulation of all these pathways
and, consequently, it is expected to be predominantly pre-
sent in the network. The enrichment of the response to
interferon gamma (IFN-g) is also expected, as IFN-g is a
potent endogenous inducer of the pro-inflammatory type-1
phenotype in tissue macrophages via signal transducer
and activator of transcription 1 (STAT1). STAT1 ampli-
fies the signal of cytokines and enhances macrophage
Fig. 5. Functional interaction network analysis of the 41 shared differentially expressed genes. Different colors indicate
sub-networks of functionally related genes. The network was constructed using the ReactomeFIVIz app (Wu et al.,
2014) from Reactome (Croft et al., 2013; Fabregat et al., 2016) and Cytoscape v3.3.0 (Shannon et al., 2003). This app
accesses the Reactome functional interaction network to reveal the interactions of a group of genes.
Environmental and Molecular Mutagenesis. DOI 10.1002/em
354 Ventura et al.
59
responses to TLR ligands. IFN-g can also inactivate feed-
back inhibitory loops, such as those mediated by IL-10
and STAT3. IFN-g may be particularly important in early
immune responses when the low IFN-g concentrations
transiently induce expression of a small subset of IFN-g-
inducible genes, including STAT1 that accumulates in
primed macrophages, with concomitant activation of
downstream STAT1-dependent genes and inflammatory
functions (Boehm et al., 1997; Hu et al., 2008; Su et al.,
2015).
All these results are compatible with the immunotoxic
adverse effects that were reviewed above, and represent
pathways that should be further investigated to test their
relevance to the pulmonary toxicity of Mitsui-7. In this
context, it should be recalled that Rimbach et al. (2000)
reported that macrophages stimulated by IFN-g increased
NF-kB transactivation in primary human endothelial cells,
accompanied by an increase in the monocyte chemoat-
tractant protein (MCP-1) mRNA, which in turn stimulates
the monocyte recruitment into the arterial wall. It was
suggested that the influx of stimulated monocytes into the
subendothelial space could lead to endothelial dysfunc-
tion. Moreover, IFN-g upregulates the expression of
TLR2–5 mRNA and accelerates the up-regulation the NF-
kB activation induced by PAMPs in biliary epithelial
cells (Harada et al., 2006). It would be pertinent to inves-
tigate the relevance of these observed biological effects in
the epithelial lung tissue.
In conclusion, the herein bioinformatics analysis of the
transcriptomic data available in the literature has the
potential of unveiling the molecular pathways of Mitsui-7
pathogenesis in the lungs, indicating future targets for
investigating its mode of action. Conversely, the anno-
tated pathways identified in this exercise, when consid-
ered in isolation from each other, may not allow
differentiating Mitsui-7 exposure from that of other
inhaled toxicants. In fact, the identification of a molecular
signature of CNT exposure that could be useful as a spe-
cific biomarker would benefit from the comparison
between these gene expression profiles and the ones pro-
duced by other inhaled materials, such as asbestos or car-
bon black, using a similar strategy. Snyder-Talkington
et al. (2016a), using a transcriptomic approach, showed
that MWCNT and asbestos affected different gene sets
and related pathways, suggesting dissimilar modes of
action, even though they produce similar major outcomes.
TABLE III.KEGG pathways, 10 major GO biological processes and molecular functions identified in the 41-gene interaction
network using Cytoscape, with a false discovery rate (FDR) of 0.1
Pathways in Network (KEGG) P value Nodes
NF-kappa B signaling pathway 8,07E-04 MYD88,LTB,BLNK,CCL19,CD14
B cell receptor signaling pathway 9,07E-04 CD72,BLNK,CD19
Pertussis 1,39E-03 MYD88,IRF1,CD14
Hematopoietic cell lineage 2,43E-03 CD2,CD19,CD14
Toll-like receptor signaling pathway 3,82E-03 CCL5,MYD88,CD14
Primary immunodeficiency 3,82E-03 BLNK,CD19
Top 10 Biological Processes (GO) P value Nodes
Positive regulation of interleukin-12 biosynthetic process 1,23E-04 LTB,IRF1
Positive regulation of tumor necrosis factor production 2,26E-04 CD2,CCL19,CD14
Positive regulation of endocytosis 6,60E-04 CCL19,CD14
Dendritic cell chemotaxis 7,56E-04 CCL5,CCL19
Cellular calcium ion homeostasis 8,32E-04 HEXB,CCL5,CCL19
Leukocyte cell-cell adhesion 1,33E-03 CCL5,NT5E
Positive regulation of calcium ion transport 1,75E-03 CCL5,P2RX4
Lymphocyte chemotaxis 2,07E-03 CCL5,CCL19
Regulation of chronic inflammatory response 2,66E-03 CCL5
Adenosine biosynthetic process 2,66E-03 NT5E
Top 10 Molecular Functions (GO) P value Nodes
Chemokine receptor binding 2,17E-04 CCL5,CCL19
Receptor binding 7,26E-04 CD72,CD2,LTB,UFD1L,P2RX4
Receptor signaling protein tyrosine kinase activator activity 2,66E-03 CCL5
Opsonin receptor activity 2,66E-03 CD14
Peptidoglycan receptor activity 2,66E-03 CD14
Chemokine receptor antagonist activity 2,66E-03 CCL5
TIR domain binding 2,66E-03 MYD88
Beta-N-acetylhexosaminidase activity 5,32E-03 HEXB
Chemokine activity 7,02E-03 CCL5,CCL19
50-nucleotidase activity 7,96E-03 NT5E
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In line with the present findings, MWCNT exposure
tended to impact on genes and pathways involved in
immune responses (Snyder-Talkington et al., 2016a).
Regarding carbon black, although the inflammatory and
immune responses, or the chemokine signaling, are also
among the up-regulated biological pathways identified in
exposed C57/BL6 mice (intratracheal instillation), other
up-regulated genes and related pathways were found, for
example, those governing cholesterol and sterol metabolic
processes that do not overlap the ones herein identified
for Mitsui-7 (Bourdon et al., 2012). This may indicate
that the above described expression profiles are globally
associated with exposure to MWCNT with physicochemi-
cal properties similar to Mitsui-7, which can further con-
tribute to a previously proposed grouping strategy
(Braakhuis et al., 2016, Dekkers et al., 2016). On the
other hand, the lack of reproducibility of the four suppos-
edly similar transcriptomic studies analysed is worrying,
and more studies with larger transcriptomic datasets are
needed to validate these findings. Clearly, relevant doses
and time points concerning human exposure should be
harmonized to allow inter-comparability of the results.
Toxicoepigenomics
Several nanomaterials seem to cause epigenetic altera-
tions (Stoccoro et al., 2013; Lu et al., 2016), and CNT
have been shown to contribute to global DNA hyperme-
thylation in A549 cells (Li et al., 2016). miRNA expres-
sion profiling is a frequent epigenetic research area.
miRNAs are small non-coding RNAs (19–25 nucleotides)
involved in nearly all key biological processes (Ha and
Kim, 2014). They represent one of the oldest and broad-
est mechanisms of gene regulation, usually acting as
endogenous repressors of gene activity via transcriptional
repression and degradation of mRNA. Lung has a very
specific miRNA expression profile, essential in its devel-
opment and homeostasis. Several pulmonary diseases
such as chronic obstructive pulmonary disease, asthma,
cystic fibrosis, pulmonary hypertension and lung cancer
have been associated with alterations in the expression of
lung related miRNAs (Yanaihara et al., 2006; Rupani
et al., 2013; Sessa and Hata, 2013). Effectively, serum
and plasma miRNAs have been successfully evaluated in
a wide range of solid cancers as promising biomarkers of
early disease onset or relapse (Redova et al., 2013). For
instance, several up- or down-regulated miRNAs have
been reported in malignant mesothelioma tumors, and
some of them have been suggested as potential bio-
markers for histopathological subtyping of tumors (Guled
et al., 2009; Busacca et al., 2010; Kubo et al., 2011; Ak
et al., 2015) or as potential regulators of the adenoma to
adenocarcinoma transition (Snyder-Talkington et al.,
2016b). miRNA differential expression was also related
to asbestos exposure, with 13 asbestos-related differen-
tially-expressed miRNAs and corresponding target genes
identified, including over-expression of the squamous cell
carcinoma-associated miR-205, linked to down-regulation
of the DOK4 gene (Nymark et al., 2011).
Few studies have been performed on the expression of
miRNAs following exposure to CNT (Li et al., 2011;
Dymacek et al., 2015; Snyder-Talkington et al., 2016b;
Nymark et al., 2015). One of those studies applied SOLiD
sequencing, a high-throughput deep sequencing method,
to mouse embryo-derived NIH/3T3 cell small RNAs.
After filtering the sequencing reads and comparing with
miRBase database, the research ended up with 172 altered
miRNAs (Li et al., 2011). In another study, the chosen
technique was a microarray containing 704 mouse
miRNA probes covering 714 mature miRNAs (Dymacek
et al., 2015).
When the results of one-day exposure to MWCNT
obtained in the Dymacek et al. (2015) study are compared
with those of the Li et al. (2011) study for 100 and
80 mg, respectively, the microarray technique identified
only eight miRNAs versus the 172 miRNAs identified in
the SOLiD sequencing study. From these eight miRNAs,
only five were shared by both studies (miR-125b, miR-
223, miR-296, miR-29b, and miR-382). Nevertheless, Li
et al. (2011) used an in vitro system with NIH/3T3 cells,
whereas Dymacek et al. (2015) performed an in vivo
study with total RNA extracted from frozen mouse lung
tissue. Thus, the discrepant miRNAs can be related to
cell/tissue specificity. Furthermore, although miR-1275 is
a possible key regulator of the BEAS-2B cells mitochon-
drial membrane potential decrease after exposure to
MWCNT and asbestos fibers (Nymark et al., 2015), it
was not identified in the two other referred studies. More-
over, from the three other differently expressed miRNA
of the Nymark et al. (2015) study (miR-1225-5p, miR-
29b-1–5p, and miR-4672) only one is in the above-
mentioned five shared miRNAs.
miRNAs are highly sensitive, reproducible, specific and
stable in serum (Chen et al., 2008). Therefore, epige-
nomic studies targeting miRNAs are a promising area of
research aiming to identify biomarkers suitable for
monitoring human exposure, especially in occupational
settings. For example, in mouse, serum miR-122 demon-
strated a sensitivity at least as good as alanine amino-
transferase and aspartate aminotransferase to predict liver
adverse effects induced by silica (nSP70; Nagano, Higa-
shisaka, and Kunieda, 2013) and miR-103 has been
already suggested as a possible biomarker for mesotheli-
oma using the cellular fraction of human peripheral blood
(Bru et al., 2012). Cancer-specific miRNA expression
profiles in whole blood samples are not determined by a
single cell type, for example, leukocytes of lung cancer
patients show a cancer-specific miRNA expression profile,
including the up-regulation of miR-21, which is associ-
ated with poor lung cancer prognosis (Leidinger et al.,
2014).
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Regarding MWCNT, the study of whole blood col-
lected from mice after inhalation exposure has correlated
the FCRL5 gene and miR-122-5p to the presence of
hyperplasia, the MTHFD2 gene and miR-206-3p to the
presence of fibrosis, the FAM178A gene and miR-130a-3p
to the presence of bronchiolo-alveolar adenoma, and the
IL7R gene and miR-210-3p to the presence of bronchiolo-
alveolar adenocarcinoma, among others (Snyder-Talking-
ton et al., 2016b). These miRNA changes are potential
blood biomarkers for MWCNT-induced lung pathological
changes.
In the near future, miRNA profiling in biological sam-
ples may become a tool to identify exposure to individ-
ual, or to groups of similar toxicants. As the above-
mentioned studies seem to point out, for example, the Li
et al. (2011) study, CNT exposure apparently causes up-
or down-regulation of cellular pathways through differen-
tial miRNA expression. If these cellular pathways are
specific, individually or as a whole, these miRNA profiles
can be useful as biomarkers of exposure to individual
CNT or to CNT with similar physicochemical properties.
In addition, bioinformatics tools are being continuously
developed to facilitate the establishment of a linkage
between the miRNAs identified, the mRNAs they regu-
late, and the corresponding genes. Therefore, the molecu-
lar and biological pathways that are involved in the
response to xenobiotics can be elucidated through miRNA
research. In fact, the relationship between specific miR-
NAs and adverse outcomes has already been established
in lung cancer, as discussed above, although in many
cases, the precise mechanisms underlying miRNA up- or
down-regulation remain unknown.
CONCLUSIONS AND PROSPECTS
Toxicological data from in vitro and in vivo studies
have suggested that some CNT represent a risk factor for
respiratory disease that may parallel that of asbestos. Cur-
rent knowledge of the high morbidity and mortality asso-
ciated with the past occupational exposure to asbestos
prompts the need for a thorough risk assessment of CNT
to allow risk management by regulatory authorities. Fur-
thermore, the lack of molecular biomarkers suitable for
exposure and biological effects assessment, before the
onset of potential disease, makes CNT biomonitoring
evenly difficult, particularly in the context of occupational
exposure. New hopes have arisen with the development
of genomic high-throughput technologies, although the
‘‘omics’’ data presently available are still complex and
hard to interpret. Nevertheless, in this review it is shown
that their meta-analysis can prove to be a valuable tool to
discover unique expression patterns, and to identify con-
sistent molecular and biological pathways involved in
lung pathology from CNT exposure. Furthermore, in
terms of mechanistic investigation, it will be important to
further elucidate how the molecular pathways identified
in this analysis contribute to the pulmonary toxicity of
CNT, for example, provide new insights on the relevance
of Toll-like receptor signaling, NF-kB activation, or
response to IFN-g to the adverse effects of CNT. This
knowledge can allow grouping approaches towards CNT
clustering according to their similar mode of action, and
contribute to a safer CNT design through the modification
of the properties identified as more critical to their toxic-
ity, for example, their surface area or functionalization.
Although the epigenomic data are still scarce, CNT have
been shown to contribute to global DNA hypermethyla-
tion, and the differentially expressed miRNA can have a
potential role in the identification of affected regulatory
pathways and even as biomarkers for occupational health
studies. However, if the difficulty to compare the
‘‘omics’’ findings from in vitro studies and in vivo studies
has been highlighted, other difficulty to overcome is the
extrapolation of results between species. Another perti-
nent topic for research would be to find out the role of
polymorphisms in genes involved in DNA damage repair
pathways as modifiers of the individual susceptibility to
the adverse effects of CNT exposure. However, it should
not be forgotten that this potential usefulness of bio-
markers for risk management and health protection in the
workplace can be misused for worker selection and dis-
crimination. Thus, an appropriate ethical framework
should be put in place before its application, ensuring
personal data confidentiality.
Nevertheless, all genomic and epigenomic information
will need to be first validated through data gathered from
workers with known levels of exposure to CNT. Only
then, the most needed development of reliable omics-
based biomarkers to allow an early detection of potential
health impacts and the implementation of preventive or
mitigating strategies will be achievable. This reinforces
the need for biomonitoring studies in occupational
settings.
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A B S T R A C T
Cellulose nanofibrils (CNF) are manufactured nanofibres that hold impressive expectations in forest, food,
pharmaceutical, and biomedical industries. CNF production and applications are leading to an increased human
exposure and thereby it is of utmost importance to assess its safety to health. In this study, we screened the
cytotoxic, immunotoxic and genotoxic effects of a CNF produced by TEMPO-mediated oxidation of an industrial
bleached Eucalyptus globulus kraft pulp on a co-culture of lung epithelial alveolar (A549) cells and monocyte-
derived macrophages (THP-1 cells). The results indicated that low CNF concentrations can stimulate A549 cells
proliferation, whereas higher concentrations are moderately toxic. Moreover, no proinflammatory cytokine IL-
1β was detected in the co-culture medium suggesting no immunotoxicity. Although CNF treatment did not
induce sizable levels of DNA damage in A549 cells, it leaded to micronuclei formation at 1.5 and 3 μg/cm2. These
findings suggest that this type of CNF is genotoxic through aneugenic or clastogenic mechanisms. Noteworthy,
cell overgrowth and genotoxicity, which are events relevant for cell malignant transformation, were observed at
low CNF concentration levels, which are more realistic and relevant for human exposure, e.g., in occupational
settings.
1. Introduction
Nanocellulose is an advanced material that exhibits unique char-
acteristics, depending on the source and production method. These
include high specific surface area, high aspect ratio (length to width
ratio) and high tensile strength and stiffness, besides being renewable
and biodegradable in nature (Eichhorn et al., 2010; Abdul Khalil et al.,
2014; Nechyporchuk et al., 2016). Cellulose nanofibrils (CNF), also
referred to as cellulose nanofibres or nanofibrillated cellulose, are
usually obtained from wood, cotton, hemp, flax, sugar beet or potato
tuber. Depending on the source and on the production method, the size
of the fibrils can vary significantly, but usually nanofibrils are defined
as materials with diameters inferior to 100 nm and lengths in the mi-
crometer scale (TAPPI standard proposal WI3021, Chinga-Carrasco
et al., 2011; Kangas et al., 2014). CNF are produced by intensive me-
chanical treatment, such as in a high-pressure homogenizer (Li et al.,
2012; Osong et al., 2016; Siró and Plackett, 2010), usually combined
with a chemical or enzymatic pre-treatment to reduce energy
consumption. One of the most effective pre-treatments is an oxidation
mediated by 2,2,6,6-tetramethylpiperidine-1-oxyl radical (TEMPO) that
introduces carboxylate and aldehyde functional groups in the cellulose
fibres, making them highly negative and more suitable for their de-
construction process (Isogai et al., 2011; Lourenço et al., 2017; Saito
and Isogai, 2007). CNF exhibits exceptional high mechanical resistance
and low density, being a prime candidate for strength-enhancement of
the mechanical properties of other composite materials, such as paper,
carton and packaging materials. They also have a wide array of appli-
cations in the form of gels or emulsions, e.g., as a rheology modifier.
Due to its likely biocompatibility, CNF have been investigated in re-
generative medicine as scaffolds for tissue-engineered meniscus, blood
vessels, ligaments or tendons (Jia et al., 2013; Lin and Dufresne, 2014;
Mathew et al., 2012, 2013). Other biomedical applications of CNF are
on wound healing (Basu et al., 2017; Hakkarainen et al., 2016; Jack
et al., 2017; Sun et al., 2017; Syverud et al., 2011), stem cell decorated
threads for surgical suturing (Mertaniemi et al., 2016), haemodialysis
membranes (Ferraz et al., 2013), long-lasting sustained drug delivery
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systems (Kolakovic et al., 2012) or 3D cell culture scaffolds
(Bhattacharya et al., 2012; Lou et al., 2014; Malinen et al., 2014).
The production of CNF at an industrial scale and its application in a
multiplicity of products and biomedical devices can represent a po-
tential hazard to workers along the lifecycle and to consumers, as well.
Vartiainen et al. (2011) concluded that workers’ exposure to particles in
the air during grinding and spray drying of birch cellulose was low or
non-existent with the implementation of appropriate protection
equipment and proper handling. However, the high aspect ratio of CNF
and its biodurability in the human lungs (Stefaniak et al., 2014) re-
sembles the fibre paradigm that has been associated to the adverse ef-
fects of other fibrous nanomaterials (e.g., carbon nanotubes, CNT).
Therefore, to ensure the safety of CNF to humans prior to their large-
scale commercialization, it is of utmost importance to investigate their
potential toxicological properties, particularly their genotoxicity that is
closely associated to carcinogenicity.
Most toxicological studies have focused on nanocellulose types with
morphological and surface chemical characteristics different from the
above-mentioned CNF. These include bacterial nanocellulose (Jeong
et al., 2010; Lin and Dufresne, 2014; Moreira et al., 2009; Pertile et al.,
2012; Saska et al., 2012; Scarel-Caminaga et al., 2014) and nanocrys-
talline cellulose (Catalán et al., 2015; Clift et al., 2011; Dong et al.,
2012; Kovacs et al., 2010; Shvedova et al., 2016; Yanamala et al.,
2014). These nanocellulose types are generally considered as nontoxic,
although nanocrystalline cellulose could induce low cytotoxicity and
immunotoxicity in vitro and in vivo (Clift et al., 2011; Yanamala et al.,
2014). Regarding CNF, the few published studies mainly indicate no
relevant cytotoxic, genotoxic or immunotoxic effects (Alexandrescu
et al., 2013; Colić et al., 2015; Nordli et al., 2016; Pitkänen et al., 2014;
Vartiainen et al., 2011). Nevertheless, a recent study by Catalán et al.
(2017) showed that C57Bl/6 mice exposure by pharyngeal aspiration to
CNF produced through TEMPO oxidation led to an acute lung in-
flammatory response and induced DNA damage in lung cells. However,
it cannot be completely excluded that the effects observed were related
to the presence of LPS, given that no information about this issue is
provided. Moreover, Lopes et al. (2018) reported that an unmodified
CNF induced a pro-inflammatory effect in THP-1 macrophages that
could be moderated by the introduction of surface modifications (Lopes
et al., 2018). Thus, more investigation is clearly required to create a
knowledge basis to assess the human health risk from exposure to CNF.
The present study aimed at investigating the immunotoxic and
genotoxic effects of a CNF produced from industrial bleached Eucalyptus
globulus kraft pulp fibrillated by a combination of high pressure
homogenization with a preliminar oxidation mediated by TEMPO on a
co-culture of A549 human lung epithelial alveolar cells and THP-1
monocyte-derived macrophages. Nowadays, it is recognized that co-
culture systems best mimic the in vivo toxicological potential of nano-
materials and are more realistic models as compared to monocultures
(Snyder-Talkington et al., 2012, 2015). Macrophages are well-re-
cognized primary immune cells in the forefront of the defence system
through the engulfment of foreign material from tissues, and alveolar
macrophages can play a key role in the biological response to inhaled
nanofibres. Histological analysis of mouse lung tissue has demonstrated
CNF accumulation in the cytoplasm of lung macrophages (Catalán
et al., 2017), and it has been suggested that the acidic pH of the mac-
rophage phagolysosome is insufficient to degrade nanocellulose
(Stefaniak et al., 2014). Thus, nanocelluloses are likely to be cleared by
mechanical movement of macrophages out of the alveoli and eventually
to the mucociliary escalator. This knowledge reinforces the relevance of
incorporating THP-1 monocyte-derived macrophages in the A549 cell
culture to reflect more realistically, in an in vitro system, the in vivo
biological response to CNF exposure.
2. Materials and methods
2.1. Nanocellulose production and characterization
Nanocelluloses were produced from industrial bleached Eucalyptus
globulus kraft pulp. In order to fibrillate the pulp, an oxidation mediated
by TEMPO was applied, according to a procedure described elsewhere
(Lourenço et al., 2017; Saito and Isogai, 2007), followed by mechanical
treatment in a high-pressure homogenizer. For that, the pulp, pre-
viously refined at 4000 rev. PFI, was mixed with TEMPO (0.016 g/g of
fibres) and NaBr (0.1 g/g of fibres) in demineralized water and, after
proper mixing, a NaClO solution (9.7% active chlorine) was slowly
added (5mM/g of fibre). The reaction was carried out for 2 h with pH
constant at 10 by adding NaOH 0.1M. The resultant fibres were thor-
oughly washed with demineralized water until the suspension final
conductivity was low (20 μS/cm). Finally, the pre-treated fibres were
passed 2 times in the homogenizer (GEA Niro Soavi Model Panther
NS3006L), the first one at 500 bar and the second one at 1000 bar, to
reduce the size of the fibrillated fibres to the nanoscale. The final
consistency of the nanocellulose aqueous suspension was 0.83 wt%
exhibiting a gel-like behaviour.
The nanocellulose was characterized for its fibrillation yield,
amount of carboxylic groups, degree of substitution, degree of poly-
merization and size. The yield was determined in duplicate by sub-
mitting a 0.2 wt% nanocellulose suspension to centrifugation at 9000 r/
min for 30min (8965g) in a Hettich Universal 32. The yield was cal-
culated as the percentage of supernatant material (w/w), corresponding
to the nanofibrillated fraction of the sample (Gamelas et al., 2015). The
concentration of carboxyl groups (CCOOH) was determined by a con-
ductometric titration according to a methodology reported elsewhere
(Lourenço et al., 2017): briefly, an aqueous suspension of nanocellulose
(0.1 g dry weight) was well stirred and its pH was set to 3.0 with HCl.
Then, a 0.01M NaOH solution was added until pH 11. The carboxylate
content was determined in triplicate from the conductivity curve and,
from this value, it was possible to estimate the degree of substitution
(DS), taking into account the molar masses of the anhydroglucose units
and of units substituted at the C6 position by COO−Na+ groups, as
explained elsewhere (Lourenço et al., 2017). The degree of poly-
merization (DP) was calculated using the Mark-Houwink equation with
the parameters reported by Henriksson (2008). The intrinsic viscosity
necessary for the calculations was determined by the cupri-ethylene-
diamine methodology (ISO standard 5351). The structure of the fibrils
was assessed by Field emission-SEM (FE-SEM) on 20 g/m2 films pre-
pared by air-drying of a 0.2% (w/v) nanocellulose suspension. The
images were acquired at 500× magnification in a Carl Zeiss Merlin
microscope, in secondary electron mode, using 1 kV voltage. Gold
sputtering (3s) was previously performed. The fibrils diameter was as-
sessed by atomic force microscopy (AFM) in a Bruker Innova micro-
scope using the aforementioned films. The peak force-tapping mode
was used with a tip radius of 8 nm. Several 2× 2 μm scans were ac-
quired and a mean diameter was computed using the Gwyddion soft-
ware. As a complement to this measurement, a non-operator dependent
technique, providing results more representative of the whole sample,
since thousands of fibrils are analysed, was used – the Dynamic Light
Scattering (DLS). For that, the supernatant of the aforementioned cen-
trifugation was analysed in a Zetasizer Nano ZS equipment (Malvern
Instruments) at a scattering angle of 173° and using the CONTIN al-
gorithm to obtain the size distribution. The value reported corresponds
to the smaller peak of the distribution. However, some caution needs to
be taken considering that this technique is not suitable for particles
with such a high aspect ratio as that of the nanocellulose. Nevertheless,
it provides information that may be used for comparison purposes,
namely with samples under similar conditions. Although the CNF was
not tested for LPS contamination, previous studies by Nordli et al.
(2016) showed that the TEMPO-mediated oxidation performed in al-
kaline conditions strongly reduces the LPS content in the sample,
C. Ventura et al. Toxicology Letters 291 (2018) 173–183
174
72
becoming easier to wash out from the fibres after the oxidation process.
Because washing was performed exhaustively in this CNF production it
is unlikely that LPS still persists in the sample.
2.2. Cell culture
The human alveolar epithelial cell line A549 (ATCC, Manassas, VA,
USA, CCL-185) and the human monocytic leukaemia cell line THP-1
(ATCC, TIB-202) were both grown in RPMI 1640 medium (Gibco,
Waltham, MA, USA) supplemented with 10% heat-inactivated foetal
bovine serum (FBSi) (Gibco), 1% penicillin/streptomycin (1.000 U/mL
penicillin and 10mg/mL streptomycin), Gibco) and 1% fungizone
(0.25 mg/mL, Gibco,) at 37 °C in an atmosphere of 5% CO2. The THP-1
monocytes were grown on transwell inserts with a nominal pore size of
0.4 μm (Greiner Bio-One GmbH, Kremsmünster, Austria) at a density of
0.2× 105 cells/mL and differentiated into macrophages by 48 h in-
cubation with 100 ng/mL of 12-O-tetradecanoylphorbol-13-acetate
(TPA, Sigma-Aldrich). The medium was then removed and substituted
by serum-free RPMI 1640 medium for further 48 h, to allow cells to
recover from the TPA effect. The A549 cells were cultured on 12–well
plates at a density of 0.5× 105 cells/mL and the inserts with differ-
entiated THP-1 cells were placed directly on the top of the A549 cells.
The resulting co-culture was incubated for further 24 h in RPMI 1640
medium. To ensure that THP-1 and A549 cells were exposed to the
same CNF concentrations (1.5, 3, 6, 12.5, and 25 μg/cm2) the disper-
sions were added to the apical and basolateral sides of the insert
whenever co-cultures were used.
2.3. MTT assay
The MTT assay was performed according to Mossmann (1983) using
three independent experiments. A549 cells were plated in 96-well
plates and allowed to attach for 24 h at 37 °C and 5% CO2. The cells
were then exposed for 24 h or 48 h to 1.5, 3, 6, 12.5, and 25 μg/cm2 of
CNF in culture medium. These concentrations were prepared from a
stock solution at 1.5 mg/mL of a 0.872% CNF gel diluted in phosphate
buffered saline (PBS) and correspond to the dry weight of the CNF. SDS
(1 μg/mL, Sigma), 1 h exposure, was used as a positive control. After
washing twice with PBS, the cells were incubated for 2 h with fresh
growth medium containing 10% of the MTT solution (5mg/mL, Cal-
biochem, Darmstadt, Germany). The MTT-containing medium was
discharged and DMSO (Sigma) was added for 20min under shaking.
The absorbance was recorded at 570 nm against a reference filter set at
690 nm using a Multiscan Ascent spectrophotometer (Labsystems,
Helsinki, Finland). The relative cell survival of exposed cultures was
expressed as the ratio between the absorbance of the exposed and un-
exposed cultures, assuming that the absorbance of the latter represents
100% cell survival.
2.4. Lactate dehydrogenase (LDH) assay
LDH determination was conducted in the supernatant removed from
CNF-exposed cultures for 48 h, used for the MTT assay. After cen-
trifugation of the supernatant at 4000g for 10min, LDH concentration
was measured using the CytoTox-ONE homogeneous membrane in-
tegrity assay (Promega, Madison, USA). A maximum LDH release con-
trol was performed by the addition of lysis solution to the untreated
control cells before adding Cyto-tox ONE. The percentage of cytotoxi-
city was calculated as the ratio between the concentration of LDH in
each supernatant (subtracting the culture medium background) and the
maximum LDH release (subtracting the culture medium background)
multiplied by 100.
2.5. Clonogenic assay
The clonogenic assay was performed as described by Herzog et al.
(2007). Briefly, a very low density of A549 cells (100 cells) was plated
in each well of a 6-well plate and allowed to attach for approximately
16 h, at 37 °C and 5% CO2. The cells were then exposed to 1.5, 3, 6,
12.5, 25, 50, and 100 μg/cm2 of CNF. For each experiment, negative
(non-treated cells) and positive (0.004 μg/mL mitomycin C, Sigma)
controls were included. Cells were incubated for 8 days, at 37 °C and 5%
CO2 to allow colonies formation. The wells were then washed twice
with PBS, fixed in absolute methanol (Sigma) and stained with 10%
Giemsa (Merck, Darmstadt, Germany) in phosphate buffer, pH 6.8. The
number of colonies formed was counted and the plating efficiency (CE)
was determined using the following equation (Herzog et al., 2007):
CE=100× (no. colonies in negative control/no. of plated cells)
The surviving fraction (SF) for each CNF concentration was calcu-
lated as follows:
SF= no. colonies formed after exposure/(no. of plated cells×CE/100)
The cytotoxicity was determined as the decrease in the SF in rela-
tion to the negative control, based on the results from three in-
dependent experiments.
2.6. Determination of IL-1β secretion
Cell culture supernatants were collected after the 24 h treatment for
the comet assay and stored at −80 °C until analysis. The IL-1β con-
centration in the supernatants of the 1.5, 6 and 25 μg/cm2 treatment
with CNF was determined using a colorimetric sandwich ELISA method
(IL-1β-EASIA Kit, Source, Louvain-la-Neuve, Belgium), according to the
manufacturer's protocol. A positive control was prepared adding
100 ng/μL of lipopolysaccharide (LPS; Sigma) and 5mM adenosine 5′-
triphosphate disodium salt (ATP; Sigma) to the supernatant of the cell
culture in the inserts (Park et al., 2007).
2.7. Comet assay
The A549 and THP-1 cells in co-culture were equally exposed for
24 h to 1.5, 3, 6, 12.5, and 25 μg/cm2 of CNF by adding the corre-
sponding volume of the dispersion medium to both sides of the trans-
well inserts placed on 12-well plates. Ethyl methanesuphonate (EMS,
5mM, Sigma-Aldrich) with an exposure time of 1 h was used as a po-
sitive control. The plates were washed with PBS and harvested after
tripsinization. The comet assay was performed as described in Louro
et al. (2016). Briefly, the cell suspensions were centrifuged (1200 r/
min, 10 min, 4 °C) and the pellets resuspended and embedded in 0.8%
low melting point agarose, then spread onto 1% agarose-precoated
microscope slides (2 gels per slide). Slides were immersed in lysis so-
lution (2.5M NaCl, 100mM EDTA, 10mM Tris, 10% DMSO and 1%
Triton X-100, pH 10) for a minimum of 1 h and washed twice with
enzyme buffer (40mM HEPES, 100mM KCl, 0.5mM EDTA, 0.2mg/mL
BSA, pH 8). The resultant agarose-embedded nucleoids were then
treated either with enzyme buffer or with 50 μL of for-
mamidopyrimidine DNA glycosylase (FpG, kindly provided by Dr. A. R.
Collins, University of Oslo, Norway), for 30min, at 37 °C. The slides
were immersed into cold electrophoresis buffer (0.3M NaOH, 1mM
hydrated Na2EDTA; pH 13) for 30min to allow DNA unwinding under
alkaline conditions followed by a 25min electrophoresis at 0.8 V/cm.
Finally, after 10min neutralization with PBS, slides were rinsed another
10min with destilled water, dried overnight and stained with ethidium
bromide (0.125 μg/μL). Three independent experiments were carried
out, each with two replicates per treatment condition. In each experi-
ment, a total of 100 randomly selected nucleoids (i.e., 50 nucleoids per
gel) were analysed in FpG-treated and untreated gels for each culture,
using an Axioplan2 Imaging epifluorescence microscope equipped with
a high resolution camera (Carl Zeiss Microscopy, Gottingen, Germany).
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Scoring was done with the Comet Imager 2.2 software (MetaSystems,
Althlussheim, Germany), choosing the percentage of DNA in the tail as
a measure of DNA damage. The results represent the Mean ± Standard
Deviation (M ± SD) of three independent experiments.
2.8. Micronucleus assay
The cytokinesis-blocked micronucleus assay was carried out as de-
scribed by Louro et al. (2016). Following the A549/THP-1 cells co-
culture exposure to 1.5, 3, 6, 12.5, and 25 μg/cm2 of CNF for 6 h, cy-
tochalasin B (Sigma) was added to each well at a final concentration of
6 μg/mL. For each experiment, negative (non-treated cells) and positive
(50 μg/mL mitomycin C, Sigma) controls were included. Briefly, at the
end of the 48 h treatment, cells were washed twice with PBS and, fol-
lowing detachment with trypsin-EDTA, cells were submitted to a hy-
potonic shock with a RPMI 1640:dH2O:FBS (37.5:12.5:1) solution,
centrifuged and the pellet spread onto microscope slides. The slides
were dried, fixed in absolute methanol (Sigma), stained with 4%
Giemsa (Merck, Darmstadt, Germany) and air-dried at room tempera-
ture. Slides were scored under a bright field microscope for the pre-
sence of micronuclei (MN), using the criteria described by Fenech
(2007). At least 2000 binucleated cells from two independent cultures
were scored per treatment condition and the results of the frequency of
micronucleated binucleated cells (MNBC) are presented as the M ±
SD. In addition, nuclear buds and nucleoplasmic bridges were also
scored in those binucleated cells and their mean frequency determined.
The proportion of mono- (MC), bi- (BC) or multinucleated-cells (MTC)
was calculated by scoring 1000 cells per treatment and the cytokinesis-
blocked proliferation index (CBPI) was calculated as follows (OECD,
2010): CBPI= (MC+2BC+3MTC)/Total cells. The Replication Index
(RI) was calculated using the following equation:
RI= [(BC+2MTC)/Total cells, in treated cells]/[(BC+ 2MTC)/Total
cells, in untreated cells]
2.9. Statistical analysis
Statistical comparisons of the clonogenic, MTT and comet assays
data between treated and control cells were performed through a one-
way analysis of variance (ANOVA) followed by Tukey's multiple com-
parison test, after testing for the data normality. Then, in the Comet
assay, the two-tailed Student's t-test was used to compare the differ-
ences between the results obtained with and without FpG treatment.
The same test was also used to compare the CBPI results between the
treated and control cells. The 2-tailed Fisher’s exact test was applied to
analyse the results of the frequency of micronucleated cells. All analyses
were performed with the SPSS statistical package (version 22, SPSS Inc.
Chicago, IL).
3. Results
3.1. Nanocellulose characterization
The nanocellulose sample was fully characterized in order to assess
the properties that could be more significant for the cytotoxicity and
genotoxicity tests. For that, their chemical and physical characteristics
(Table 1) were evaluated by measuring the amount of carboxylic groups
attached to the cellulose chain after the TEMPO-mediated oxidation, as
well as the obtained degree of substitution and degree of polymeriza-
tion.
A FE-SEM image of low magnification is presented to show the
structure organization of the cellulose nanofibrils (Fig. 1), in which
agglomeration of the fibrils is observable. The size of the fibrils was
assessed by AFM (Fig. 2). As visible in Fig. 2B, the sample presents a
wide distribution of diameters, with the mode in the 20–25 nm range. A
value for the length of the nanofibrils could not be assessed by AFM
since they are several micrometers long. In fact, for nano-objects with
such a high aspect ratio, this is a common limitation. In order to analyse
a larger number of nanofibrils, a dynamic analyser based on light
scattering was also used. Although not adequate for non-spherical
particles, it provides a comparison between different samples. The re-
sult obtained in this study is of the<50 nm magnitude.
3.2. Cytotoxic effects
Fig. 3 presents the results of the MTT assay and shows that none of
the CNF concentrations tested during a 24-h exposure period induced a
significant cytotoxic effect in A549 cells, as compared to controls
(p > 0.05, one-way ANOVA). Following 48 h of exposure to the same
CNF dose-range, an increase in cells viability was observed for the two
lowest concentrations (1.5 and 3 μg/cm2) and a significant decrease in
cell viability was observed for the two highest concentration tested
(p=0.003 and p=0.0004, respectively). Nevertheless, according to
the ISO 10995-5, a clear cytotoxic effect was observed for the 25 μg/
cm2 concentration only (51 ± 1.42%), whereas the 12.5 μg/cm2 con-
centration decreased cells viability to 72 ± 2.13%, i.e., slightly above
the 70% imposed by international standards. A dose-response effect was
obtained following a potential function (r2= 0.987). The positive
control showed a relative cell viability of 2.1% and 2.6% at 24 h and
48 h, respectively.
Regarding the results of the LDH assay following a 48-h incubation
time, a statistically significant membrane integrity loss was observed
only for the highest CNF concentration tested (p=0.03). Nevertheless,
it should be highlighted that this difference corresponds merely to a 4%
increase in cytotoxicity relatively to control cells (Fig. 4).
The clonogenic assay was additionally used to assess the CNF ability
to impair cell proliferation following a longer exposure period (8 days).
A statistically significant increase in the number of A549 colonies
formed was observed for the 1.5 μg/cm2 of CNF, as compared to con-
trols (p < 0.05, Tukey HDS), followed by a slight non-significant de-
crease in cell proliferation ability for higher CNF concentrations. The
dose-response relationship was fitted to a sigmoidal curve (r2= 0.987,
Fig. 5). The positive control produced a decrease of cells surviving
fraction to 50% relatively to control.
3.3. Immunotoxic effects
Cells exposure to three CNF concentrations (1.5, 6 and 25 μg/cm2)
during 24 h did not induce the release of detectable levels of IL-1β to
the culture medium (detection limit of 0.35 pg/mL). The positive con-
trol had a determination of 57 pg/mL of IL-1β in the cell culture su-
pernatant.
3.4. Genotoxic effects
The genotoxic effects of the CNF under study were assessed by the
comet and the micronucleus assays performed in A549 cells cultured in
the above described co-culture system. The selection of the concentra-
tion-range was based on the results of the cytotoxicity tests with A549
cells monocultures, assuming that the presence of THP-1 cells would
not negatively affect A549 cells viability. The results of the comet assay
(without FpG treatment) revealed a significant genotoxic effect of CNF
in the co-culture of A549 cells and THP-1 differentiated macrophages,
Table 1
Characterization of the nanocellulose sample.
Yield (%) CCOOH (μeq g/g) DS DP dAFM (nm) dDLS (nm)
82.4 1177 0.19 289 25.9 18.5
CCOOH: Carboxyl group content; DS: Degree of substitution; DP: Degree of
polymerization; dAFM,DLS: Diameter (obtained by AFM or DLS).
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following exposure to the highest concentration tested (25 μg/cm2), as
compared to controls (p=0.019 one-way ANOVA, Tukey post-hoc test)
(Fig. 6). However, even for this concentration, the level of DNA damage
measured is quite low (6.68%) and may not have biological relevance.
The DNA damage detected by the comet assay with FpG apart from
DNA single- and double-strand breaks includes also oxidative lesions
that are converted in DNA breaks. For CNF-treated cells the overall
level of DNA breaks was not statistically different from that of control
cells (p > 0.05, ANOVA). The comparison between the mean percen-
tage of DNA in tail obtained with and without FpG treatment was only
statistically significant for cells exposed to 12.5 μg/cm2 of CNF
(p < 0.05) but still within very low levels. The mean percentage of
DNA in tail obtained for EMS, the positive control, was 30.0% and
38.2%, without and with FpG treatment, respectively (Fig. 7).
The frequencies of MNBCs and the CBPI estimated following co-
cultures exposure to CNF are presented in Fig. 8 (and Table 1 Supple-
mentary material). Nanocellulose induced a statistically significant in-
crease in the frequency of MNBCs at the two lowest concentrations (1.5
and 3 μg/cm2) tested (p=0.035 and 0.001, respectively); the fre-
quency of nuclear buds was also significantly increased by 3 μg/cm2 of
CNF (p=0.05). No significant induction of nucleoplasmic bridges was
Fig. 1. Field-Emission SEM of films of cellulose nanofibrils.
Fig. 2. Cellulose nanofibrils AFM image in phase imaging mode (A) and nanofibrils diameter distribution obtained by AFM (B).
Fig. 3. Relative viability of A549 cells after exposure to different concentrations
of CNF (24 h and 48 h) as assessed by the MTT assay. Results are expressed as
M ± SD of 3 independent experiments.
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observed in all CNF concentrations tested.
4. Discussion
The substantial number and variety of nanocellulose applications
has raised the likelihood of human exposure in environmental and oc-
cupational settings, or as consumers and, consequently, has increased
the concern about their potential adverse health effects. All high aspect-
ratio nanomaterials, as nanofibrillated cellulose is, are recommended to
be tested for their toxicity at the first phase of a flow chart developed by
Dekkers et al. (2016) that attempts to prioritize the hazard assessment
of nanomaterials and develop a nanospecific approach for their risk
assessment. For this purpose, several complementary in vitro assays
covering biological effects relevant for the occurrence of long-term ef-
fects, particularly cancer, are used. Compared with in vivo approaches,
in vitro assays to characterize nanomaterials toxicity have shown to
generate results in a simpler, faster and economic manner. Moreover,
they can provide a basis for evaluating potential health risks of ex-
posure and they can give insights into the mechanisms underlying the
effects of nanomaterials on cells (Collins et al., 2017). For example,
measuring the levels of pro-inflammatory cytokines may give a first
indication on the ability of the nanomaterials to cause immunotoxic
effects in vivo whereas the cytotoxicity is central for a good inter-
pretation of the results of the in vitro genotoxicity assays and can pro-
vide also mechanistic information about the interactions with the in-
tracellular organelles, e.g., mitochondria or lysosomes. The strategy for
in vitro genotoxicity testing of nanomaterials needs to include the de-
tection of the most relevant events for the multistep process of malig-
nancy, i.e., DNA damage, clastogenicity and aneugenicity, which are
covered by the combination of the comet assay and the in vitro micro-
nucleus assay (Louro et al., 2015).
In this study, a preliminary safety assessment of a CNF produced by
TEMPO-mediated oxidation of an industrial bleached Eucalyptus glo-
bulus was conducted before its production is scaled-up. Following CNF
production, its physicochemical characterisation showed that a high
fibrillation degree (yield) was achieved, with 100% of the material in
the nanoscale. In fact, with the pre-treatment, a high amount of car-
boxylic groups was introduced in the cellulose molecules, confirmed by
Fig. 4. Cytotoxicity results after a 48 h exposure of A549 cells to a concentration-range of CNF, as assessed by the LDH release assay. Results are expressed as
M ± SD. * p < 0.05.
Fig. 5. Colony forming ability of A549 cells after 8 days exposure to different concentrations of CNF, as assessed by the clonogenic assay. Results are expressed as
M ± SD of the cells surviving fraction relative to control.
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the degree of substitution close to 0.2. The high charge caused repulsion
between the nanofibrils that compose the fibre wall. The subsequent
high-pressure homogenization was therefore able to effectively separate
and break the fibre chains, producing a nanocellulose sample with a
small degree of polymerization. The results are in accordance with the
literature for CNF produced by TEMPO-mediated oxidation applying ca.
5mM NaClO/g of cellulose fibre (Jin et al., 2014; Lourenço et al., 2017;
Saito and Isogai, 2007). As mentioned before, the diameter of the na-
nofibres was assessed by AFM and compared to that obtained from DLS
measurements. The achieved mode of diameter is a common value for
this type of material (Gamelas et al., 2015; Hänninen et al., 2015;
Lourenço et al., 2017), and the DLS result is of the same magnitude of
those obtained for identical nanofibrils (Gamelas et al., 2015; Lourenço
et al., 2017; Mandal and Chakrabarty, 2011).
The cytotoxicity of the CNF was assessed in A549 cells by three
assays spanning different endpoints, from the alteration of cells meta-
bolic activity (MTT assay) or loss of membrane integrity (LDH assay) to
the cells proliferative ability in the presence of the nanofibres. All as-
says revealed the capacity of the highest CNF concentration (25 μg/
cm2) to induce alveolar cells death, following a 48-h or 8 days exposure
Fig. 6. Comet assay results obtained in the co-culture of A549 epithelial cells and THP-1 differentiated macrophages exposed to CNF, without and with FpG addition.
Results are expressed as M ± SD. * p < 0.05.
Fig. 7. A549 cell nucleoids observed under the fluorescence microscope in the comet assay with FpG addition. (A) Non-exposed cells control (B) A549 cells exposed
to 12.5 μg/cm2 of CNF (C) Positive EMS exposed cells control.
Fig. 8. Results of the micronucleus assay after A549 cells ex-
posure to CNF. In columns, frequency of micronucleated bi-
nucleated cells (MNBCs) per 1000 binucleate cells (BNC); the
dotted line represents the cytokinesis-blocked proliferation
index (CBPI). Mitomycin C was used as a positive control and
induced 54.5 MNBNC/1000BNC (p=0.000). Results are ex-
pressed as M ± SD. * p < 0.05.
C. Ventura et al. Toxicology Letters 291 (2018) 173–183
179
77
(Figs. 3–5). In contrast, the 48 h of treatment with the lowest CNF
concentration (1.5 μg/cm2) resulted in a significant increase in cell
viability (MTT assay) and the 8 days treatment stimulated cells pro-
liferation and their capacity to form colonies (clonogenic assay). Thus,
the results of the MTT and the clonogenic assays are in general agree-
ment in that the effect of CNF on cell viability is concentration-de-
pendent whereas the LDH assay revealed a lower sensitivity to detect
CNF influence on cells viability. These findings agree with those re-
ported by Colić et al. (2015), showing a dose-dependent decrease in
L929 fibroblastic cell proliferation and metabolic activity after an in-
cubation of 48 h with a high CNF concentration (250 μg/mL–1mg/mL).
However, as the cell proliferation inhibition was less than 30% and not
associated with cell death or oxidative stress, the CNF was considered
as non-cytotoxic (Colić et al., 2015). It should be noted, however, that
the concentration-range tested in the referred work was much higher
than that herein used and does not encompass the ones that increased
cell proliferation. Other studies have addressed the cytotoxic potential
of nanocelluloses in several cell lines and the majority showed non-
toxic effects following a 24-h exposure, similarly to the data obtained in
this study for the same exposure length. Kollar et al. (2011) observed no
significant effect on THP-1 cell growth and viability after treatment
with six variously modified types of non-nanosized cellulose after 24-h
incubation, except for dialdehyde cellulose that significantly decreased
cell viability. Likewise, Lopes et al. (2018) reported the absence of
cytotoxic effects in THP-1 differentiated macrophages, HDF and MRC-5
cells exposed to three types of CNF for 24 h (Lopes et al., 2018).
Pitkänen et al. (2014) reported no cytotoxic effect of a finest fraction of
CNF in human cervix carcinoma (HeLa229) cells, as assessed by the
highest tolerated dose (HTD) test. However, they reported the inhibi-
tion of cellular growth and viability decrease at the highest dose using
the total protein content (TPC) test (24- and 72-h exposures). Hua et al.
(2015) also reported the absence of toxicity in the indirect cytotoxicity
test performed in THP-1 cells exposed for 24 h to the extract medium of
three differently functionalized CNF films. No toxic effects in indirect
cytotoxicity assays (crystal violet, MTT and LDH) were found in mouse
fibroblasts incubated with the extracts of TEMPO-oxidized CNF and
carboxymethylated CNF during 1, 4, and 7 days (Rashad et al., 2017).
On the other hand, very high concentrations (2–5mg/mL) of a needle-
like cellulose nanowhisker from cotton cellulose were cytotoxic to bo-
vine fibroblasts exposed for 24 h (Pereira et al., 2013); an upregulation
of the expression of stress- and apoptosis-related genes (HSP70.1,
PRDX1 and BAX) was also identified.
None of those studies has reported a stimulation of cell metabolism
upon nanocellulose exposure. A hypothesis for the effect herein ob-
served is that CNF, at low concentrations, may stimulate alveolar cells
to proliferate because they are biocompatible, and they mimic en-
dogenous fibrous structures that may facilitate cell adhesion. Indeed,
the observation under phase contrast microscopy of cells grown during
48 h in the presence of CNF confirmed that they were attached to CNF
aggregates/agglomerates in the bottom of the culture well. At higher
concentrations, however, CNF may slowdown cell proliferation due to
increased mechanical stress, mimicking what has been observed in CNF
hydrogels for 3D cell cultures (Nordli et al., 2016; Malinen et al., 2014).
On the other hand, uncontrolled cell proliferation may also be a con-
sequence of the nanofibre interaction with the mitotic spindle appa-
ratus, as it has been described in vitro for asbestos fibres in various types
of cells (Huang et al., 2011), for 1 to 4 nm width single-walled CNT in
BEAS2B and SAEC cells (Sargent et al., 2009), for 10 to 20 nm thin
multi-walled CNT in BEAS2B cells (Siegrist et al., 2014), and hy-
pothesised for 13 and 14 nm multi-walled CNT in A549 and BEAS2B
cells (Louro et al., 2016). These diameters are close to the ones of the
CNF under study and thereby interference with the mitotic spindle can
be also a plausible explanation for the observed increase in cell viability
at low concentrations. At high concentrations agglomeration/aggrega-
tion occurs and the availability of single CNF to be uptaken by cells and
interact with the spindle fibres greatly decreases. Interestingly, this
effect resembles the induction of fibroblasts proliferation in vitro fol-
lowing exposure to thin and curled dispersed single-walled CNT (Vietti
et al., 2013; Wang et al., 2010) as this CNF is. The fibroblastic response
to CNT is known to play a key role in tissue fibrosis that, in turn, may
result in a carcinogenic effect on the long-term.
Overall, the referred studies evidence the gap that exists regarding
long-term toxicity studies of CNF. Once we observed a significant cy-
totoxic effect only with an exposure length of 48 h or more, there is still
a need of focusing the CNF toxicity studies on longer exposure times
and encompassing the low-dose range. This is particularly important
since low-dose chronic studies are nowadays considered more suitable
experimental models for risk assessment than single acute exposure
studies in that they better mimic human exposure (Oberdörster, 2010).
Immunotoxicity of CNF was assessed by determining the con-
centration of the proinflammatory cytokine IL-1β in the A549 cell co-
culture supernatant. Our finding of unchanged levels of IL-1β in the co-
culture of A549 and THP-1 is in agreement with the overall results from
more comprehensive studies available in the literature that CNF has no
proinflammatory effect (Basu et al., 2017; Colić et al., 2015; Hua et al.,
2015; Mertaniemi et al., 2016; Nordli et al., 2016; Vartiainen et al.,
2011). In addition, toxicological studies on the pulmonary toxicity of
carbon nanotubes have suggested that when the nanofibre length ex-
ceeds the macrophages length, it triggers frustrated phagocytosis,
which in turn stimulates a cytokine proinflammatory response (Brown
et al., 2007; Murphy et al., 2012). However, Clift et al. (2011) reported
that cellulose nanowhiskers from cotton, a nanocellulose that more
resembles the needle-like structure of asbestos, did not cause any form
of frustrated phagocytosis in macrophages, being instead internalized
within vesicles. No signs of phagocytosis were also found in THP-1
macrophages exposed to three different modified CNF (Lopes et al.,
2018). Nevertheless, Catalán et al. (2017) reported that CNF produced
using TEMPO oxidation trigged the recruitment of neutrophils, mac-
rophages, lymphocytes and eosinophils to the lungs of C57Bl/6 mice
exposed by pharyngeal aspiration, indicating an acute inflammatory
response. A significant dose-dependent increase in mRNA of the pro-
inflammatory cytokines IL-1β and IL-6, tumour necrosis factor α (TNF-
α) and chemokine (C-X-C motif) ligand 5 (CXCL5) was detected in the
lung tissue, but without an increase in their protein levels. Lopes et al.
(2018) also reported increased levels of Il-1β and TNF-α in THP-1
macrophages treated with 250 and 500 μg/mL, and 500 μg/mL, re-
spectively, of unmodified CNF (Lopes et al., 2018). These CNF con-
centrations are in the range of those tested in the Colić et al. (2015)
study that, conversely, reported no induction of those pro-inflammatory
cytokines in peripheral blood mononuclear cells (PBMCs) cultures sti-
mulated with phytohemagglutinin (31.25–1000 μg/mL). Still, the CNF
concentrations herein used are below 31.25 μg/mL and, therefore, a
negative result was not unexpected. Non-nanometric cellulose fibres
also trigger an inflammatory response in Wistar rats by inhalation, but
it appears to be transient, declining in a 14-day period (Cullen et al.,
2000).
Concerning the genotoxic effects of exposure to nanocellulose, the
present results showed that the CNF under study induced a low but
significant level of DNA damage in A549 cells in co-culture with THP-1
cells, at the 25 μg/cm2 concentration. In addition, two CNF con-
centrations (1.5 and 12.5 μg/cm2) caused a slight induction of the level
of oxidative DNA lesions detected as FpG-sensitive sites, e.g., oxidised 8-
oxoGua. It is known that oxidative stress can be rapidly repaired by the
cell repair systems and thereby the 24-h timepoint might have been too
long to allow the detection of this type of DNA damage in exposed cells.
In fact, there are studies e.g., with TiO2 nanomaterials, that showed an
induction of FpG-sensitive sites in A549 cells at 2 or 3 h, which were not
apparent at 24 h exposure (El Yamani et al., 2017; Ursini et al., 2014)
indicating that from this study data the induction of oxidative DNA
damage cannot be completely excluded. In the study by Stefaniak et al.
(2014) nanocellulose, including CNF, induced significantly more free
radicals than that of the essentially inert cellulose microcrystals, which
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180
78
could lead to reactive oxygen species formation and DNA damage. Low,
but significant values of DNA damage, detected by the comet assay,
were also obtained in vitro in human lymphocytes exposed to brown
cotton and curauá nanofibres (Lima et al., 2012). Regarding in vivo
studies, Catalán et al. (2017) reported significant positive comet assay
results (p < 0.001) in the lung cells of mice exposed to 10 and 40 μg/
mouse of CNF by pharyngeal aspiration, but non-significant values of %
DNA in tail compared to the zero dose for the highest concentrations
tested, 80 and 200 μg/mouse. This observation agrees with the present
in vitro results in that low CNF concentrations seem to induce more
toxicity in lung cells than the higher ones, either in vitro or in vivo.
Interestingly, the two lowest CNF concentrations tested by the in
vitro micronucleus assay were also able to increase significantly the
frequency of chromosome numerical or structural anomalies in A549
cells, while for the highest does no effects were observed. On the other
hand, the results of the CBPI did not show any significant decrease of
A549 cells capacity to divide at those higher dose levels of CNF and thus
an influence of toxicity on the micronucleus frequency is not likely. This
result confirms the incidence of the CNF biological effects on the low-
concentration range. A decrease in the genotoxic effect associated with
a dosage increase has been reported for other nanomaterials, e.g. carbon
nanotubes, and it is thought to be related with the aggregation or ag-
glomeration of nanomaterials at the highest dose levels that decreases
the bioavailability of nano-objects (Brown et al., 2007; Rittinghausen
et al., 2014; Shvedova et al., 2005). A hypothesis associated with the
decreased toxicity observed with functionalized carbon nanotubes is
that their functionalization, with either carboxyl or amino groups, in-
crease the adsorption of proteins in protein-rich biological media,
which promotes their agglomeration (Allegri et al., 2016). Cellulose
nanofibres also show a strong tendency to agglomerate, especially after
drying and in highly concentrated aqueous solutions due to strong
inter- and intra-molecular hydrogen bonding; in nonpolar media they
tend to form aggregates (Lima et al., 2012). These authors observed an
inverse association between CNF aggregation and toxicity while Pereira
et al. (2013) observed that high concentrations of cotton CNF resulted
in large CNF aggregates and increased cytotoxicity. In the present
study, an aggregation/agglomeration of CNF in the cell culture medium
was clearly observed under the optical microscope (Fig. 1 Supplemen-
tary material) 24 h after cells treatment with the highest concentrations
(25 μg/cm2), supporting the hypothesis that the decreased toxicity is
related to a lower bioavailability of CNF in its nanosized form.
Catalán et al. (2017) reported no micronucleus induction in the
bone marrow erythrocytes of mice exposed to CNF by pharyngeal as-
piration, but the time between the exposure of mice to CNF and the
bone marrow sampling might not have been sufficient to allow a sys-
temic genotoxic effect (Catalán et al., 2017). Even though we observed
micronuclei induction by the two lowest CNF concentrations tested,
whether they were mediated by clastogenic or aneugenic mechanisms,
both leading to irreversible chromosome damage linked to early events
in carcinogenesis, was not investigated (Bonassi et al., 2011). Clasto-
genic events can often be associated to the formation of DNA adducts
and to oxidative stress that result in DNA breakage that should have
been distinguished by the comet assay. On the other hand, loss of
chromosomes may be explained by a direct interaction of the CNF with
tubulin from the mitotic spindle, or with proteins involved in the seg-
regation of the chromosomes in metaphase, events that are not detected
in the comet assay. Likewise, a significant disruption of the mitotic
spindle by multi-walled CNT has been previously reported (Siegrist
et al., 2014). Several studies have stated that the micronucleus assay is
more sensitive to detect genotoxic effects of nanomaterials than the
comet assay (Louro et al., 2016), but the type and repair capacities of
target cells, the stage of cell cycle, and the time elapsed between ex-
posure and analysis are additional factors that may contribute to the
different sensitivities of these assays (Valentin-Severin et al., 2003).
5. Conclusions
Overall, the data of the present work suggests that CNF produced
with an oxidative pre-treatment mediated by TEMPO is able to produce
concentration-dependent effects in the viability and proliferation of
human alveolar cells and genotoxic effects in these cells co-cultured
with THP-1 macrophages, particularly at a low concentration-range.
The results of cytotoxicity assessment also suggest that CNF exposures
longer than 24 h are needed to yield detectable effects. The use of A549
cells co-cultured with THP-1 monocyte-derived macrophages allowed a
preliminary assessment of CNF immunotoxicity that confirmed the
absence of a proinflammatory effect at a low CNF concentration.
Concerning CNF genotoxicity assessed in the same in vitro system, al-
though no biologically relevant DNA damage was detected in A549
cells by the comet assay, the formation of micronuclei at the two lowest
concentrations tested raised some concern about the safety of this na-
nofibre. Further studies should be performed to complement these
findings, since they suggest that low CNF doses, which are the most
realistic exposure doses to humans, may stimulate cell proliferation and
induce aneugenic/clastogenic events in alveolar cells, representing a
potential risk for human health. Given that this toxicity assessment of a
newly produced CNF was conducted in an early phase of the nanofibre
development, the present findings are expected to stimulate its mod-
ification towards a safer material.
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4.1.      Abstract 
In the past years, several in vitro studies have addressed the pulmonary toxicity of 
multi-walled carbon nanotubes (MWCNT) and compared it with that caused by 
asbestos fibers, but their conclusions have been somewhat inconsistent and difficult to 
extrapolate to in vivo. Since cell co-culture models were proposed to better represent 
the in vivo conditions than conventional monocultures, this work intended to compare 
the cytotoxicity and genotoxicity of MWCNT-7 (Mitsui-7) and crocidolite using A549 
cells grown in a conventional monoculture or in co-culture with THP-1 macrophages. 
Although a decrease in A549 viability was noted following exposure to a concentration 
range of MWCNT-7 and crocidolite, no viability change occurred in similarly exposed 
co-cultures. Early events indicating epithelial to mesenchymal transition (EMT) were 
observed which could explain apoptosis resistance. The comet assay results were 
similar between the two models, being positive and negative for crocidolite and 
MWCNT-7, respectively. An increase in the micronucleus frequency was detected in 
the co-cultured A549-treated cells with both materials, but not in the monoculture. On 
the other hand, exposure of A549 monocultures to MWCNT-7 induced a highly 
significant increase in nucleoplasmic bridges in which those were found embedded. 
Our overall results demonstrate that (i) both materials are cytotoxic and genotoxic, (ii) 
the presence of THP-1 macrophages upholds the viability of A549 cells and increases 
the aneugenic/clastogenic effects of both materials probably through EMT and (iii) 
MWCNT-7 induces the formation of nucleoplasmic bridges in A549 cells. 
 
4.2.      Introduction 
In the past years, several toxicological studies have addressed the hazard of multi-
walled carbon nanotubes (MWCNT), a nanomaterial composed of multiple graphite 
sheets assembled in concentric layers, displaying various lengths and a diameter 
within the nanoscale. MWCNT applications are a fast-evolving field, with many different 
employments in industry and biomedicine1. However, there is the concern that MWCNT 
inhalation may cause adverse pulmonary effects resulting from their physical properties 
and biopersistency, particularly when these are similar to asbestos fibers. Human 
exposure to asbestos fibres has been associated with the development of 
bronchogenic carcinoma, malignant mesothelioma, and interstitial pulmonary fibrosis 
(asbestosis)2. In turn, rodents exposed to liquid suspensions of carbon nanotubes 
(CNT) by intratracheal instillation or pharyngeal aspiration developed acute or 
persistent pulmonary inflammation and persistent interstitial fibrosis with granuloma 
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formation, and bronchiolar or bronchioloalveolar hyperplasia1,3. Moreover, the MWCNT-
7 (Mitsui-7) induced malignant mesothelioma in mice4,5 and rats6,7,8,9, and lung 
carcinomas in rats10,9. Similarly to asbestos, MWCNT-7 injection in the peritoneal cavity 
of rats induced an early and selective sustained immunosuppressive response 
characterized by the accumulation of monocytic myeloid derived suppressor cells 
(CD11b/cint and His48hi) that possess the ability to suppress polyclonal activation of T 
lymphocytes11. Besides, mesotheliomas induced by thin (diameter ~ 50 nm) and highly 
crystalline MWCNT present a homozygous deletion of the tumour suppressor genes 
Cdkn2a/2b, comparable to mesotheliomas induced by asbestos7. These evidences led 
the International Agency for Research on Cancer (IARC) to categorize the MWCNT-7 
as possibly carcinogenic to humans (Group 2B)12.  
Concerning in vitro toxicological assays, divergent results have been reported. These 
can reflect different methodological approaches13,3, different CNT physicochemical 
characteristics14,15,16,17,18 or even the use of different cell lines19. For instance, some 
MWCNT have been reported to induce DNA damage in A549 cells20,21 and in Met-5A 
cells, but not in BEAS 2B cells22 and to stimulate micronuclei formation in A549 cells23 
but not in the other two cell lines22,24. Catalán et al. (2015) observed that straight 
MWCNT induced DNA strand breaks at low doses, while tangled MWCNT did so only 
at a higher dose 24. In an in vitro study of 15 different MWCNT, increased levels of DNA 
strand breaks were observed for treatments with thick and high Fe2O3 and Ni 
containing MWCNT, but overall MWCNT were weakly genotoxic and not cytotoxic25. It 
has been recognized that the physicochemical characteristics of the MWCNT are major 
contributors for their toxicity. Pristine MWCNT are more cytotoxic than functionalized 
MWCNT, while functionalized MWCNT are more genotoxic compared to their pristine 
form26. It has been proposed that the formation of larger agglomerates, dependent 
upon different protein coronae, contributes to mitigate the biological effects of 
functionalized MWCNT in protein-rich biological media27. 
Moreover, a modest correlation has been found between in vitro and in vivo 
toxicological studies that may be due to the use of conventional in vitro monocultures 
that do not mimic well the in vivo organization. Thus, it is expected that the 
simultaneous culture of cell types that co-exist in the organism will provide a more 
reliable toxicological information28,29. For instance, a co-culture of human small airway 
epithelial cells (SAEC) and human microvascular endothelial cells (HMVEC) has 
correlated better with the in vivo mouse lung transcriptomic profile following MWCNT 
exposure than the two monocultures separately30. Consequently, efforts are currently 
being made to implement co-culture models31. 
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In this study, we investigated the toxicity of the MWCNT-7 (Mitsui-7) and crocidolite 
asbestos, comparing the results obtained in a conventional A549 alveolar epithelial cell 
culture with those of a co-culture of the same cells with THP-1 differentiated 
macrophages. As already mentioned, MWCNT-7 and crocidolite share strong 
resemblances in their physical characteristics and a high biopersistence, as well. 
Moreover, crocidolite is a well-known cause of lung diseases2, and consequently, a 
well-documented standard to compare the adverse effects of MWCNT-7. Alveolar 
macrophages are key cells in the immune response to CNT exposure. It has been 
proposed that macrophages try to degrade CNT. However, when the nanotube length 
exceeds that of the macrophage cell, they trigger frustrated phagocytosis32,33,3, leading 
to the release of proinflammatory cytokines and chemokines (e.g., TNFα, IL-1β, IL-6, 
IL-10 and MCP1) and activation of associated transcription factors (NF-kB and AP-
1)34,35. Inflammation can provide a tumour-promoting microenvironment crucial in the 
pulmonary outcome of exposure to both MWCNT-7 and crocidolite.  
Here we report relevant toxicological findings in the monoculture and co-culture models 
per se, but also show that the results obtained in both cell cultures are not alike for the 
most part of the assays we performed. We suggest that toxicological outcomes may 
differ when different cell types are added into in vitro models, allowing further 
understanding of the complexity of the cell interplay. 
 
4.3.      Materials and Methods 
4.3.1.   Fiber characterization and preparation 
The MWCNT-7, also known as Mitsui-7 (Mitsui & Co, Lda. Ibaraki, Japan), was 
provided as a sub-sample by the National Research Centre for the Working and 
Environment (NRCWE-006). Its physicochemical characteristics were described 
previously and are listed in table I. 
Immediately before the experiments, a 2.56 mg/mL stock dispersion of the NRCWE-
006 was prepared according to Jensen et al. (2011)36.  The hydrodynamic particle size-
distribution (Zav, nm) and the polydispersity index (PDI) of MWCNT-7 stock dispersion 
were measured shortly after sonication (Malvern Nano ZS, Malvern Inc., UK) by  
dynamic light scattering (DLS) and expressed as the mean of 10 consecutive 
measurements37.  Scanning electron microscopy (SEM) of the stock solution was also 
performed using a Phantom XL microscope. 
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Table I. Physicochemical characteristics of the MWCNT-7 (NRCWE-006, Mitsui-7). 
Specific 
surface 
area (m2/g)a 
Thickness 
± SD 
(nm)b 
Geodesic 
length ± SD 
(nm)b 
Aspect 
ratio ± SDb 
Impurities 
%a 
Minor Impurity 
phasese 
Minor 
elements/coatingse 
24-28 69.4 ± 1.4 4423.6 ± 2.3 63.7 ± 2.4 <1% Fe2O3 
Na: 499 ± 103 μg/g  
Mg: 1 ± 1 μg/g 
Al: 66 ± 19 μg/g 
Fe: 355 ± 2 μg/g 
Ni: 1 μg/g 
a Information provided by manufacturer or the Joint Research Center 
(http://ihcp.jrc.ec.europa.eu/our_activities/nanotechnology/nanomaterials-
repository/list_materials_JRC_rep_oct_2011.pdf). 
b Values reported by Tavares et al. 201437. 
c Values reported in the NANOGENOTOX  Joint Action by Jensen 2013. 
 
The crocidolite fibers are a standard reference mineral from the Union for International 
Cancer Control (UICC, Geneva, Switzerland) and were kindly provided by Dr. Fátima 
Aguiar from the Environmental Health Department of INSA. Their preparation and 
characterization have been described in detail38,39,40,41. A stock solution was prepared 
at 1 mg/mL in phosphate buffer saline (PBS), pH 7.4 (Gibco). Prior to dilution in culture 
medium, fibers were passed through a syringe needle to ensure a better uniformity of 
the suspension. 
 
4.3.2.      Cell culture 
The human alveolar epithelial cell line A549 (ATCC, Manassas, VA, USA, CCL-185) 
and the human monocytic leukaemia cell line THP-1 (ATCC, TIB-202) were both grown 
in RPMI 1640 medium (Gibco, Waltham, MA, USA) supplemented with 10% heat-
inactivated foetal bovine serum (Gibco), 1% penicillin/streptomycin (10.000 U/mL, 
Gibco) and 1% fungizone (0.25 mg/mL, Gibco) at 37ºC in 5% CO2. THP-1 monocytes 
were grown on transwell inserts with a nominal pore size of 0.4 µm (Greiner Bio-One 
GmbH, Kremsmünster, Austria) at a density of 0.2×105 cells/mL and differentiated into 
macrophages by a 48 h incubation with 100 ng/mL of 12-O-tetradecanoylphorbol-13-
acetate (TPA, Sigma-Aldrich). The medium was substituted by serum-free medium for 
further 72 h to allow cells to recover from the TPA effect. In co-culture experiments, 
A549 cells were cultured in 12–well plates at a density of 0.5×105 cells/mL and the 
inserts with differentiated THP-1 cells were placed directly on top. The resulting co-
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culture presented a 1:5 proportion of THP-1:A549 cells based on Pinkerton KE et al. 
(1992)42, and was incubated for 24 h at 37º C and 5% CO2. To ensure that THP-1 and 
A549 cells were exposed to the same concentrations of MWCNT-7 or crocidolite, the 
dispersions were added to the apical and basolateral sides of the insert. 
 
4.3.3.      MTT assay 
A549 cells were exposed to 6.25, 12.5, 25, 50 and 100 µg/cm2 of MWCNT-7, or 1.25, 
2.5, 5, 10, 20 and 40 µg/cm2 of crocidolite, for 24 h or 48 h. Co-cultures were exposed 
to 6.25,  25 and 100 µg/cm2 of MWCNT-7, and 2.5, 10 or 40 µg/cm2 of crocidolite, for 
24 h or 48 h. SDS (0.1 µg/mL, Sigma) was used as a positive control with 1 h 
exposure. When studying the co-culture, the transwell inserts were separated from the 
plate, and the following steps of the assay performed independently in the A549 cells 
(plate) and in the THP-1 cells (inserts). After washing with PBS, cells were incubated 
for 2 h with fresh medium containing 10% of MTT solution (5 mg/mL, Calbiochem, 
Darmstadt, Germany). The medium was discharged and DMSO (Sigma) was added for 
20 min under shaking. The absorbance was recorded at 570 nm against a reference 
filter set at 690 nm using a Multiscan Ascent spectrophotometer (Labsystems, Helsinki, 
Finland). 
 
4.3.4.      Determination of IL-1β 
Cell culture supernatants were collected separately from the well plates and the 
corresponding inserts, after the 24 h and 48 h treatment of the comet and micronucleus 
assay, respectively, and stored at −80 °C until analysis. IL-1β concentrations were 
determined with the commercially available colorimetric sandwich ELISA – IL-1β-
EASIA Kit KAP1211 (DIASource, Louvain-la-Neuve, Belgium), according to the 
manufacturer's protocol. A positive control was prepared adding 100 ng/μL of 
lipopolysaccharides (LPS; Sigma) and 5 mM adenosine 5’-triphosphate disodium salt 
(ATP; Sigma) to the cells cultured on the inserts43. 
 
4.3.5.      SDS-PAGE and Western Blotting 
Whole cell lysates from three different replicas of A549 cells grown in monoculture or 
co-culture with THP-1 macrophages and exposed to 25 µg/cm2 of MWCNT-7 or 10 
µg/cm2 of crocidolite, for 24 h and 48 h, were analysed by western blotting. These 
concentrations were chosen because they had the highest change in cell viability 
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between the two cell culture models. Cells were lysed in SDS sample buffer, boiled for 
10 min, centrifuged at 2,500 ×g for 30 s, and proteins resolved in 12% SDS-PAGE 
mini-gels. Proteins were then transferred onto polyvinylidene difluoride (Bio-Rad) 
membranes using a Mini Trans-Blot cell (Bio-Rad). Membranes were probed using the 
indicated antibodies, and specific binding was detected via a secondary peroxidase-
conjugated antibody (Bio-Rad) followed by chemiluminescence. Monoclonal anti-E 
cadherin was from BD transduction laboratories, anti-vimentin from Santa Cruz, 
polyclonal anti-GADPH from Abcam, and monoclonal anti-PCNA from Oncogene. 
 
4.3.6.      Evaluation of apoptosis 
Apoptosis was evaluated after 48 h exposure to the lowest, medium and highest 
concentrations of crocidolite and MWCNT-7. For this purpose the activity of caspases 
3/7 were measured using the Caspase-Glo® 3/7 Assay (Promega, Madison, USA) 
according to the manufacturer's instructions. The luminescence, proportional to the 
caspase activity, was measured using a Lucy2 microplate luminometer (Anthos Labtec 
Instruments GmbH, Austria). Background luminescence was determined in the culture 
medium and subtracted from all experimental values. 
Apoptotic cells were also scored under bright field microscopy based on their typical 
morphologic features in Giemsa-stained slides prepared for the micronucleus assay 
from cultures exposed to 50 µg/cm2 MWCNT-7. 
 
4.3.7.      Comet assay  
Cells were exposed for 24 h to 6.25, 12.5, 25, 50 and 100 µg/cm2 of MWCNT-7 or 1.56, 
3,125, 6.25, 12.5, and 25 µg/cm2 of crocidolite in 12-well plates. Ethyl 
methanesuphonate (EMS, 5mM, Sigma-Aldrich) was used as a positive control with 1-h 
exposure. The cells were washed with PBS, harvested after tripsinization and 
centrifuged, the pellets embedded in 0.8% low melting point agarose, then spread on 
1% agarose-precoated microscope slides. Slides were immersed in lysis solution (2.5 
M NaCl, 100 mM EDTA, 10 mM Tris, 10% DMSO, 1% Triton X-100, pH 10) for a 
minimum of 1 h and washed twice with enzyme buffer (40 mM HEPES, 100 mM KCl, 
0.5 mM EDTA, 0.2 mg/mL BSA, pH 8). The agarose-embedded cells were treated with 
enzyme buffer or 50 µL of formamidopyrimidine DNA glycosylase (FpG, kindly provided 
by Dr. A. Collins, University of Oslo, Norway) for 30 min at 37ºC. Apart from quantifying 
DNA single and double strand breaks, FpG allows the detection of oxidative DNA 
lesions. The slides were immersed into cold electrophoresis buffer (0.3 M NaOH, 1 mM 
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hydrated Na2EDTA; pH 13) for 30 min, followed by a 25 min electrophoresis at 0.8 
V/cm. Finally, after 10 min neutralization with PBS, slides were rinsed, dried and 
stained with ethidium bromide (0.125 µg/µL). Three independent experiments were 
carried out, each with two replicates per treatment condition. In each experiment, a 
total of 100 randomly selected nucleoids were analysed in FpG treated and untreated 
gels for each culture, using an Axioplan2 Imaging epifluorescence microscope 
equipped with a high resolution camera (Carl Zeiss Microscopy, Gottingen, Germany). 
Scoring was done with the Comet Imager 2.2 software (MetaSystems, Althlussheim, 
Germany), choosing the percentage of DNA in the tail as a measure of DNA damage. 
The results represent the mean (±SE) of three independent experiments. 
 
4.3.8.      Micronucleus assay 
Following 6 h exposure to 6.25, 12.5, 25, 50 and 100 µg/cm2 of MWCNT-7 or 2.5, 5, 
10, 20, and 40 µg/cm2 of crocidolite, cytochalasin B (Sigma) was added to the 12-well 
plates at a final concentration of 6 µg/mL. For each experiment, negative (non-treated 
cells) and positive (50 µg/mL mitomycin C, Sigma) controls were included. Briefly, at 
the end of the 48 h-treatment in the monoculture, cells were washed with PBS, 
detached with trypsin-EDTA, submitted to a hypotonic shock with a RPMI 
1640:dH2O:FBS (37.5:12.5:1) solution, centrifuged and the pellet spread onto 
microscope slides. In order to obtain binucleated cells after cytochalasin B addition, the 
exposure had to be prolonged for further 2 h in the co-culture. The slides were dried, 
fixed in absolute methanol (Sigma) and stained with 4% Giemsa (Merck, Darmstadt, 
Germany). Slides were scored under a bright field microscope for the presence of 
micronuclei using the criteria described by Thomas and Fenech (2011) in, at least, 
2000 binucleated cells from two independent cultures44. The proportion of mono-, bi- or 
multinucleate cells in 1000 cells per treatment was used to calculate the cytokinesis-
blocked proliferation index (CBPI)45. 
 
4.3.9.      Fluorescence in situ hybridization (FISH) 
Additional glass slides prepared for the micronucleus assay of A549 cells exposed to 
50 µg/cm2 of MWCNT-7 were used for FISH using a biotin-labelled pan-centromeric 
probe and a FITC-labelled pan-telomeric probe (starFISH, Cambio, Cambridge, UK). 
Briefly, slides were treated with 0.1 mg/mL acid pepsin (0.01 N HCl), then fixed in 1% 
(wt/v) formaldehyde–PBS before dehydration through 5 min in ethanol series. Cellular 
DNA was denatured at 80°C for 2 min in 70% formamide (in 2xSSC), and dehydrated 
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through ethanol series. Probes were denatured 5 min at 37º C followed by 10 min at 
85°C and hybridization was performed overnight at 37°C in a humid chamber. Post 
hybridization washes were performed at 37ºC with 2xSSC (5 min), three times 0.5xSSC 
(3 min), two times 2xSSC (5 min, room temperature) and 0.45% BSA in a 0.15 M 
NaHCO3 solution with 0.1% wt/vol Tween 20 (BT; 5 min). Cellular DNA were 
counterstained with 4′,6-diamidino-2-phenylindole (DAPI; 0.5 g/mL) and mounted in 
Vectashield (Vector Laboratories, Burlingame, CA, USA). The hybridization signal of 
the telomeric probe was first analysed under a fluorescence microscope (Zeiss, 
Axioplan 2) using filters for DAPI and FICT. Then, the slides were incubated for 1 h at 
40°C with Avid-Cy3 antibody (Amersham, Uppsala, Sweden), washed three times in 
BT at 40ªC (5 min), re-mounted and analysed using filters for DAPI and Cy3. 
Hybridization signals were captured with a cooled charge-coupled device camera 
controlled by MacProbe software (PSI, Applied Imaging), processed using image 
analysis software, and overlaid electronically. 
 
4.3.10.     Immunofluorescence and confocal microscopy 
For immunofluorescence analysis, cells were grown on coverslips, treated with 50 
µg/cm2 of MWCNT-7 as described for the micronucleus assay, fixed in ice-cold 
methanol at -20°C for 30 min, washed with PBS (Sigma-Aldrich), and incubated for 1 h 
with mouse anti-α-tubulin (clone B-5-1-2, Sigma-Aldrich). Cells were then thoroughly 
washed with PBS and incubated for 30 min with AlexaFluor488-conjugated secondary 
antibody (Life Technologies Invitrogen Corporation). Following thorough washing in 
PBS and DAPI staining of nuclei, coverslips were mounted on microscope slides with 
Vectashield (Vector Laboratories) and sealed with nail polish. Images were recorded 
and processed on a Leica TCS-SPE confocal microscope and assembled into figures 
with Adobe Photoshop software. 
 
4.3.11.     Statistical analysis 
Statistical comparisons of the treated and control cells in the MTT and comet assays 
were evaluated through a one-way analysis of variance (ANOVA) followed by Tukey's 
multiple comparison test, after testing for normality. The two-tailed Student's t-test was 
used in the comet assay to compare results with and without FpG, and to compare the 
CBPI in treated and control cells. The 2-tailed Fisher’s exact test was applied to 
analyse the results of the frequency of micronucleated cells. All analyses were 
 93 
 
performed with the SPSS statistical package (version 25, SPSS Inc. Chicago, IL). The 
results are presented as the mean ± standard deviation. 
 
4.4.        Results 
4.4.1.     MWCNT-7 characterization 
The physicochemical properties of MWCNT-7 have been previously characterized, and 
are presented in the materials and methods section. Although some disagreement 
exists if DLS is applicable to non-spherical particles, the size distribution of the 
MWCNT was measured shortly after sonication in the stock solution, revealing a PDI of 
0.381 ± 0.02 (mean ± SD) and a Zav of 1004 ± 34.03 (mean ± SD).  
 
4.4.2.      Cytotoxicity 
MWCNT-7 treatment of A549 cells in monoculture caused a significant and dose-
dependent decrease in cell viability, being more pronounced at 48 h than at 24 h (figure 
1). However, a similar treatment of A549 cells in co-culture with THP-1 macrophages 
induced a milder effect on A549 cell viability. The comparison of the viability measured 
at each concentration between both types of cultures revealed highly significant 
differences (p < 0.001 for all concentrations at 48 h; p < 0.05 for all concentrations at 
24 h, t-test). These differences were supported by the results of the cytokinesis-block 
proliferation index (CBPI) derived from the micronucleus assay (figure 2A) in that a 
decrease in the cell proliferative capacity was observed in the monoculture at the 
highest MWCNT-7 concentration, while no effect was observed in the co-culture. 
THP-1 cells were more sensitive to the cytotoxicity of MWCNT-7 than A549 cells, as 
can be observed in figure 1. 
Regarding crocidolite cytotoxicity, A549 cell viability at 24 h decreased in a 
concentration-dependent and statistically significant manner for all concentrations 
tested (p < 0.005, Tukey test) except at the lowest one (1.25 µg/cm2), reaching values 
below 70% viability at the highest concentrations tested. No significant differences 
were detected between the 24 h and 48 h exposure (p > 0.05) (figure 1).  Although the 
co-culture exposure to crocidolite for 48 h resulted in a dose-dependent effect similar to 
that observed for the monoculture, the 24 h exposure retained or even increased 
significantly the A549 viability, at the two lowest concentrations tested (p < 0.001). 
CBPI analysis showed no signs of toxicity for both culture models (figure 2B). 
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As observed with the MWCNT-7 treatment, the crocidolite cytotoxicity was more 
pronounced in the THP-1 cells present in the co-culture, than in A549 cells, especially 
at 48 h exposure (figure 1). 
 
 
Figure 1. Relative viability of A549 cells in monoculture, and of A549 and THP-1 cells in co-culture, after 
exposure to different concentrations of MWCNT-7 for 24 h (A) and 48 h (B) and crocidolite for 24 h (C) and 
48 h (D) as determined by the MTT assay. 
 
 
 
Figure 2. Cytokinesis-block proliferation index (CBPI) of A549 cells in monoculture and co-culture with 
THP-1 cells, after exposure to MWCNT-7 (A) or crocidolite (B) for 48 h (monoculture) or 50 h (co-culture). 
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4.4.3.      Apoptosis and epithelial-mesenchymal transition (EMT)  
In an attempt to elucidate how the presence of THP-1 cells in the co-culture influenced 
the viability of A549 cells exposed to both materials, we first investigated differences in 
apoptotic cell death by measuring caspase 3/7 activity.  
 
 
Figure 3. Caspase 3/7 activity in A549 cells in monoculture and co-culture with THP-1 cells, after exposure 
to MWCNT-7 (A) or crocidolite (B). RLU – Relative light units. * p < 0.005. 
 
As shown in figure 3, the results obtained on the A549 cells exposed to MWCNT-7, 
either in monoculture or in co-culture, were not statistically significant from those of the 
controls, indicating that it does not induce apoptosis in the conditions tested. However, 
the result for the 100 μg/cm2 concentration was not reliable, because at that 
concentration the interference from black MWCNT particle density is too high to allow a 
correct luminescence measurement, even with blank correction. 
The exposure to several crocidolite concentrations increased apoptosis in a 
concentration-dependent manner reaching statistical significance at 10.0 μg/cm2 and 
40.0 μg/cm2 of crocidolite comparatively to the non-exposed cells (ANOVA, p < 0.005; 
Tukey, p = 0.01 and p = 0.005, respectively). Although an increase of apoptosis was 
also observed in the co-cultured A549 cells after similar treatments, no statistically 
significant increase over the control value were found (p > 0.05, Kruskal-Wallis test). 
The comparison of the results between the monoculture and the co-culture revealed a 
significant difference in the caspases 3/7 activity, both for the non-exposed cells and 
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for the cells exposed to all concentrations of MWCNT-7 and crocidolite (except for 10 
μg/cm2 crocidolite) (p < 0.001, t-test). These data suggest that macrophages protect 
A549 cell from death through apoptosis. 
Second, the hypothesis that A549 cells may undergo EMT in the presence of THP-1 
cells leading to growth arrest at G1/S phase and evasion from apoptosis was also 
explored. EMT of A549 cells in the presence of THP-1 cells was evaluated by western 
blotting through changes in the expression of the marker proteins E-cadherin, vimentin 
and proliferating cell nuclear antigen (PCNA) (figure 4). Upon the initiation of EMT, loss 
of cell-cell adhesion involves cleavage of epithelial cadherin (E-cadherin) at the plasma 
membrane and its subsequent degradation, and changes in the intermediate filament 
composition with the activation of vimentin expression46. PCNA is a ring-shaped 
homotrimeric protein that acts as a cofactor of DNA polymerase delta in eukaryotic 
cells in both DNA replication and repair of excised damaged strands47,48. Thus, it 
indicates if normal cell division is maintained or not in the exposed cell cultures. 
The overall results are shown in figures 4 and 5. At 24 h exposure, the level of E-
cadherin that is expressed in the A549 monoculture exposed to MWCNT-7 shows a 
slight but non-significant decrease. However, it is significantly lower in cells exposed to 
crocidolite comparatively to that of non-exposed cells. PCNA levels follow E-cadherin 
levels, suggesting that this decrease is a result of cell death. At 48 h exposure, PCNA 
also decreased compared to the non-exposed cells, particularly in the monoculture 
exposed to MWCNT-7, indicating, once again, cell death. Regarding the co-culture, 
there is no indication of PCNA loss, and E-cadherin is significantly lower in crocidolite-
treated cells (t-test, p < 0.05) except at 48 h exposure to MWCNT-7, which seems to 
indicate an early EMT.  
 
 
Figure 4. Expression levels of E-cadherin, vimentin, proliferating cell nuclear antigen (PCNA) and 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in A549 cells by western blotting. 
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Figure 5. Mean levels of E-cadherin and PCNA in three replicates of A549 cells analysed by western 
blotting. Cells were cultured without (A and B) and with THP-1 macrophages (C and D) and exposed to 25 
µg/cm2 MWCNT-7 or 10 µg/cm2 crocidolite for 24 h (A and C) and 48 h (B and D). * p < 0.05. 
 
4.4.4.      IL-1β determination 
In order to understand the differences in the cellular response between A549 cells in 
monoculture or in co-culture, we determined the levels of the cytokine IL-1β, which is a 
key mediator of pro-inflammatory responses, in the conditioned culture media after 
exposure to MWCNT-7. IL-1β concentration presented a potential dose-effect 
relationship following cells exposure to MWCNT-7 (comet assay supernatants), with 
higher IL-1β concentrations in the inserts medium (THP-1 cells) than in the plate wells 
medium (A549 cells) (figure 6). IL-1β was not detectable in the micronucleus assay 
supernatants. 
 
Figure 6. IL-1β determination in the cell culture supernatants of A549 medium (dark grey) and THP-1 
medium inserts (light grey) after exposure to a concentration range of MWCNT-7. 100 ng/μl LPS with 5mM 
ATP was used as a positive control. Results are expressed as means of two independent determinations. 
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4.4.5.      Genotoxicity  
The genotoxicity of MWCNT-7 and crocidolite was investigated through the comet 
assay and the cytokinesis-block micronucleus assay, in both A549 monocultures and 
co-cultures with THP-1 cells. No DNA damage was induced in the monoculture of A549 
cells exposed to MWCNT-7 (ANOVA, p > 0.05), and the differences in the mean level 
of DNA damage without and with FpG were not significant (t-test, p > 0.05), either in 
A549 cells cultured in monoculture or in co-culture. Moreover, when comparing the 
genotoxicity of both culture types, there was no significant difference for any 
concentration, without or with FpG (t-test, p > 0.05) (figure 7). 
In contrast, crocidolite induced a concentration-dependent increase in the level of DNA 
lesions, both in the A549 monoculture and in the co-culture with THP-1 macrophages 
(p < 0.001, ANOVA). A significant increase in the percentage of DNA in tail was 
observed in the monoculture with FpG addition at the highest concentration tested (p < 
0.05, t-test). The mean level of DNA damage in A549 cells was not altered between the 
monoculture and the co-culture, except for the lowest concentration (1.5 μg/cm2 
crocidolite) without FpG (p = 0.01, t-test), where more damage was induced in the co-
culture than in the monoculture (figure 7). 
 
 
Figure 7. Comparison of the comet assay results in the A549 culture and co-culture with THP-1 cells 
exposed to a concentration-range of MWCNT-7 and crocidolite. * p < 0.05 for comparisons between 
treated and control cells in each culture model.  
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The results of the micronucleus assay show that neither MWCNT-7 nor crocidolite were 
able to induce micronucleus formation in A549 cells cultured under standard conditions 
(figure 8). Yet, in the co-culture with THP-1 cells, an increase of micronucleated 
binucleated cells (MNBC) frequency was observed for both materials. Concerning the 
MWCNT-7, this increase was significant at the two lowest concentrations (p < 0.05 for 
6.25 µg/cm2 and p < 0.005 for 12.5 µg/cm2; Fisher’s exact test), whereas for crocidolite, 
significance was reached for the three highest concentrations (p < 0.005 for 10 µg/cm2, 
p < 0.05 for 20 µg/cm2 and p < 0.001 for 40 µg/cm2; Fisher’s exact test) (figure 8). At 
100 µg/cm2 of MWCNT-7, micronuclei were not scored, since only mononucleated cells 
were present. In addition, in the co-culture after cytochalasin addition, A549 cells had 
to be incubated for 2 hours more to achieve binucleated cells, and a monoculture of 
A549 cells plated simultaneously with the co-culture presented a CPBI 13% higher, 
with 20% multinucleated cells compared with 7% in the co-culture. 
 
 
Figure 8. Frequency of micronucleated binucleated cells (MNBCs) per 1000 binucleated cells (BNC) in 
A549 cells in monoculture and co-culture with THP-1 cells, after exposure to MWCNT-7 (A) and crocidolite 
(B). Mitomycin (MMC) was used as a positive control, with a result of 40 and 48.5 MNBNC/1000BNC in the 
monoculture and co-culture exposed to MWCNT-7, respectively (p < 0.001), and  39 and 44 
MNBNC/1000BNC in the monoculture and co-culture exposed to crocidolite, respectively (p < 0.001). * p < 
0.05. 
 
In addition, cells were scored for the presence of typical features of apoptosis after 
exposure to 50 µg/cm2 of MWCNT-7. The results showed a significant increase of 
apoptotic cells relatively to the normal controls (p < 0.001, Fisher’s exact test). 
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4.4.6.      Nucleoplasmic bridges characterization 
During the above experiments, a distinct feature uniquely observed in the monoculture 
treated with 50 μg/cm2 of MWCNT-7 was a significant increase in long and thin 
nucleoplasmic bridges (47 ± 1 in exposed cells vs 1 ± 0 in non-exposed cells, in 1000 
BC, p < 0.001, Fisher’s exact test) (figure 9). 
 
 
Figure 9. Optical microscopy photographs of A549 binucleated cells displaying nucleoplasmic bridges 
following exposure to 50 μg/cm2 of MWCNT-7 (magnification 1000x). 
To further investigate whether the origin of the nucleoplasmic bridges induced by 
MWCNT-7 were related to chromosomal fusion events, cells were analysed using FISH 
with pan-telomeric and pan-centromeric probes. The results showed the absence of 
centromeric signals in all nucleoplasmic bridges (80/80 bridges analysed), and a low 
frequency of telomeric signals (about 30% (16/23)), indicating that telomere end fusion 
is not the main origin of the nucleoplasmic bridges (figure 10). 
 
Figure 10. FISH investigation of the nucleoplasmic bridges detected in A549 cells exposed to 50 μg/cm2 of 
MWCNT-7. Centromere and telomere probe signals are shown in red and in green, respectively. FISH 
images were also acquired as DAPI inverse counterstain to better distinguish the thin nucleoplasmic 
bridges (magnification 1000x). 
 101 
 
Next, we used confocal microscopy analysis to study the morphology of these bridges. 
MWCNT were detected as black straight lines crossing or along the microtubule 
cytoskeleton and were localized in several intracellular focal planes, including the 
nuclei and nucleoplasmic bridges. All nucleoplasmic bridges analysed had one or more 
MWCNT either longitudinally or transversally embedded in the bridges (Figure 11). 
  
 
Figure 11. Confocal microscopy projection images of A549 cells after cytochalasin B treatment, incubated 
in the absence (A) or with 50 µg/cm2 of MWCNT-7 (B). A nucleoplasmic bridge is distinguished between 
the two cell nuclei of the exposed cell. Tubulin is stained in green and DNA in blue. In (B), the presence of 
MWCNT crossing the nucleoplasmic bridges is shown with white arrows. Scale bars correspond to 10 μm. 
 
4.5.       Discussion 
In this work, we characterized the cytotoxicity and genotoxicity of MWCNT-7 (Mitsui-7), 
a thick and long needle-like MWCNT, and compared it to that of crocidolite, a well-
known carcinogenic asbestos fiber.  In order to further increase the physiological 
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relevance of the study, we used a co-culture model of A549 alveolar cells and THP-1 
macrophages to better approach the in vivo complexity of the pulmonary alveoli.  
Our results confirm that both materials are toxic to A549 cells in conventional cultures, 
the MWCNT -7 being more cytotoxic than the crocidolite. Interestingly, the alveolar 
cells in co-culture with activated THP-1 showed a higher survival following treatment 
with both materials. This differential response was more pronounced after a 48 h 
exposure to MWCNT-7, which resulted in a 60% higher viability of co-cultured A549 
cells than that of the monoculture. The CBPI values and the results of caspase 3/7 
activity support that observation, in that the CBPI was not affected and the level of 
apoptosis was lower in A549 cells in co-culture than in the classic monoculture.  
Moreover, even thought caspase 3/7 activity was not significantly different in cells 
exposed to 6.25 and 25 µg/cm2 of MWCNT-7, a significant increase of cells with the 
typical features of apoptosis was microscopically observed in monocultures treated 
with 50 µg/cm2 of MWCNT-7. This observation is in agreement with the CBPI results 
and indicates that, probably, apoptosis increases in MWCNT-7 concentrations higher 
than 25 µg/cm2.  
To explore whether the differences in cells fate following exposure to each material 
could be a consequence of EMT of A549 cells in the co-culture model, the expression 
of E-cadherin, vimentin and PCNA was analysed.  EMT is a biologic process that 
drives an epithelial cell to assume a mesenchymal cell phenotype, with enhanced 
migratory capacity during embryonal development, but also as a stress response 
leading to invasiveness, elevated resistance to apoptosis, and greatly increased 
production of extra cellular matrix components during tumorigenesis49. In the case of 
lung cancer, EMT is related to an increased metastatic ability50 and an unfavourable 
prognosis for non-small cell lung cancer51 and other types of lung cancer52. It has been 
described that MWCNTs can directly promote EMT in rat alveolar type-II epithelial cells 
RLE-6TN through the activation of TGF-β/Smad2 signalling pathway53, whereas the 
Akt/GSK-3β/SNAIL-1 pathway is activated in BEAS-2B cells54, contributing to the 
MWCNT-induced pulmonary fibrosis. Crocidolite fibers also induce EMT in mesothelial 
cells55. In the monoculture, EMT was not visible by the E-cadherin and vimentin 
expression upon treatment with both materials for 24 h and 48 h; however, early EMT 
events, i.e., decrease in E-cadherin expression, was noticeable in the co-culture. 
Accordingly, Kawata et al. (2012) described that RAW 264.7 mouse macrophages 
induced EMT in A549 cells by TNF-α stimulation of transforming growth factor-β (TGF-
β) expression, partially transduced by NF-κβ signalling56. Wang et al. (2013) also 
described that long MWCNT stimulated alveolar macrophages to secrete TGF-β1 that 
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activated TGF-β/Smad2 signalling in lung fibroblasts, leading to pulmonary fibrosis53. 
TGF-β is involved in the regulation of both apoptosis and EMT, and its cellular effects 
are dependent on the cell cycle stage: apoptosis occurs mostly in the G2/M phase, 
whereas EMT is only induced in the G1/S phase57.  Our results suggest that most A549 
cells in monoculture treated with MWCNT-7 were committed to apoptosis, given that 
both E-cadherin and PCNA levels decreased. By contrary, following co-culture 
treatment with MWCNT -7 or crocidolite, most A549 cells might have undergone early 
EMT, since E-cadherin expression decreased, vimentin remained constant and PCNA 
levels provided no evidence of cell death. This marked effect in the co-culture might be 
explained by growth arrest of A549 cells at G1/S triggered by TGF-β secreted by THP-
1 macrophages, thus allowing maintenance of cell survival.  
Regarding the genotoxicity assessment, MWCNT-7 failed to produce DNA damage 
detectable by comet assay but, interestingly, the two lowest concentrations (6.25 and 
12.5 µg/cm2) induced micronuclei in co-cultured A549 cells. Crocidolite exposure raised 
the micronucleus frequency in the same culture system, reaching a significant 2.29-fold 
increase at the highest concentration tested (40 µg/cm2). In contrast with MWCNT-7, 
crocidolite was able to induce DNA lesions in the monocultured or co-cultured A549 
cells. 
In agreement with the results obtained, low levels, or no induction, of DNA strand 
breaks was reported in A549 cells, BEAS-2B cells and MeT-5A mesothelial cells after 
exposure to MWCNT-7 and other MWCNT22,19. On the other hand, given that a 
crocidolite genotoxic mode of action is through ROS generation, mainly via the iron-
catalysed reduction of oxygen (Fenton-like reaction), mitochondria-derived ROS, and 
ROS release from inflammatory cells58,59, the positive comet assay results were 
expected. Moreover, the addition of FpG, a DNA repair enzyme that converts oxidative 
DNA lesions into DNA breaks, raised the level of DNA breaks in monocultured but not 
in co-cultured cells, which suggests that macrophages are not their main contributors. 
This finding agrees with previous reports that the long length of crocidolite fibers results 
in the secretion of inflammatory cytokines, but not in a strong ROS production by the 
macrophages60.  
On the other hand, MWCNT-7-induced micronuclei in A549 cells in the presence of 
THP-1 cells were not presumably produced by ROS-mediated DNA and subsequent 
chromosome breakage, since the FpG-comet assay yielded a negative result. Previous 
studies have reported that long CNT induce NLRP3 inflammassome activation61 and 
macrophage secretion of IL-1β, IL-6 and IL-8 as a consequence of frustrated 
phagocytosis33. Indeed, we found increased levels of IL-1β in the supernatant of the co-
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culture exposed to the MWCNT, especially in the THP-1 supernatant, indicating a 
differentiation towards the pro-inflammatory M1 phenotype. However, IL-1β was not 
detected in the co-cultures used for the micronucleus assay, probably because 
cytochalasin B is an inhibitor of actin polymerization and inhibits phagocytosis by 
macrophages. Consequently, micronuclei are probably not caused by an inflammatory 
effect. In alternative, micronuclei might be related to the suggested EMT of A549 cells 
as above discussed. It is likely that the higher survival rate of mesenchymal cells may 
lead to an enrichment of a cell population with chromosomal alterations, which may be 
translated into an increased micronucleus frequency. For instance, Kajita et al. (2004) 
reported that Snail and Slug, two transcriptional repressors involved in the regulation of 
EMT, may promote cell survival after genotoxic stress through direct transcriptional 
repression of genes involved in many aspects of programmed cell death, as TP5362.  
Micronucleus increase has been related to an increased risk of cancer44. The 
micronucleus induction by the two lowest concentrations of MWCNT-7, allied to its 
possible contribution to stimulate EMT of alveolar cells, raises some concern about the 
carcinogenic potential of this CNT. It should be noted that this is the only CNT 
categorized by IARC as possibly carcinogenic to humans (Group 2B) due to evidences 
of carcinogenicity in rodents12. Crocidolite is a well-known cause of mesothelioma and, 
like all other forms of asbestos, it is classified as carcinogenic to humans (group 1; 
IARC 2012). 
Noteworthy, a pronounced increase in nucleoplasmic bridges (p < 0.001), without a 
corresponding micronucleus increase was observed in A549 cells exposed to 50 
μg/cm2 MWCNT-7, but only in the monoculture. These bridges that are formed 
between the two nuclei of a binucleated cell have been deemed to be originated from 
dicentric chromosomes and have been found associated to the formation of 
micronuclei with acentric chromosome fragments, which result from asymmetrical 
chromosome exchanges63,64. In this work, the absence of micronuclei in the 
binucleated cells with nucleoplasmic bridges suggested a mechanism other than 
clastogenesis. FISH telomeric probes were used to evaluate if they were caused by 
telomere end fusions due to telomere shortening, loss of telomere capping proteins or 
defects in telomere cohesion65. The results indicated that telomeric end fusions could 
not explain the formation of those bridges, since telomeric probe signals were not 
visualized in most of them. On the other hand, by confocal microscopy, the presence of 
MWCNT-7 embedded or intruding the nucleoplasmic bridges were clearly observed 
that might suggest a physical interference with chromatin. It is known that A549 cells 
can internalize single-walled CNT (SWCNT) that accumulate in the perinuclear 
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region66. Although Kang et al. (2010) reported that MWCNT of 10-30 nm diameter and 
1-2 µm or 0.5-1 µm length were excluded from the Hep G2 cells67, intracellular 
trafficking of individual or small bundles of functionalized MWCNT towards the 
perinuclear region was observed by Kostarelos et al. (2007) in several cell types, even 
under endocytosis-inhibiting conditions68. In A549 cells, a contribution of direct 
translocation through the plasma membrane into the cytoplasm (the “nanoneedle” 
activity) and a mix of energy-dependent mechanisms (endocytosis and 
macropinocytosis) are possible ways  of internalisation of functionalized MWCNT that 
were found free in the cytoplasm or wrapped into endosome-like structures66. Once 
inside the cell, there is evidence that CNT may interact with or interfere with the 
organization of DNA, actin, microtubules and, probably, with intermediate filaments 
such as the nuclear laminas69. A biomimetic microtubule model was proposed where 
bundles of MWCNT longitudinally associate with microtubules, or one or more of the 13 
microtubule profilaments is substituted by a MWNCT, ultimately leading to cell division 
arrest and apoptosis69. A dose-related increase in the frequency of disrupted 
centrosomes and abnormal mitotic spindles was observed in BEAS-2B cells exposed 
to MWCNT70, and in SAEC and BEAS-2B cells exposed to SWCNT71. SWCNT were 
observed in association with mitotic spindle microtubules, within the centrosome 
structure and in condensed chromatin, leading to fragmented centrosomes, disrupted 
mitoses, and an aneuploid chromosome number71. Previously, Muller et al. (2008) had 
found that MWCNT induced both centromere-positive and -negative micronuclei in 
MCF-7 cells72. Although the presence of nucleoplasmic bridges could be related to 
chromosomal mis-segregation caused by mitotic spindle aberrations, our observation 
that MWCNT can intersect the bridges indicates a mechanism based on direct 
mechanical interference of CNT with the chromosomes during their segregation. It 
might happen that these cells lose the ability to divide, and, thus, be over-represented 
in the binucleated cell population. On the other hand, the absence of a significant 
number of nucleoplasmic bridges in the co-cultured binucleated cells may be related to 
the nuclear division delay estimated by the CBPI, which might be a consequence of 
A549 G1/S phase arrest.  
 
4.6.      Conclusions 
CNT toxicity has been intensively investigated and several studies have highlighted 
their potential for causing adverse effects in lung cells similarly to asbestos. In this 
study, using a monoculture of A549 epithelial alveolar cells and a co-culture of those 
cells with THP-1 macrophages, we show that MWCNT-7, also known as Mitsui-7, is 
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toxic to A549 cells and to THP-1 macrophages, and induces chromosome alterations 
(micronucleus assay) in co-cultured A549 cells, as does crocidolite. However, the 
capacity of crocidolite to induce DNA lesions in A549 cells (comet assay) was not 
observed for MWCNT-7. On the other hand, the comparison of these endpoints in a co-
culture model vs the classical monoculture of A549 cells, provided evidence for some 
dissimilar responses between MWCNT-7 and crocidolite exposure that were further 
explored. A plausible explanation for the higher A549 cell survival observed in the co-
culture after exposure to both materials may be that the presence of THP-1 
macrophages induces epithelial to mesenchymal transition of the alveolar cells, with 
mesenchymal cells being more resistant to cell death. This hypothesis was supported 
by the expression of E-cadherin, vimentin and PCNA in unexposed and exposed cells 
in monoculture and co-culture, which were compatible with apoptosis preferentially 
occurring in treated (24 h and 48 h) monocultures and EMT occurring in co-cultured 
A549 cells. In addition, the higher survival rate of A549 cells in co-culture with THP-1 
macrophages is likely to result in an enrichment of cells with DNA or chromosome 
damage, which may explain the induction of micronuclei by both materials exclusively 
in co-cultured alveolar cells. Moreover, the origin of the nucleoplasmic bridges induced 
by a single concentration of Mitsui-7 in A549 cells monocultures (without concomitant 
micronucleus formation) was suggested to derive from a direct interference of the CNT 
with chromatin or cytoskeletal filaments during mitosis, as visualized under confocal 
microscopy. Taken together, our in vitro findings using the co-culture of A549 cells and 
macrophages highlight some important effects of MWCNT-7, including its potential to 
increase cell survival by induction of epithelial to mesenchymal transition, and 
accumulation of chromosome damage that may lead to chromosome instability, two 
hallmarks of cancer cells. Given that macrophages have an important role in the alveoli 
defence against biopersistent particles, and that inflammation can provide a tumour-
promoting microenvironment, these co-cultures are likely to better mimic the in vivo 
outcomes associated to CNT exposure, e.g., lung fibrosis and carcinogenesis, 
indicating that the use of co-cultures can provide critical toxicological information that 
will be missed when using the classic lung cells monocultures.  
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5.1. Abstract 
Multi-walled carbon nanotubes (MWCNT) are widely used engineered nanomaterials in 
industrial and biomedical applications. Yet, several studies have demonstrated that 
MWCNT inhalation may induce pulmonary adverse effects, and one of these, the 
MWCNT-7 (Mitsui-7), has been classified as possibly carcinogenic to humans. 
However, its molecular mechanisms of action are poorly understood and there are no 
known biomarkers of exposure or effect for occupational monitoring. More recently, 
several pulmonary diseases, including lung cancer, have been associated with 
alterations in microRNA expression that are considered useful to detect or evaluate 
disease progression. Differentially-expressed microRNAs (DE miRNAs) also allow 
understanding the molecular effects induced by a toxicant. In this study, we describe 
the identification of a set of DE miRNAs in A549 epithelial alveolar cells, following 24 
hours exposure to an occupationally relevant dose of MWCNT-7 (0.25 µg/cm2) or an 
equivalent dose of crocidolite. The functional pathways enriched with genes targeted 
by these DE miRNAs indicate that exposed cells change their survival, differentiation 
and proliferative properties under the influence of the AMPK, FoxO, TGF-β and Hippo 
pathways, as well as their metabolic activity and cell-to-cell communication. In addition, 
MWCNT-7 affects the actin cytoskeleton regulation, ubiquitin mediated proteolysis, and 
extracellular matrix-receptor interactions. In turn, crocidolite more intensely affects the 
PI3K-Akt and mTOR pathways, endocytosis, and central carbon metabolism. Since 
deregulation of these pathways is related to carcinogenesis, an interaction network of 
DE miRNAs and corresponding target cancer-related genes was constructed, 
highlighting the carcinogenic potential of both materials, even at low dose and short-
term exposure. 
 
5.2. Introduction 
Carbon nanotubes (CNT) are one of the most promising products of nanotechnology 
with an extensive variety of applications in industry and biomedicine1. Multi-walled 
carbon nanotubes (MWCNT) consist of multiple cylindrical graphite sheets assembled 
in concentric layers with nanoscale diameter (less than 100 nm). They can be 
functionalized by the introduction of specific elements on the original pristine form, and 
display unique physicochemical properties, e.g., are mechanically strong, flexible, 
lightweight, heat resistant, and high electrical conductors. 
Several toxicological studies have demonstrated that exposure to some MWCNT can 
induce immunotoxic, cytotoxic and genotoxic effects, and nowadays they are 
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considered an occupational hazard2. In rodents, exposure to MWCNT have caused 
acute or persistent pulmonary inflammation, persistent interstitial fibrosis, granuloma 
formation, and bronchiolar or bronchioloalveolar hyperplasia1,3. These adverse 
pulmonary effects are associated with the intrinsic physicochemical properties and 
biopersistence of MWCNT4,3. Particularly, those that have similarity with the fiber-like 
shape of asbestos have raised a strong concern about their carcinogenic potential5. 
The discordant carcinogenic evidence obtained for different carbon nanotubes led the 
International Agency for Research on Cancer (IARC) to categorize them as not 
classifiable as to their carcinogenicity to humans (Group 3), with the exception of the 
MWCNT-7 (Mitsui-7) that was classified as a possibly human carcinogenic (Group 
2B)6. This MWCNT induced peritoneal mesothelioma after a single intraperitoneal 
injection in mice (0.003–3 mg/animal)7,8, two intraperitoneal injections with a one-week 
interval in rats (0.5-5 mg/animal)9, intrascrotal injection (1 mg/animal) in rats10 and 
promoted lung carcinomas after whole-body inhalation exposure of male (0.2 and 2 
mg/m3) and female rats (2 mg/m3)11. Moreover, it promoted growth and neoplastic 
progression of mice lung cells previously exposed to methylcholanthrene, causing lung 
bronchioloalveolar adenomas and adenocarcinomas at doses similar to the ones that 
can be achieved in human occupational exposures12. Like asbestos, Mitsui-7 injection 
in the peritoneal cavity of rats induced an early and selective sustained 
immunosuppressive response characterized by the accumulation of monocytic Myeloid 
Derived Suppressor Cells that possess the ability to suppress polyclonal activation of T 
lymphocytes13. Interestingly, mesotheliomas induced by thin (diameter ~ 50 nm) and 
highly crystalline MWCNT share a homozygous deletion of the tumour suppressor 
genes Cdkn2a/2b, similar to mesotheliomas induced by asbestos9. In the Nagai et al. 
(2011) study, it was proposed that thin and crystalline MWCNT might have a piercing 
effect in the mesothelial cell membrane, but aggregative and thick MWCNT do not 
cause direct injury in mesothelial cells, the carcinogenicity of those being mediated by 
indirect effects.  
In the last years, genomic approaches have been applied to study CNT toxicity with the 
aim of obtaining insightful information on the genes and corresponding functional 
pathways that they affect. Toxicogenomics expects to find unique transcriptional 
profiles that, besides providing evidence of the cellular mechanistic mode of action of 
CNT, may also be used as biomarkers for biomonitoring purposes14,15. Some of the 
most frequently disturbed biological processes following cell or animal exposure to 
CNT include apoptosis, inflammation, oxidative stress, fibrosis, cell cycle and 
proliferation, among others16.  
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Moreover, several nanomaterials have been associated with epigenetic alterations, i.e., 
changes in the regulation of gene expression caused by DNA methylation, histone tail 
alterations and differential microRNA (miRNA) expression17,18. miRNAs are small 19 to 
25 nucleotides-long non-coding RNAs usually acting as endogenous repressors of 
gene activity via post-transcriptional binding to a “seed” sequence in the 3´ 
untranslated region (3’-UTR) of mRNA19. Lung cells have a specific miRNA profile, and 
several pulmonary diseases, such as chronic obstructive pulmonary disease, asthma, 
cystic fibrosis, pulmonary hypertension and lung cancer, have been associated with 
alterations in miRNA expression20,21,22. Several under- or over-expressed miRNAs have 
been reported in malignant mesothelioma tumours, and some have been suggested as 
potential biomarkers for histopathological subtyping of tumours23,24,25 or as potential 
regulators of the adenoma to adenocarcinoma transition26. Moreover, cell-free 
circulating miRNAs in plasma are highly sensitive, reproducible, specific and stable27,28. 
In addition to be promising biomarkers for tumour classification and staging29,30, they 
are considered potential blood biomarkers for monitoring human exposure, especially 
in occupational settings.  
In rodents exposed to MWCNT, miRNA analysis in whole blood correlated FCRL5/miR-
122-5p to the presence of hyperplasia, MTHFD2/miR-206-3p to fibrosis, 
FAM178A/miR-130a-3p to bronchiolo-alveolar adenoma, and IL7R/miR-210-3p to 
bronchiolo-alveolar adenocarcinoma, among others26. In two other studies, one 
identified the altered miRNAs and the corresponding pathways in mouse embryo-
derived NIH/3T3 cells using a high-throughput deep sequencing method31, and other 
identified global lung miRNA/mRNA regulatory relationships associated with 
inflammation and fibrosis using a microarray32. Nymark et al. (2011), also using 
microarray technology, studied mRNA and miRNA expression changes associated with 
mitochondrial dysfunction in human bronchial epithelial cells exposed to MWCNT-7 and 
found a 330-gene miRNA signature, of which four miRNAs were associated with 
decreased mitochondrial membrane potential33.  
Asbestos exposure was also associated with changes in miRNA expression in patient’s 
tumours and normal lung tissues, with 13 asbestos-related differentially expressed 
(DE) miRNAs, including over-expression of the squamous cell carcinoma-associated 
miR-205, linked to down-regulation of the DOK4 gene, an insulin receptor substrate 
gene involved in cellular growth, signalling, and survival34. 
In this study, we used next-generation sequencing (NGS) technology to sequence 
miRNAs in A549 epithelial alveolar cells exposed to MWCNT-7 (Mitsui-7) or crocidolite 
asbestos during 24 hours, and bioinformatics tools to identify DE miRNAs, their 
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corresponding target genes and deregulated cellular pathways. Since much criticism 
has emerged from the high carbon nanotube mass doses commonly used in in vitro 
toxicity studies, as it can take a long time to reach them in the human airways in real 
life35,3, we used a dose of MWCNT-7 (0.25 µg/cm2) that has been considered as 
occupationally relevant36. Crocidolite was used to compare the miRNA profile and 
molecular pathways with MWCNT-7 exposure, due to their strong similarity in terms of 
physical characteristics and high biopersistence, and because of the well-known lung 
adverse effects of crocidolite, namely, asbestosis, lung cancer and mesothelioma37. 
This methodology allowed to identify a set of miRNAs associated to the exposure to 
MWCNT-7 or crocidolite, and to deepen the knowledge on its molecular modes of 
action at occupational relevant doses, their similarities and differences. Our results also 
point towards possible future targets for mechanistic research on the toxicity of these 
materials.  
 
5.3 Materials and Methods 
5.3.1 Fibre characterization and preparation 
The MWCNT-7, also known as Mitsui-7 (Mitsui and Co, Lda. Ibaraki, Japan), was 
provided as a sub-sample by the National Research Centre for the Working and 
Environment (NRCWE-006). Its physicochemical characteristics were described 
previously and are listed in table I. 
 
Table I. Physicochemical characteristics of the MWCNT-7 (NRCWE-006, Mitsui-7). 
Specific 
surface area 
(m2/g) 
Thickness 
± SD (nm) 
Geodesic 
length ± SD 
(nm) 
Aspect 
ratio ± SDb 
Impurities 
% 
Minor Impurity 
phasesc 
Minor elements/coatingsc 
24-28a 
22c 
 
69.4 ± 1.4b 
74 ± 28c 
49 – 100d 
 
 
4423.6 ± 2.3b 
5730 ± 3674c 
3000 – 5000d 
 
63.7 ± 2.4 
<1%a 
< 0.5%d 
Fe2O3 
Na: 499 ± 103 μg/g  
Mg: 1 ± 1 μg/g 
Al: 66 ± 19 μg/g 
Fe: 355 ± 2 μg/g 
Ni: 1 μg/g 
aInformation provided by manufacturer or the Joint Research Center 
(http://ihcp.jrc.ec.europa.eu/our_activities/nanotechnology/nanomaterials-repository/list_materials_JRC_rep_oct 
_2011.pdf). 
b Values reported by Tavares et al. 201438 
cValues reported in the NANOGENOTOX  Joint Action by Jensen 201339. 
d Values reported by Poulsen et al. 201340.  
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Immediately before the experiments, a 2.56 mg/mL stock dispersion of the NRCWE-
006 was prepared according to41.  The hydrodynamic particle size-distribution (Zav, nm) 
and the polydispersity index (PDI) of MWCNT-7 stock dispersion were measured 
shortly after sonication (Malvern Nano ZS, Malvern Inc., UK) by  dynamic light 
scattering (DLS) and expressed as the mean of 10 consecutive measurements38.  
Scanning electron microscopy (SEM) of the stock solution was also performed using a 
Phantom XL microscope. 
The crocidolite fibres are a standard reference mineral from the Union for International 
Cancer Control (UICC, Geneva, Switzerland) and were kindly provided by Dr. Fátima 
Aguiar from the Environmental Health Department of INSA. Their preparation and 
characterization have been described in detail42,43,44,45. A stock solution was prepared 
at 1 mg/mL in phosphate buffer saline (PBS), pH 7.4 (Gibco, Waltham, MA, USA). Prior 
to dilution in culture medium, fibres were passed through a syringe needle to ensure a 
better uniformity of the suspension. 
 
5.3.2. Cell culture 
The A549 cell line was obtained from the American Type Culture Collection 
(ATCC® Manassas, VA, USA, CCL-185™) and grown in RPMI 1640 medium (Gibco) 
supplemented with 10% heat-inactivated fetal bovine serum (FBSi) (Gibco), 1% 
penicillin/streptomycin (1.000 U/mL penicillin and 10 mg/mL streptomycin, Gibco) and 1 
% fungizone (0.25 mg/mL, Gibco) at 37 ºC in an atmosphere of 5% CO2. The cells 
were cultured on 6–well plates at a density of 1 x 105 cells/mL in a total volume of 2 
mL/well and exposed to 0.25 µg/cm2 of MWCNT-7 or crocidolite during 24 h. Non-
exposed cells were used as controls. 
 
5.3.3. RNA extraction 
Total RNA was isolated from non-exposed A549 cells, and A549 cells exposed to 
MWCNT-7 or crocidolite, using the miRNeasy Mini Kit (Qiagen) according to the 
manufacturer’s protocol. Total RNA was eluted in RNase-free water and stored at -
80ºC until use. RNA concentration and purity was determined using a NanoViewPlus 
Spectrophotometer (General Electric, Boston, Massachusetts, USA). RNA quality was 
assessed using the Fragment Analyser (Advanced Analytical Technologies, Santa 
Clara, California, USA) and the HS RNA kit. All samples showed an RNA quality 
number ≥ 9. Samples were diluted to a final concentration of 1 µg of RNA in 5 µL 
nuclease-free water. 
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5.3.4. Library preparation and sequencing 
Three RNA samples and a control sample (Human Brain Total RNA, Thermo Fisher 
Scientific) were used to generate indexed cDNA libraries with the TruSeq Small RNA 
Library Prep kit (Illumina, San Diego, California, USA) with minor protocol adaptations 
as follows. Library amplification was performed using 18 cycles to increase the yield of 
miRNA fragments. The purification of the amplified cDNA constructs was carried out 
using a 4% agarose gel. Product recovery was made by immersing the gel slices in 
200 µl ultrapure water followed by incubation at 300 rpm for 2 hours at room 
temperature and overnight at 4ºC in a Thermomixer Compact (Eppendorf). The eluate 
was then transferred to a QIAshredder column (Qiagen) and centrifuged at 10.000 rpm 
for 1 minute. Purified libraries were quantified using Qubit (Thermo Fisher Scientific) 
and their sizes were quality checked using the Fragment Analyzer with the HS NGS 
Fragment kit and 2% agarose gel electrophoresis. After normalization, libraries were 
pooled, denatured and diluted according to standard procedures for the MiSeq 
instrument (Illumina). Two sequencing runs of 1x75 bp read length were performed 
using the Small RNA workflow with loading library concentrations of 10 pM and 20 pM. 
The control sample was included in the first sequencing run. 
 
5.3.5. Sequencing data analysis 
Sequencing raw data was processed using the built-in Small RNA analysis workflow of 
the MiSeq instrument (Illumina). In brief, sequencing reads were aligned to 2578 
human mature miRNA sequences obtained from miRBase v20 database46 using 
bowtie47. A matrix containing raw counts of reads per mature miRNA sequence in each 
sample (supplementary files 1 and 2) was obtained for each sequencing run. 
 
5.3.6. Differential expression analysis 
Raw counts were used to perform differential expression analysis of miRNAs between 
non-exposed cells and cells exposed to MWCNT-7 or crocidolite. All analyses were 
conducted using R v3.4.248 and RStudio v1.0.14349. Two R software packages, 
DESeq2 v1.18.150 and RNASeqGUI v1.1.251, were used for differential expression 
analysis. The latter was used for performing differential expression with the EdgeR 
Exact Test52. A p-adjusted (padj) value of 0.1 and a false discovery rate (FDR) of 0.1 
were used in DESeq2 and EdgeR, respectively. Two independent matrix files were 
constructed containing only the replicate counts for non-exposed and MWCNT-7-
exposed cells, and for non-exposed and crocidolite-exposed cells, using the original 
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raw counts. The miRNAs with low counts were filtered prior to differential expression 
analysis from each matrix using the Filtering Interface of RNASeqGUI. The 'counts per 
million' (CPM) was chosen as the filtering method with parameter values cpm = 20 and 
cv.cutoff = 25. The filtered count matrices (supplementary files 3 and 4) were used as 
direct input in DESeq2 using the script described in supplementary file 5. In the case of 
EdgeR Exact Test, the raw counts in the filtered matrices were further normalized 
according to the trimmed mean of M values method53 in the Normalization Interface of 
RNASeqGUI (supplementary files 6 and 7). The set of miRNAs identified by DESeq2 
and EdgeR are described in supplementary files 8-11. Selected sets of differentially-
expressed (DE) miRNAs in MWCNT-7- and crocidolite-exposed cells were 
subsequently defined according to the following criteria: 
1. padj < 0.05 in DESeq2 or FDR < 0.05 in EdgeR Exact Test 
and 
2. log2 fold-change > |0.5| in  DESeq2 or log2 fold-change > |0.75| in EdgeR 
The log2 fold-change cut-off was set higher in EdgeR than in DESeq2 because EdgeR 
showed a larger distribution of fold-change values. 
 
5.3.7. Pathway analysis of miRNA target genes  
The DIANA-miRPath v3.0 web server54 was used for the identification of miRNA target 
genes, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways55 and GO 
terms56,57. miRNA target genes were initially identified using experimentally-supported 
interactions contained in Tarbase v7.058 or, in its absence, of predicted interactions 
available in TargetScan 6.259. The “Genes intersection” method was used for pathway 
analysis. An intersection set composed of 3 miRNAs was used, i.e., all genes targeted 
by at least 3 miRNAs contained in the selected set was used for enrichment analysis. 
The p-value threshold was of 0.05. Advanced statistic options included “FDR 
Correction” and “Conservative Stats” (which penalizes pathways with very few target 
gene nodes). The resulting list of KEGG affected pathways was manually filtered 
according to the main categories “metabolism”, “genetic information processing”, 
“environmental processing” and “cellular processes”. The category “organismal 
systems” was removed from the analysis since it does not cover biological systems 
related to the lung function. In addition, only the pathways related to lung pathology in 
the category “human diseases” were retained. 
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5.3.8. miRNA - target gene network analysis 
DE miRNAs in crocidolite- or MWCNT-7-exposed cells for which target genes were 
identified in KEGG´s 'Pathways in Cancer' (hsa05200) were loaded into Cytoscape 
version 3.7.060 for network extension using CyTargetLinker 4.0.161. miRBase accession 
numbers were retrieved for each of the miRNA names (miRBase v.20) using 
miRNAmeConverter web interface62. miRTarBase63 miRNA-target gene validated 
interactions (release 7.0) were used as the link set in CyTargetLinker. The extended 
networks were filtered using a text file containing a list of the 'Pathways in Cancer' 
target genes detected in pathway analysis (Supplementary files 12 and 13). Log2-fold 
change values and corresponding FDR obtained with EdgeR Exact Test for each of the 
miRNAs were uploaded in filtered networks to visualize the over- or under-expression 
of miRNAs and their FDR, respectively. 
 
5.4. Results 
5.4.1. miRNA differential expression analysis 
Several under- and over-expressed miRNAs were identified in the A549 cell cultures 
after exposure to MWCNT-7 or crocidolite. The total number of DE miRNAs was 
dependent on the tool used to assess differential expression, with DESeq2 identifying a 
lower number of DE miRNAs comparatively to EdgeR. Thus, the total number of DE 
miRNAs in MWCNT-7- and crocidolite-exposed cells identified with DESeq2 and 
EdgeR was of 49 and 48, and of 85 and 86, respectively. All the miRNAs identified as 
DE in DESeq2 were also found using EdgeR. After filtering the above-mentioned 
miRNAs according to the criteria previously described, a total of 17 and 21 miRNAs 
were DE in cells following 24 h exposure to MWCNT-7 or crocidolite, respectively 
(Table 2). 
 
5.4.2. Functional pathways and gene ontology analyses 
The prediction of the molecular KEGG pathways that were affected by the under- or 
over-expression of the miRNAs listed in Table 1 is represented in figures 1 and 2. 
These functional pathways were grouped according to the KEGG subcategories and 
represented as pie charts (figure 3).  
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Table 2. Differentially expressed miRNAs in A549 cells after 24 hours exposure to MWCNT-7 or 
crocidolite, comparatively to non-exposed cells. miRNA names shown in bold represent under- or over-
expressed miRNAs found by both DESeq2 and EdgeR Exact Test.  
DESeq2 miRNA name log2-fold change padj/FDR 
MWCNT-7 
under-
expressed 
hsa-miR-1910-5p -1.271318978 0.009759099 
hsa-miR-99b-3p -0.798281222 0.028683657 
hsa-miR-423-5p -0.763078633 3.10E-16 
hsa-miR-1180-3p -0.735194908 1.59E-06 
hsa-miR-744-5p -0.65453858 0.0021697 
hsa-miR-181b-5p -0.590474101 3.32E-12 
hsa-miR-28-3p -0.58369319 2.65E-28 
hsa-miR-423-3p -0.580059647 9.12E-25 
hsa-miR-181a-3p -0.553571253 4.24E-06 
over-
expressed 
hsa-miR-27a-3p 0.59466829 2.60E-06 
hsa-miR-15b-5p 0.619551169 0.000271135 
hsa-miR-30c-5p 0.674722475 0.034758839 
hsa-miR-23a-3p 0.688561186 0.002886279 
hsa-miR-222-3p 0.889045128 0.037397783 
crocidolite 
under-
expressed 
hsa-miR-24-3p -0.73414992 0.034786063 
hsa-miR-101-3p -0.713150785 0.004304365 
hsa-miR-340-5p -0.582456605 0.008301919 
hsa-miR-1180-3p -0.547168087 0.00139618 
hsa-miR-28-3p -0.542911017 5.28E-21 
hsa-miR-409-3p -0.530453512 0.002514626 
over-
expressed 
hsa-miR-27a-3p 0.505266368 0.000380578 
hsa-miR-15b-5p 0.66820634 0.000380578 
hsa-miR-30c-5p 0.798185792 0.011901228 
hsa-miR-23a-3p 0.842683962 0.000380578 
EdgeR Exact Test miRNA name log2-fold change padj/FDR 
MWCNT-7 
under-
expressed 
hsa-miR-654-5p -1.845844483 0.007762024 
hsa-miR-1908-3p -1.487354661 0.041120488 
hsa-miR-1910-5p -1.168992982 0.000451106 
hsa-let-7d-3p -0.789489298 0.003483815 
over-
expressed 
hsa-miR-23a-3p 0.747148058 1.70E-07 
hsa-miR-222-3p 0.951838697 0.000112017 
crocidolite 
under-
expressed 
hsa-miR-654-5p -2.211630362 0.003227417 
hsa-miR-1908-3p -1.626975718 0.049569238 
hsa-miR-382-5p -1.49883479 0.039304006 
hsa-miR-193a-5p -1.021835193 0.010603353 
hsa-miR-210-5p -0.886993244 0.041209528 
over-
expressed 
hsa-miR-134-5p 0.777447093 0.011187302 
hsa-miR-30c-5p 0.823403475 1.32E-06 
hsa-miR-23a-3p 0.873117105 7.84E-12 
hsa-miR-758-3p 0.9645798 0.019932114 
hsa-miR-548o-3p 0.987369546 0.040452333 
hsa-miR-215-5p 1.174234661 0.040628046 
hsa-miR-130b-5p 1.324235257 0.035406988 
hsa-miR-422a 1.333924898 0.001101338 
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.  
Figure 1. KEGG pathways enriched with genes targeted by the differentially expressed miRNAs in A549 
cells exposed to MWCNT-7, ordered by decreasing p-value. 
 
 
Figure 2. KEGG pathways enriched with genes targeted by the differentially expressed miRNAs in A549 
cells exposed to crocidolite, ordered by decreasing p-value. 
The main enriched KEGG categories are environmental information processing 
(encompassing the subcategories “signal transduction” and “signalling molecules and 
interaction”), and cellular processes (encompassing the subcategories “transport and 
catabolism”, “cell growth and death” and “cellular community”). As shown in figure 3, 
most of the enriched cellular pathways are shared between MWCNT-7 and crocidolite 
and are related to cell metabolism, processes of cell growth and death, cell-to-cell 
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communication, protein processing in the endoplasmatic reticulum, and signal 
transduction. Furthermore, other molecular pathways are enriched for each exposure, 
namely, “regulation of actin cytoskeleton”, “ubiquitin mediated proteolysis” and “ECM-
receptor interaction” in cells exposed to MWCNT-7, and “endocytosis”, “central carbon 
metabolism in cancer”, “microRNAs in cancer”, “non-small cell lung cancer”, “P13K-Akt 
signalling pathway” and “mTOR signalling pathway” in cells exposed to crocidolite. 
 
 
Figure 3. Pie charts of the proportion of enriched pathways in A549 cells after 24 h exposure to MWCMT-7 
or crocidolite, organized according to KEGG sub-categories. In bold, unique pathways and subcategories 
found in MWCNT-7 or crocidolite exposed cells. 
 
Pathway analysis identified miRNA target genes in 'Pathways in Cancer' for 14 out of 
17 DE miRNAs in MWCNT-7-exposed cells. miRNAs with no target genes in this 
pathway included hsa-miR-1180-3p, hsa-miR-1910-5p and hsa-miR-654-5p. Likewise, 
17 out of 21 miRNAs had 'Pathways in Cancer' target genes in crocidolite-exposed 
cells. miRNAs hsa-miR-1180-3p, hsa-miR-215-5p, hsa-miR-134-5p and hsa-miR-654-
5p had no target genes in this pathway. The number of target cancer genes was of 56 
and 60 in MWCNT-7-exposed and crocidolite-exposed-cells, respectively. 
Ontology analysis showed that four molecular functions (RNA binding, poly(A) RNA 
binding, ion binding, enzyme binding) and four cellular components (organelle, cytosol, 
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protein complex and micro-ribonucleoprotein complex) were enriched in both MWCNT-
7 and crocidolite exposures. Exposure to the latter included three other cellular 
components (nucleoplasm, RISC complex and cytoplasmic mRNA processing body). 
The enriched GO biological processes for each material are shown in figures 5 and 6, 
and the majority are associated to regulation of gene expression, e.g., positive 
regulation of nuclear-transcribed mRNA catabolic process - deadenylation-dependent 
decay, positive regulation of nuclear-transcribed mRNA poly(A) tail shortening, 
negative regulation of translation involved in gene silencing by miRNA, and 
nucleobase-containing compound catabolic process, among others. Of special interest, 
we found enrichment of the fibroblast growth factor receptor, epidermal growth factor 
receptor, and Notch signalling pathways in cells exposed to either MWCNT-7 or 
crocidolite. 
 
 
Figure 4. GO terms enriched with target genes of the differentially expressed miRNAs in A549 cells 
exposed to MWCNT-7, ordered by decreasing p-value. 
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Figure 5. GO terms enriched with target genes of the differentially expressed miRNAs in A549 cells 
exposed to crocidolite, ordered by decreasing p-value. 
 
5.4.3. miRNA - target cancer genes interaction network  
We performed a network analysis of the DE miRNAs and their target genes included in 
the KEGG subcategory “pathways in cancer” because of the over-representation of 
cancer-related molecular pathways in cells exposed to MWCNT-7 or crocidolite. 
“Pathways in cancer” is a global KEGG subcategory, i.e., it includes many pathways of 
other subcategories that are related to cancer, for instance, many signal transduction 
or metabolic pathways. Thus, it allows an overview of many linked pathways that 
determine cell survival, differentiation and proliferation. In this analysis, only a part of 
the possible miRNA-target gene interactions were represented since for some miRNAs 
and some target genes no interactions are described in mirTarBase. These included 3 
out of 14 miRNAs (hsa-miR-1908-3p, hsa-let-7d-3p and hsa-miR-181a-3p) and 20 out 
of 56 target genes in MWCNT-7-exposed cells and 4 out of 17 miRNAs (hsa-miR-548o-
3p, hsa-miR-210-5p, hsa-miR-422a and hsa-miR-1908-3p) and 9 out of 60 target 
genes in crocidolite-exposed cells. However, several oncogenes including CCND1, 
EGFR, MDM2 and MYC, and several tumour suppressor genes including PTEN, 
RUNX1 or SMAD2 are included in the networks. The comparison of both networks 
suggests that crocidolite has a higher impact than MWCNT-7 in the A549 cell pathways 
related to cancer (figure 6). 
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Fig 6. Networks of miRNA-target gene interactions in MWCNT-7- (A) and crocidolite- (B) exposed A549 
cells. The yFiles Tree Layout version 1.0.1 (yWorks, Germany) was used as the algorithm to visualize the 
networks. Nodes colored blue indicate lower expression in exposed cells whereas nodes colored red 
indicate higher expression, relatively to non-exposed cells. miRNA nodes with thicker borders indicate 
higher FDR values whereas those with thinner borders indicate lower FDR values. Thus, network nodes 
with darker blue or red circles and thinner borders represent miRNAs with potential higher impact in the 
network.  Gene nodes are shown in white. The "hsa-miR-" prefix of miRNA names was omitted for a better 
visualization.  
 
5.5. Discussion 
In this study, using alveolar epithelial cells exposed to a low concentration of MWCNT-
7 or crocidolite we identified sets of miRNAs associated with the exposure to each 
material. Some of those miRNAs have been reported as regulators of cellular pathways 
A 
B 
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related to control of cell growth, proliferation, differentiation and survival. For both 
materials, signal transduction was the main enriched cellular process, and several well-
known pathways such as the transforming growth factor-β (TGF-β), the mammalian 
target of rapamycin (mTOR), and the Forkhead box O (FoxO) pathways were enriched 
in the functional pathway analysis.  
The AMP-activated protein kinase (AMPK) pathway and the FoxO pathway are 
commonly deregulated in cells exposed to MWCNT-7 and crocidolite. AMPK is a highly 
conserved metabolic sensor of intracellular adenosine nucleotide levels that is 
activated when ATP production decreases, resulting in relative increases in AMP or 
ADP64. This cell signalling pathway plays critical roles in regulating growth and 
reprogramming metabolism, and other cellular processes including autophagy and cell 
polarity64. AMPK, upon oxidative and nutrient stress, e.g., low glucose or oxygen levels, 
leads to a concomitant inhibition of anabolic pathways, such as protein, fatty acid and 
glycogen synthesis, and activation of catabolic pathways, such as fatty acid oxidation 
and glycolysis. One of its downstream effects is the activation of FoxO transcription 
factors, increasing the expression of its target genes that regulate cellular 
differentiation, growth, survival, cell cycle, metabolism, stress and tumour suppression 
pathways65. By contrary, phosphorylation by the phosphatidylinositol 3-kinase/serine-
threonine kinase (PI3K/Akt) pathway, that was found to be enriched in cells exposed to 
crocidolite, inactivates FoxO proteins decreasing gene expression of negative cell cycle 
regulators and promoting cell survival, growth and proliferation65. In addition, the 
PI3K/Akt pathway positively regulates the mTOR pathway, which was also enriched 
upon crocidolite exposure, while the AMPK pathway acts as a negative regulator of the 
mTOR pathway. The mTOR pathway regulates cell metabolism, growth, proliferation 
and survival through several cellular processes, including lipid metabolism, autophagy, 
protein synthesis and ribosome biogenesis, and is deregulated in human diseases 
such as cancer and type 2 diabetes66,67. This is in line with the metabolic pathways that 
were identified as being affected in cells exposed to each of the materials, i.e., fatty 
acid biosynthesis, lysine degradation and mucin type O-glycan biosynthesis in KEGG 
analysis, or biosynthetic processes, cellular nitrogen compound metabolic process, 
nucleobase-containing compound deadenylation and several other catabolic processes 
involved in regulation of transcription and translation in GO analysis. It is known that 
cancer cells show alterations in mucin-type O-glycosylation, which is a widespread 
post-translational modification of proteins involved in a variety of important biological 
processes in eukaryotes68. Moreover, proteoglycans in cancer is the second major 
enriched KEGG pathway. Proteoglycans are proteins with one or more covalently 
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bound glycosaminoglycan chain that are constituents of the extracellular matrix (ECM) 
or are located in the basement membrane or plasma membranes of cells, either 
directly via an intercalated protein core or via a glycosyl-phosphatidyl-inositol 
anchor69,70. ECM proteins and structures can determine cell behaviour, polarity, 
migration, differentiation, proliferation and survival by communicating with the 
intracellular cytoskeleton and transmitting growth factor signals71. Hence, alterations in 
the EMC proteoglycans can interfere with these cell functions, and ECM-receptor 
interaction is one enriched KEGG subcategory, as well as adherens junction and focal 
adhesion. Another commonly affected pathway, the Hippo pathway, is regulated by 
cell-cell contact, cell polarity and actin cytoskeleton, among other signals, like the cell 
state of energy and hormonal72. Hippo major functions are restricting tissue growth in 
adults and modulating cell proliferation, differentiation, and migration in developing 
organs72. Many upstream regulators for the Hippo pathway are components of tight 
junctions and adherens junctions. 
A pathway differentially enriched in cells exposed to MWCNT-7, also enriched in GO 
analysis, is the ubiquitin proteolytic system. The ubiquitin proteolytic system has 
influence on a broad spectrum of cellular processes, e.g., regulation of cell cycle, 
differentiation and development, response to extracellular effectors and stress, 
modulation of cell surface receptors and ion channels, DNA repair, regulation of the 
immune and inflammatory responses and biogenesis of organelles73. One of the 
cellular pathways this system tightly regulates is the TGF-β signalling pathway, another 
enriched pathway. The TGF‐β is a superfamily of cytokines crucial in regulating cell 
growth, differentiation, apoptosis, motility, invasion, extracellular matrix production, 
angiogenesis, and immune response74. In the early stages of cancer development, 
TGF‐β acts as a tumour suppressor, whereas in later stages, supports invasion and 
metastasis by modulating the immune system and tumour microenvironment74. The 
main signal transducers for TGF-βsignalling are the Smads, a family of structurally 
related proteins75. Smad2, which his represented in the gene networks of figure 6, is 
one of these essential mediators. Its possible down-regulation through the 
overexpression of the miRNAs hsa-miR-15b-5p and hsa-miR-27a-3p can reduce the 
inhibitory response of TGF-β, thus causing dysregulation of cell growth. 
GO analysis has also highlighted the involvement of the epidermal growth factor 
receptor (EGFR) and Notch signalling pathways in the molecular effects of MWCNT-7 
and crocidolite. EGFR and Notch signalling are essential in cell proliferation, 
differentiation, and apoptosis76,77. Their deregulation is a common event in cancer, 
including in non‐small‐cell lung cancer (NSCLC), and EGF and Notch receptors are 
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widely used targets of cancer therapy78,79. Overexpression of EGFR was detected in 
more than half cases of NSCLC, most frequently in squamous cells, associated with a 
poor prognosis and chemoresistance. As to the Notch signalling, its role in NSCLC is 
more complex, but there as several theories trying to explain the crosstalk between 
Notch and EGFR80.  
Since the deregulation of the above-mentioned pathways, in which the well-known p53 
pathway can be included, are related to malignancy and tumorigenesis, cell cycle 
regulation is an affected function in cells exposed to MWCNT-7 and crocidolite. In fact, 
“pathways in cancer” is altered in the KEGG category human diseases. This pathway 
was also found enriched in the analysis of the mRNA targets of upregulated miRNA in 
the whole blood of 8 workers with no less than 6 months exposure to MWCNTs by 
inhalation81, confirming its in vivo relevance. The richness of interconnections between 
the cancer related genes depicted in figure 6suggests that cancer is an important 
outcome of MWCNT-7 and crocidolite exposures. 
Non-small cell lung cancer is significantly enriched in crocidolite exposure, although 
from the 40 and 28 miRNAs found differently expressed, respectively, in tumour 
samples of stage I squamous cell carcinoma and adenocarcinoma, only the hsa-miR-
758-3p, associated to squamous cell carcinoma, is upregulated in crocidolite 
exposure82. MicroRNAs in cancer and central metabolism in cancer are also specific 
crocidolite-enriched pathways, which may suggest that crocidolite is more carcinogenic 
than MWCNT-7. However, miR-hsa-222-3p is upregulated in cells exposed to 
MWCNT-7, but not to crocidolite. The miR-hsa-222 regulates the expression of a 
potent inhibitor of cell cycle and tumour suppressor protein, p27, and is overexpressed 
in NSCLC, indicating poor prognostic factors and poor survival83,84,85. The miR-hsa-
222-3p has been found in exosomes released from epithelial ovarian cancer cells that 
are transferred to macrophages causing their polarization towards the M2 phenotype, 
further enhancing tumour progression86. Moreover, it was present in patient serum 
exosomes and proposed as a biomarker of epithelial ovarian cancer. Furthermore, 
exosomic miR-hsa-222-3p seems to play a critical role in gemcitabine resistance in 
NSCLC chemotherapy. Exosomes rich in miR-222-3p, transferred from gemcitabine 
resistant A549 cells to recipient A549 cells via caveolin- and lipid raft-dependent 
endocytosis, have enhanced their proliferation, gemcitabine resistance, migration, 
invasion, and anti-anoikis by directly targeting the promoter of SOCS387. In addition, a 
higher level of exosomic miR-222-3p in patient’s sera predicted worse prognosis in 
NSCLC following gemcitabine therapy. Let-7d is another miRNA down-regulated in 
MWCNT-7 exposure. It belongs to the Let-7 family, a group of miRNAs that act as a 
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tumour suppressor miRNAs and regulate the expression of oncogenes in several types 
of human cancers, including lung cancer88. A549 cells express high levels of Let-7d 
and its down-regulation has been associated to the development of idiopathic 
pulmonary fibrosis89 and non-small cell lung cancer (NSCLC), being also related to a 
shortened postoperative survival90. 
The regulation of cell actin cytoskeleton pathway is also affected after exposure to 
MWCNT-7, but not to crocidolite. It is thought that MWCNT may interact with or 
interfere with actin, microtubules and probably with intermediate filaments such as the 
nuclear laminas 91. A biomimetic microtubule model was proposed, where bundles of 
MWCNT are longitudinally associated with microtubules or where one or more of the 
13 microtubule profilaments is substituted by a MWNCT, ultimately leading to cell 
division arrest and apoptosis91. Consequently, a dose-related increase in the frequency 
of disrupted centrosomes and abnormal mitotic spindles was observed in human 
bronchial epithelial cells exposed to MWCNT92. 
Finally, endocytosis was affected in cells exposed to crocidolite, suggesting a more 
significant role of this mode of cell entry for crocidolite fibres than for MWCNT-7 
nanofibres. MWCNT can have a piercing effect in the plasma membrane and directly 
translocate into the cytoplasm due to their needle-like structure.93 observed intracellular 
trafficking of MWCNT towards the perinuclear region in several cell types, even under 
endocytosis-inhibiting conditions. Moreover, MWCNT were found free in the A549 cell 
cytoplasm or wrapped into endosome-like structures, possibly due to the contribution of 
direct translocation, endocytosis and micropinocytosis94. 
Overall, we identified several functional pathways in epithelial cells that are affected by 
MWCNT-7 or crocidolite exposure, which is one great advantage of using NGS. This 
sequencing technique detects all cellular miRNAs, and not only the ones predefined by 
microarrays, allowing a complete profile of the gene regulation changes occurring 
through miRNA expression. It should not be forgotten that, as in all in vitro studies 
using representative established cell lines, as the A549 human alveolar type II 
epithelial cells95,96, we cannot exclude that other functional pathways would be 
significantly affected in normal primary epithelial lung cells. 
 
5.6 Conclusion 
The role of miRNAs in regulating gene expression is being increasingly understood, 
either promoting or supressing biological pathways. Consequently, the identification of 
the differently expressed miRNAs in cells or tissues after exposure to a toxic can allow 
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the recognition of its possible mechanisms of action. Our results strongly indicate that 
A549 cells exposed to an occupationally relevant dose of MWCNT-7, and an identical 
dose of crocidolite, are changing their survival, differentiation and proliferative 
capabilities under the major influence of the AMPK, FoxO, TGF-β and Hippo pathways, 
thus influencing cell-to-cell communication and their metabolic activity. A gene network 
analysis of pathways related to cancer showed the involvement of several oncogenes 
and tumour suppressor genes in the alveolar cell response to exposure to MWCNT-7 
and crocidolite that can represent future targets of research on its molecular effects. 
Moreover, the overall results suggest that crocidolite has a greater impact than 
MWCNT-7 in cell survival, differentiation and proliferation. Furthermore, MWCNT-7 
seems to affect the regulation of the actin cytoskeleton, the ubiquitin mediated 
proteolysis system, and ECM-receptor interactions. In turn, crocidolite more profoundly 
affects the P13K-Akt and mTOR signalling pathways, endocytosis, and central carbon 
metabolism in cancer. 
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Manuscript supplementary material 
The contents of each supplementary file are the following: 
Supplementary_file_1.txt: Output file ('Hits.txt') of the Small RNA analysis workflow of 
the MiSeq instrument corresponding to the first sequencing run. The file presents the 
number of miRNA hits in each library according to miRBase version 20 database. The 
correspondence between the libraries and column labels is the following: 
S1: non-exposed cells 
S2: MWCNT-7-exposed cells 
S3: crocidolite-exposed cells 
S7: human brain total RNA (control) 
Supplementary_file_2.txt: Output file ('Hits.txt') of the Small RNA analysis workflow of 
the MiSeq instrument corresponding to the second sequencing run. The file presents 
the number of miRNA hits in each library according to miRBase version 20 database. 
The correspondence between the libraries and column labels is the following: 
S1: non-exposed cells 
S2: MWCNT-7-exposed cells 
S3: crocidolite-exposed cells 
Supplementary_file_3.csv: Matrix containing the replicate counts corresponding to the 
non-exposed and MWCNT-7-exposed cells after filtering. The correspondence 
between the libraries and column labels is the following: 
Exp1_0_1d_A: non-exposed cells (first run) 
Exp1_0_1d_B: non-exposed cells (second run)  
Exp1_CNT_1d_A: MWCNT-7-exposed cells (first run) 
Exp1_CNT_1d_B: MWCNT-7-exposed cells (second run) 
Supplementary_file_4.csv: Matrix containing the replicate counts corresponding to the 
non-exposed and crocidolite-exposed cells after filtering. The correspondence between 
the libraries and column labels is the following: 
Exp1_0_1d_A: non-exposed cells (first run) 
Exp1_0_1d_B: non-exposed cells (second run)  
Exp1_ASB_1d_A: crocidolite-exposed cells (first run) 
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Exp1_ASB_1d_B: crocidolite-exposed cells (second run) 
Supplementary_file_5.doc: Template R script used for the analysis of differential 
expression of miRNAs between non-exposed cells and cells exposed to MWCNT-7 or 
crocidolite in DESeq2. The 'filtered.csv' file corresponds to the filtered counts file and 
the 'conditions.csv' file was used as the design file for the analysis. A 'conditions.csv' 
design file for the comparison between non-exposed and MWCNT-7-exposed cells was 
constructed. 
Supplementary_file_6.csv: Normalized counts file corresponding to the non-exposed 
and MWCNT-7-exposed cells. The correspondence between the libraries and column 
labels is the same as in 'supplementary_file_3.csv'. 
Supplementary_file_7.csv: Normalized counts file corresponding to the non-exposed 
and crocidolite-exposed cells. The correspondence between the libraries and column 
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Nanotechnologies have a great potential for advancing society, as nanomaterials 
applications expand throughout hundreds of consumers products, ranging from 
industrial to biomedical purposes. However, assessing their safety should keep pace 
with their development, to the best use of their benefits without the costs of their 
potential human adverse effects. This responsible development and innovation of 
nanotechnologies includes research efforts to predict the possible occupational health 
hazards that can result from workers’ exposure to these new materials, in order to 
prevent occupational diseases, particularly, on the long term. In this context, apart from 
the exposure evaluation, in vitro toxicological studies to assess their potential hazard 
are crucial to contribute for the risk assessment framework. Nowadays, although there 
are some data about MWCNT pulmonary effects, the mechanisms undelying those 
effects are still under debate. As to CNF, this data is still missing due to its more recent 
applications.  
In this study, the toxicity of two nanofibres, MWCNT-7 (Mitsui-7) and a CNF produced 
by TEMPO-mediated oxidation of an industrial bleached Eucalyptus globulus kraft pulp, 
was characterized, and insigts on the Mitsui-7 mechanism of action were obtained. For 
this purpose, several in vitro complementary approaches were used, encompassing a 
wide spectrum of methodologies from well-established cytotoxicity and genotoxicity 
assays to a forefront epigenotoxic approach using high throughput sequencing 
technology. Moreover, a co-culture of A549 epithelial alveolar cells with THP-1 
macrophages was implemented, in an attempt to better resemble the in vivo situation, 
since macrophages have an important role in the alveoli defence against biopersistent 
particles. Crocidolite was used as a positive control material, due to its similarity with 
nanofibres, particularly, its shape and high biopersistence, and the well-known 
professional diseases induced in exposed workers, namely, asbestosis, mesothelioma 
and lung cancer.  
Overall, the present findings demonstrate that the tested CNF stimulate alveolar cell 
proliferation at low concentrations, whereas higher concentrations are moderately toxic. 
Although no relevant DNA damage was detected in these epithelial cells by the comet 
assay, the formation of micronuclei was observed at low CNF concentrations, which 
are the ones more realistic and relevant for human exposure in occupational settings. 
Moreover, no immunotoxic effects were detected.  
MWCNT-7 (Mitsui-7) is cytotoxic and genotoxic to alveolar cells. Moreover, the 
comparison of results obtained for MWCNT-7 and crocidolite toxicities using a 
conventional A549 cell culture and a co-culture with macrophages evidenced some 
dissimilarities in toxicity between both in vitro models that were further explored. An 
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important one is that, after exposure to each of the materials, A549 cells in co-culture 
exhibit a higher survival ability than in monoculture. This may happen because THP-1 
macrophages induce epithelial to mesenchymal transition in A549 cells, with 
mesenchymal cells being more resistant to cell death. Such transformation may result 
in the enrichment of DNA damaged cells, explaining the induction of micronuclei by 
both materials observed exclusively in co-cultured alveolar cells. Remarkably, a single 
MWCNT-7 concentration induced a high frequency of nucleoplasmic bridges in 
monocultured A549 cells, probably through a direct interference of the rigid nanofibres 
with chromatin or cytoskeletal filaments during mitosis. 
In addition, a unique set of DE miRNAs was identified in response to A549 cells 
exposure to a MWCNT-7 dose that has been considered occupationally relevant. 
These DE miRNAs indicate some of the molecular mechanisms of action of this 
nanomaterial through the analysis of the cellular pathways that were enriched in genes 
regulated by these miRNA.  Furthermore, their comparison with crocidolite DE miRNAs 
shows that each material can affect different cellular functional pathways, e.g., the 
mTOR or the ubiquitin-mediated proteolysis pathways, but they also share high 
similarity in respect to the deregulation of cell survival, differentiation and proliferation, 
namely, through the AMPK, FoxO, TGF-β and Hippo pathways. Additionally, the 
potential carcinogenic effects of MWCNT-7 were highlighted not only by its similarity 
with crocidolite, but also by the creation of a well-linked network of genes related to 
cancer that are up- or down-regulated by the DE miRNAs in alveolar cells. 
Overall, this research contributed to the risk assessment of nanofibres to which man is, 
or will likely be, exposed in environmental, including occupational, settings. In addition, 
a miRNA signature of the MWCNT-7 exposure was identified in alveolar cells, which 
may be further explored as a future molecular biomarker for monitoring occupational 
exposure toi this nanofibre. Furthermore, some molecular and cellular mechanism 
underlying the toxicity of MWCNT-7 were investigated in comparison to those of 
crocidolite, pointing to a similar outcome, i.e., lung disease. Ultimately, these findings 
are expected to contribute to healthy and safer workplaces, by excluding or reducing 
the handling of hazardous nanomaterials in the workplace and supporting the 
implementation of regulation to protect workers health.   
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7. Future Perspectives 
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Nowadays, there are still several scientific knowledge gaps concerning the health 
protection of workers that may be exposed to nanofibres and subjected to its resulting 
potential health adverse effects. An increased understanding of the hazard of these 
nanomaterials, such as MWCNT-7 and CNF, is needed to develop effective risk 
management practices. Although the potential toxicity of these two nanofibres has 
been demonstrated in this work, and a miRNA profile suggested as a possible 
biomarker of occupational exposure, several aspects should be further developed in 
order to translate research into practice and fill those gaps.  
The DE miRNA here identified should be confirmed using a different methodology, e.g., 
reverse transcription – quantitative polymerase chain reaction (RT-qPCR). Moreover, it 
would be important to experimentally test if the cellular functional pathways, identified 
by bioinformatics tools as being enriched in genes regulated by these DE miRNAs, are 
effectively being activated or repressed in cells exposed to MWCNT-7 or crocidolite. 
For that purpose, additional studies of gene expression should be performed. On the 
other hand, key events of these materials mode of action were identified and can be 
further explored from a mechanistic point of view.  
Furthermore, following in vitro studies, the miRNA expression should be investigated in 
vivo, in order to identify the ones that are concominantly differentially expressed as 
cell-free circulating miRNAs. If some or all of these miRNAs are simultaneously altered 
in blood circulation, then they could effectively be useful in the biomonitoring of human 
respiratory exposure to MWCNT-7, crocidolite or, possibly, other nanofibres. 
Noteworthy, all technical procedures for miRNA analysis are now implemented in the 
Department of Human Genetics of the National Institute of Health Doutor Ricardo 
Jorge, allowing their application to a multitude of new epigenomic and toxicological 
reseach. Several different nanomaterials, as well as other chemicals, can be tested 
through the exposure of target cells to the agent under study, miRNA extraction of 
these cells, next-generation sequencing and bioinformatics analysis of the DE miRNAs 
and functional pathway enrichment analysis. With this technological improvement, it is 
expected to deepen the study of the toxicological adverse effects of nanomaterials and 
contribute to the implementation of preventive strategies of human exposure to their 
hazards. 
Ultimatly, the data here presented can be one more contribution to develop 
recommendations for the manufacturing and handling of these nanofibres from a health 
and safety perspective, and to integrate more knowledge into regulatory frameworks of 
Occupational Health and Safety. 
